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''Models: All are wrong. Some are useful. " 
George Box 
''It is a capital mistake to theorize in advance of the facts." 
Sherlock Holmes 
The Adventure of the Second Stain 
... thought Alice, and she went on, "Would you tell me, please, which way I ought to wa1k 
from here?" 
''That depends a good deal on where you want to get to," said the Cat. 
Alice's Adventures in Wonderland 
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ABSTRACT: THE FUMONISIN Bl-FED RAT AS A MODEL FOR LIVER INJURY, 
OVAL ('PROGENITOR') CELL PROLIFERATION, AND CARCINOGENESIS 
Eric R. Lemmer. MRCIUCT Liver Research Centre and Department of Medicine, 
University of Cape Town, South Africa 
9 
Fumonisin B 1 (FB 1) is a carcinogenic mycotoxin produced by the fimgus Fusarium moniliforme in 
maize, and is hepatotoxic and hepatocarcinogenic in rats. The goal of this dissertation was to 
characterise the FBI-fed rat as a model for liver injury and carcinogenesis, and to examine the role 
of oval ('progenitor') cells during these processes. Male Fischer 344 rats were fed FBI 250 
mglkg diet for five weeks, and this basic feeding regimen was modified in individual experiments. 
Short-term feeding of FBI caused a severe 'toxic' hepatitis, apoptosis and regeneration of 
hepatocytes, fibrosis, proliferation of OV -6 positive oval cells, and formation of GS T pi positive 
hepatic foci and nodules. Oval cells were noted inside some of the hepatic nodules. There were 
marked increases in the expression of mRNA transcripts for mature TGF-~ 1 and c-myc in livers 
of FBI-fed animals. The overexpression ofTGF-~1 by hepatocytes may be responsible for the 
prominent apoptosis and fibrosis seen with liver injury due to FBI. Increased expression of c-myc 
and TGF-~l may cooperate during FBI-induced promotion of liver tumours, pOSSloly by 
providing an environment that selects for the growth ofTGF-~l-resistant transformed liver cells. 
In rats given FB 1 in the presence of dietary iron overload, FB 1 augmented iron-induced lipid 
peroxidation in the liver. However, dietary iron loading appeared to protect against the cancer-
promoting properties ofFBt, posSloly due to a stimulatory effect on hepatocyte regeneration. 
Long-term feeding of FBI caused fibrosis and regenerative nodules, dysplastic hepatic nodules, 
cholangiofibrotic lesions, intraductal cholangiocarcinomas, and a hepatocellular carcinoma. 
2-Acetylaminofluorene enhanced the effects of FBI in the liver, presumably by bloclting 
hepatocyte regeneration in response to FBI toxicity. Proliferating oval cells were found 
inside/adjacent to GST pi positive lesions, dysplastic nodules, and cholangiofibrotic lesions, 
suggesting that oval cells may be involved in FBI-induced hepato- and cholangiocarcinogenesis in 
the liver. Furthermore, the OV-6 antigen was expressed by proliferating oval cells and bile 
ductules, hepatic nodules, cholangiofibrotic lesions, and cystic lesions, indicating that all of these 
cells may have a common ('stem') cell of origin. In conclusion, the FBI-fed rat is a promising 
model for the study of liver injury, oval ('progenitor') cell proliferation, and carcinogenesis. 
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SUMMARY OF FUMONISIN B.-FEEDING 
STUDIES IN RATS 
Animals and diet 
10 
In all the feeding studies, male Fischer 344 rats (weight approximately 150 to 200 g) were given 
FBI 250 mglkg diet for five weeks, a dose known to cause severe hepatotoxicity and the 
generation of 'preneoplastic' liver lesions, and this basic feeding regimen was modified in 
individual experiments. FBI was mixed into American Institute of Nutrition (AIN)-76A control 
diet for all the experiments (see Appendix C). 
5-Week FBI Feeding Study: Liver Pathology 
In order to study the histopathology in the rat liver during short-term treatment with FBI, rats 
were fed either FBI 250 mglkg or control diet for 5 weeks. FBI caused a predominantly zone 3 
'toxic' liver injury, with hepatocyte death due to apoptosis. Hepatocyte injury and death were 
mirrored by hepatic stellate cell proliferation and marked fibrosis, with progressive disturbance of 
architecture and formation of regenerative nodules. Despite ongoing hepatocyte mitotic activity, 
oval cell proliferation was noted from week 2, glutathione S-transferase (GST) pi positive hepatic 
foci and nodules developed and, at later time points, oval cells were noted inside some of the 
'atypical' nodules. 
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5-Week FBI Feeding Study: Molecular Mechanisms 
There is currently no information on the molecular mechanisms underlying the pathological 
changes in the liver caused by FBI. Northern blot (mRNA) analysis was performed on timed rat 
liver specimens during feeding of FBI 250 mglkg for 5 weeks, in order to examine the changes in 
hepatic gene expression. Changes in gene expression were correlated with the liver 
histopathology, and immunolocalization of mature transforming growth factor (TGF)-131 protein 
was performed using LC(I-30) antibody. There was progressive increase in hepatic gene 
expression for a-fetoprotein (AFP), hepatocyte growth factor (HGF), TGF-a ,and especially 
TGF-131 and c-myc during week 3 to 5 offeeding. Immunostaining with LC(1-30) antibody 
demonstrated a progressive increase in expression of mature TGF-131 protein by zone 1 and 2 
hepatocytes over the 5 week feeding period. The overexpression of TGF-131 by hepatocytes may' 
be causally related to the prominent apoptosis and fibrosis seen with liver injury due to FBI. 
Increased expression of c-myc and TGF-131 may cooperate in the promotion of liver tumour 
development in the FBI-fed rat, possibly by providing a milieu that selects for the growth ofTGF-
131-resistant transformed oval cells. 
5-Week FBI Feeding Study: Effects of Dietary Iron Overload 
In order to determine whether excess hepatic iron modulates the cancer initiating and promoting 
properties of FBI, thirty eight male F344 rats were divided into four dietary treatment groups: (i) 
control diet (AIN, n = 8); (ii) FBI 250 mglkg diet (FBI, n = 10); (iii) I - 2% carbonyl iron (CI, n = 
10); or (iv) FBI plus iron loading (FBdCI, n =10) for 5 weeks. Hepatic iron concentrations 
(Ilmol/g dry weight) in iron-loaded animals at five weeks were 444 ± 56 (CI) and 479 ± 80 
(FBI/CI) (mean ± SEM). All the FBI-fed rats, in the presence or absence ofCI, developed a toxic 
hepatitis with a fourfold rise in serum alanine transaminase (ALT) levels. FBI appeared to 
augment iron-induced hepatic lipid peroxidation, as measured by the generation ofthiobarbituric 
acid reacting substances (TBARS) in liver homogenates (p<0.0001). Morphometric analysis 
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showed that FBI caused a significantly greater mean ± SEM number ofGST pi positive foci and 
nodules per cm2 (5.34 ± 1.42 vs. 1.50 ± 0.52, P < 0.05), as well as a greater area (%) of liver 
occupied by foci and nodules (0.33 ± 0.12% vs. 0.05 ± 0.03%, P < 0.001), compared with 
FBdCI. The addition of FBI to dietary iron loading caused a shift in distribution of iron from 
hepatocytes to Kupffer cells, probably due to phagocytosis of necrotic iron-loaded hepatocytes. 
In conclusion, (i) FB 1 appears to cause toxicity in the liver independently from effects on lipid 
peroxidation; (ii) FBI has a potentiating effect on iron-induced lipid peroxidation; and (iii) dietary 
iron loading appears to protect against the cancer promoting properties of FBI, possibly due to a 
stimulatory effect of iron on hepatocyte regeneration. 
25-Week Onl25-Week Off FBI Feeding Study: Long-Term Effects 
In order to determine the long-term effects of FBI feeding on rat liver, 54 male F344 rats were 
allocated to the following treatment groups: (1) FB I 250 mglkg for 5 weeks then FB I 100 mglkg 
to 25 weeks (n=12); (2) FBI 250 mglkg for 5 weeks then control diet to 25 weeks (n=12); (3) 
FBI 250 mg/kg for 5/52 then two weeks of 0.02% acetylaminofluorene (AAF), followed by 100 
mglkg of FBI to 25 weeks (n=12); (4) FBI 250 mglkg for 5/52 then 0.02% AAF for 2 weeks then 
control diet till 25 weeks (n=12); (5) control diet (AIN-76A) for 25 weeks (n=6). Rats of all 
groups were subsequently returned to control diet for a further 25 weeks ('stop study'). Rats 
from each group were biopsied serially at intervals throughout the study (biopsy results not 
presented here). Surviving animals were sacrificed at 50 weeks. Post mortem data are given for 
rats culled at the end of the study and within 6 weeks of the sacrifice date. Liver sections were 
scored 1 - 4 for the amount of oval cell proliferation. The percentage area of hepatocyte nodules 
(0 = 0%, 1 = 1 - 25%, 2 = 26 - 50%,3 = 51 - 75%, 4 = 76 - 100%) was scored and the number of 
rats with cholangiofibromas (CF) were also counted. Results of post mortem liver data are 
presented in TABLE I below: 
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TABLE I. Post mortem liver findings in the different treatment groups in the 25-week onl25-
week off FBI feeding studya. 
Treatment 
group 
FBIIFBI 
FBI/AIN 
FBdAAFlFB1 
FBdAAF/AIN 
AIN 
No. of rats Oval cellsb 
per group (mean 
score) 
6 2.17 
6 1.17 
10 2.60 
10 2.10 
5 0 
Nodules 
(mean 
score) 
1.17c 
0.50 
1.40 
0.50 
0 
Nodule 
score 
(range) 
(0 - 4) 
(0 - 2) 
(0 - 2) 
(0 - 1) 
(0 - 0) 
No. of rats 
with CF 
1 
0 
7 
4 
0 
apost mortem data are given for rats culled at the end of the study and within 6 weeks of the 
sacrifice date. 
bOval cells were identified within nodules. 
cOne animal in this group had a trabecular hepatocellular carcinoma 
Thus, (i) dietary FB I in the long term resulted in oval cell proliferation with formation of 
persistent hepatic nodules and a hepatocellular carcinoma; (ii) cholangiofibromas were also 
introduced by FBI in some rats; (iii) addition of AAF enhanced the effects of FBI feeding, 
probably by inhibiting hepatocyte regeneration in response to FBI toxicity; and (iv) this study 
supports the involvement of dietary FBI in liver carcinogenesis in male F344 rats. 
13 
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Chapter 1 
Introduction and aims 
1.1. Liver stem cells 
21 
My interest in liver stem cells was first stimulated by an immunohistochemical study from the 
MRC/uCT Liver Research Centre at the University of Cape Town, which showed that in 
developing human liver the haematopoietic stem cell markers CD34 and c-kit are co-expressed 
in ductal plate cells in a pattern similar to early cytokeratin markers CAM 5.2 and CK18 
(Blakolmer et at., 1995). Results from this and other studies suggested that similarities might 
exist between hepatic and bile duct precursors and bone marrow stem cells, with respect to the 
expression of prototypic early cellular markers. My initial 'stem cell' project was to develop a 
method for the isolation ofhepatic 'progenitor' cells from normal human fetal liver (see 
Appendix D). The identification of ductal plate cells as likely progenitors for both bile duct 
epithelial cells and hepatocytes and their possible reappearance in the regenerating liver have 
generated much interest in their pluripotential capacities. The intention was to perform further 
studies on the 'progenitor' cells that were isolated from human fetal liver, to determine the 
growth and differentiation capacity of these cells. However, progress was hampered by a 
severe shortage of supply of 'normal' livers from human fetuses of appropriate gestational age. 
It was thus decided to look for a suitable animal model for further studies on the role of 
progenitor cells in the liver. 
1.2. The fumonisin Bl-fed rat 
There is a long history of research on the toxicology and carcinogenic effects of the mycotoxin 
fumonisin BI (FBI) at the Programme on Mycotoxins and Experimental Carcinogenesis 
(PROMEC), a division of the South African Medical Research Council (MRC). The 
fumonisin B mycotoxins are natural contaminants of maize infected with the fungus Fusarium 
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moniliforme. Ingestion ofFBl, the major fumonisin produced by the fungus, causes a variety 
of naturally occurring toxicoses in domestic animals. Human dietary consumption of 
Fusarium-contaminated maize products has been linked epidemiologically to increased rates of 
oesophageal cancer in regions of the world in which maize is the staple grain. In rats, feeding 
with FBI causes severe hepatotoxicity, chronic liver injury progressing to cirrhosis, and 
sometimes hepatocellular carcinoma or cholangiocarcinoma. To date, however, there have 
been no studies on the role of 'oval cells', putative liver progenitor cells, during the events that 
occur in rat liver during feeding with FB 1. 
The FBI-fed rat seemed to hold promise as a model for the study of liver injury, oval 
('progenitor') cell proliferation, and carcinogenesis for several reasons: (i) this animal model 
for hepatocarcinogenesis appears to resemble the scenario in humans, where hepatocellular 
carcinoma usually occurs in the setting of chronic necrointlammatory liver disease and 
cirrhosis; (ii) the ''bile duct hyperplasia" that has been reported during FBI-induced 
hepatotoxicity may in fact represent the proliferation of oval cells; (iii) FBI causes both 
hepatocellular carcinoma and cholangiocarcinoma in rats, indirect evidence for a stem cell 
origin of liver tumours; and (iv) it is possible that ingestion of FBI might be a risk factor for 
human hepatocellular carcinoma in regions of the world where maize is the staple diet. 
1.3. Hypothesis and aims 
The hypothesis of this dissertation was thatfeeding with FBI causes proliferation of oval cells 
in rat liver, and that these putative progenitor cells are the precursors of both the 
hepatocellular and bile duct tumours that are seen in this animal model of carcinogenesis. 
The specific aims were to: (i) describe the histopathology of acute hepatotoxicity due to FBI 
and the role of oval cell proliferation; (ii) study the changes in hepatic gene expression during 
acute FBI-induced hepatotoxicity and oval cell activation; (iii) assess the effect of oxidative 
stress due to dietary iron loading on FBI-induced cancer induction; and (iv) study the hepatic 
effects oflong-term FBI feeding and the role of oval ('progenitor') cells in the development of 
hepatocellular and bile duct tumours. 
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Chapter 2 
The fumonisin mycotoxins 
2.1. Introduction 
The fumonisins are natural contaminants of maize (Zea mays L) infected with the fungus 
Fusarium moniliforme Sheldon (Gelderblom et al., 1988a; Sydenham et al., 1990a). These 
food-borne carcinogenic mycotoxins became the spotlight of mycotoxin research in 1988, 
when researchers at the South African Medical Research Council isolated and structurally 
characterised the fumonisins (Gelderblom et al., 1988a; Bezuidenhout et al., 1988). Since 
1988, there has been intense interest in these mycotoxins, mainly by toxicologists, maize 
producers, commodity groups, food processors and regulatory agencies (Riley et al., 1993; 
Norred, 1993; Voss et al., 1995). The reason for the concern regarding the fumonisin 
mycotoxins is threefold: (i) fumonisins are found in measurable concentrations in maize grown 
throughout the world (Thiel et al., 1991a; Sydenham et al., 1991; Sydenham et al., 1992a; 
Ueno et al., 1993 Murphy et al., 1993; Chamberlain et al., 1993); (ii) these compounds have 
been implicated as the causative ag nts in a variety of naturally occurring animal diseases, 
including fatal illnesses in horses (Marasas et al., 1988b; Kellerman et al., 1990) and pigs 
(Harrison et al., 1990; Colvin et al., 1993); and (iii) there is speculation that fumonisin may in 
part be responsible for the high incidence of oesophageal cancer in regions of the world in 
which maize is the staple grain (Marasas, 1994; Chu and Li, 1994). Because of these factors, 
there is little doubt that these mycotoxins will continue to have a significant, adverse impact on 
the maize industry, including export markets. 
In rats, feeding with fumonisins causes liver and kidney toxicity (Gelderblom et al. 
1988a; Voss et al. 1993; Voss et al., 1994; Bondy et al. 1996; Bucci et al., 1998), as well as 
liver tumours (Gelderblom et al., 1991). Fumonisin-fed rats develop a chronic toxic hepatitis, 
cirrhosis, cholangiofibrosis, hepatocellular carcinoma and cholangiocarcinoma (Gelderblom et 
al., 1988a; Gelderblom et al., 1991; Voss et al. 1993;). These carcinogenic mycotoxins are 
nongenotoxic, and act as strong promoters (and possl.bly weak initiators) of tumours 
(Gelderblom et aI, 1991; Gelderblom et aI, 1992b; Norred et al., 1992). 
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Fumonisins are sphinganine analogues that inhibit ceramide synthase and block the 
biosynthesis of complex sphingolipids, promoting accumulation of sphinganine and 
sphinganine I-phosphate (Wang et al., 1991; Yoo et al., 1992; Norred et al., 1992b). 
Disruption of sphingolipid metabolism by FBI alters cell-cell interactions, the behaviour of 
cell-surface proteins, the activity of protein kinases, the metabolism of other lipids, and cell 
growth and viability (Merrill et al., 1996). This multitude of effects may account for the 
toxicity and carcinogenicity of these mycotoxins. Naturally occurring inhibitors of 
sphingolipid metabolism such as fumonisins are proving to be powerful tools for studying the 
diverse roles of sphingolipids in cell regulation and disease (Merrill et al., 1996). 
Ceramide, a recently identified lipid second messenger (Spiegel et al., 1996; Hannun, 
1996), has been implicated in the induction of apoptosis in tumour cells (Bose et al., 1995; 
Jaffrezou et al., 1996) and the ovary (Witty et al., 1996; Kaipia et al., 1996; Martimbeau and 
Tilly, 1997). Manipulation of apoptosis-associated ceramide signalling pathways with agents 
such as fumonisin B I and sphingosine-I-phosphate has most recently been attempted in order 
to prevent chemotherapy-induced destruction of oocytes and resultant permanent female 
sterility (Perez et al., 1997) 
2.2. Isolation and chemical characterisation 
The fumonisins (diesters ofpropane-l,2,3-tricarboxylic acid and 2-amino-12,16-polyhydroxy-
icosanes) were first isolated in 1988 from cultures ofF. moniliforme strain MRC 826, known 
to be hepatocarcinogenic in rats (Gelderblom et al., 1988a), and the structures were 
subsequently elucidated (Bezuidenhout et ai, 1988). Six fumonisins have been isolated to date 
and characterised (Cawood et al., 1991; Gelderblom et al., 1992a). Three of these, fumonisin 
BI (FBI), fumonisin B2 (FB2), and fumonisin B3 (FB3) are the major fumonisins produced in 
nature, while fumonisin B4 (FB4) and fumonisins Al and A2 (FAI and FA2 respectively) are 
produced in relatively minor quantities. The chemical structures of the three major fumonisins 
(FB 1, FB2, and FB3) are shown in Figure 2.1. 
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FB : R = OH' R = OH 1 1 '2 
FB : R = H; R = OH 2 1 2 
FB : R = OH' R = H 
3 1 '2 
Figure 2.1. Structure of the three major fumonisins (FBI, fumonisin BI; FB2, fumonisin B2; 
FB3, fumonisin B3). 
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The most important producer offumonisins is F. moniliforme (Gelderblom et al., 1988a, 
Gelderblom et al. 1988b; Thiel et al., 1991a; Thiel et al., 1991b; Ross et al., 1990), and most 
isolates ofF. moniliforme from maize analysed to date have been found to produce 
fumonisins. Other Fusarium species that produce FBI and FB2 are F. proliftratum (Thielet 
al., 1991a; Ross et al., 1990) and F. nygamai (Thiel et al., 1991a). 
A variety of analytical methods have been used by different laboratories for the 
quantification of naturally occurring levels offumonisins. These include liquid 
chromatography (Bennett and Richard, 1994), gas chromatography (GC) (Jackson and 
Bennett, 1990; Sydenham et al., 1990a), thin layer chromatography (TLC) (Gelderblom et al., 
1988a; Jackson and Bennett, 1990; Sydenham et al., 1990a; Wilson et aI., 1990), liquid 
secondary ion mass spectroscopy (LSIMS) (Bezuidenhout et al., 1988; Platttner et al., 1990; 
Voss et al., 1989), high performance liquid chromatography (HPLC) (Alberts et al., 1990; 
Gelderblom et al., 1988a; Shephard et al., 1990; Sydenham et al., 1990a; Sydenham et al., 
1992b; Wilson et al., 1990), and gas chromatography-mass spectrosopy (GC-MS) (Jackson 
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and Bennett, 1990; Plattner et al., 1990; Voss et al., 1989; Wilson et al., 1990). The HPLC 
method of Shephard et al. (Shephard et al., 1990) as modified by Sydenham et al. (Sydenham 
et al., 1992b) is currently recommended by the South African Programme on Mycotoxins and 
Experimental Carcinogenesis (PROMEC) for the quantitative analysis of fumonisins in maize.. 
based foods and feeds (Marasas, 1994). This analysis involves fluorescence detection of the 
o-phthaldialdehyde (OPA) derivatives of FBI and FB2 (Shephard et al., 1990; Sydenham et al., 
1992b). All of the available analytical methods are laborious and require extensive extraction, 
clean-up and derivatisation procedures. Currently, immunoassays are being developed as an 
ahemative rapid, reliable, and relatively inexpensive method for the detection of fumonisins in 
food and feed samples (Abouzied et al., 1996; Ueno et al., 1997). 
2.3. Toxicity in domestic animals 
Ingestion of Fusarium-contaminated maize causes a variety of toxic effects in domestic 
animals. Equine leukoencephalomalacia or ')nouldy com poisoning" is a syndrome of acute 
illness and death in horses (Kellerman et al., 1972) that can be reproduced by feeding animals 
with FBI (Marasas et al., 1988b; Kellerman et al., 1990; Ross et al., 1990, Wilson et al., 
1990). Clinical features include incoordination, aimless wallcing, blindness and head pressing 
(Marasas et al., 1976; Kriek et al., 198Ia). Necropsy characteristically reveals liquefactive 
necrotic lesions in the white matter of the cerebral hemispheres (Marasas et al., 1976). FBI is 
also responsible for natural outbreaks ofporcine pulmonary oedema (Harrison et al., 1990; 
Ross et al., 1990), a syndrome of pulmonary oedema and pleural effusions in pigs associated 
pathologically with evidence of damage to the pulmonary microvasculature (Casteel et al., 
1994). Contamination of the 1989 US maize crop by F. moniliforme caused widespread 
outbreaks of equine leukoencephalomalacia and porcine pulmonary oedema in the USA during 
the autumn of 1989 and winter of 1990 (Harrison et al., 1990; Ross et al., 1990; Wilson et al., 
1990). In early 1995, an outbreak of equine leukoencephalomalacia killed at least 38 horses in 
Kentucky and Virginia, and fumonisin was identified in the maize-based feed the horses had 
consumed (House, 1995). FBI has also been shown to cause toxicoses in cattle, sheep, 
chickens, turkeys and ducks in controlled studies (Miller et al., 1996). While the acute 
toxicity of FBI has been described in several species, the chronic effects oflower doses on 
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animal health and loss of productivity are less well defined. 
2.4. Oesophageal carcinoma in humans 
The geographical distribution of oesophageal carcinoma is enigmatic because the disease 
occurs world-wide with a marked variation in incidence, even within relatively small 
geographical areas (Rose, 1973; Liu and Li, 1984). In particular, extremely high incidence 
rates of oesophageal carcinoma of more than 50 per 100000 population per annum have been 
recorded in three areas of the world: the south-western districts of Transkei in South Africa 
(Rose, 1973; Jaskiewicz et al., 1987a), the Linxian County of Henan Province in northern 
China (Liu and Li, 1984; Li et al., 1980; Yang, 1980), and the Caspian littoral of Iran (Kmet 
and Mahboubi, 1972; Hormozdiari et al., 1975). This marked geographical variation in 
incidence rates suggest that environmental factors are involved in the aetiology of oesophageal 
carcinoma. In the high-risk population in Transkei, the coexistence of deficiencies in vitamin 
A, vitamin Bl2, vitamin E, and folic acid (Van HeIden et al., 1987; Jaskiewicz et aI., 1988a) 
and selenium (Jaskiewicz et al., 1988b) with exposure to fumonisins in the maize staple diet 
(Sydenham et al. 1990b) is well established. The consumption ofmaize as a dietary staple 
and/or as a home-brewed alcoholic beverage has been implicated as a risk factor of 
oesophageal carcinoma in Africa (Van Rensburg, 1981; Cook, 1971; Marasas, 1982; Marasas 
et al., 1988a), China (Li et aI., 1980; Yang, 1980; Zhen, 1984), Italy (Rossi et al., 1982; 
Franceschi et al., 1990), and the United States (Brown et al., 1988). 
The incidence rate of oesophageal carcinoma in males as well as females in the 
southern part of Transkei is among the highest in the world, whereas the rate in the northern 
part ofTranskei is moderate to low (Jaskiewicz, 1987a). The staple diet in both areas is 
home-grown maize. Detailed mycological analyses of home-grown maize samples intended 
for human consumption from different oesophageal carcinoma rate areas in Transkei during six 
seasons over the period 1976 - 1989 revealed a statistically significant correlation between the 
incidence ofF. moniliforme in maize and oesophageal carcinoma rate (Rheeder et al., 1992; 
Marasas et al., 1981; Marasas et al., 1988a). In these studies, the correlation between F. 
moniliforme and oesophageal carcinoma rate was based on death certificate cancer registry 
data. The correlation also was shown to exist between F. moniliforme contamination of maize 
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and premalignant oesophageal brush cytological changes in living individuals (Marasas et al., 
1988a). 
In the high-incidence area of oesophageal carcinoma in northern China, an association 
between F. moniliforme contamination of maize and the incidence of oesophageal carcinoma 
also has been found (Li and Cheng, 1984; Li et ai, 1980; Yang, 1980). The natural 
occurrence of fumonisins in maize used as the staple diet by people at high risk for 
oesophageal carcinoma in Linxian County in northern China has recently been reported (Chu 
and Li, 1994). The association between the incidence ofF. moniliforme in maize and the 
oesophageal carcinoma rate that has been established in Transkei and China does not exist in 
the high-incidence area of Iran, in which the staple diet is wheat, and the most prevalent 
fungus associated with wheat is Alternaria altemata (Fr.) Keissler (Kmet and Maboubi, 1972; 
Hormozdiari et al., 1975; Van Rensburg, 1981). Thus, it seems that if the fumonisins 
produced in maize by F. monoliforme are foodborne carcinogens involved in the aetiology of 
oesophageal carcinoma in Transkei and China, other factors must be involved in Iran. 
Interestingly, the carcinogenic fumonisins produced by F. moniliforme are structurally very 
similar to the Alternaria (AAL) toxins, a group ofhost-specific phytotoxins produced by A. 
alternate f sp. Iycopersici (Bezuidenhout, 1988). Preliminary reports suggest that FBI and 
AAL toxin have similar biological effects on plants (Mirocha et al., 1990) and cultured 
mammalian cells (Shier et al., 1991). The examination of wheat from the high-incidence area 
of oesophageal carcinoma in Iran for A. altemata metabolites related to fumonisins and AAL 
toxins is clearly indicated. 
2.5. Toxicity and tumours in rats 
Both culture material ofF. moniliforme and the fumonisins are hepatotoxic (Gelderblom et. 
al., 1988a; Voss et al., 1993) and hepatocarcinogenic (Marasas et al., 1984a; Wilson et al., 
1985; Jaskiewicz et al., 1987b; Gelderblom et al., 1991) in rats. The principal pathological 
change in rats treated with FBI in the diet (1000 mg/kg) in short-term toxicity tests (21-33 
days) is progressive ''toxic hepatitis" characterised by hepatocellular necrosis, bile duct 
proliferation ("hyperplasia"), and fibrosis (Gelderblom et. al., 1988a), identical to that induced 
by the culture material ofF. moniliforme MRC 826 (Kriek et al., 1981 b). During a chronic 
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feeding study over a period of26 months with FBI 50 mg/kg and a modified diet, the liver was 
shown to be the major organ affected (Gelderblom et aI., 1991). Pathological changes in the 
liver were characterised by a "chronic toxic hepatitis" that progressed to cirrhosis and 
"cholangiofibrosis", and which terminated in hepatocellular carcinoma and 
cholangiocarcinoma respectively. Ten out of 15 FBI-treated rats (66%) developed 
hepatocellular carcinoma from 18 months onwards, and metastases to the lungs and kidneys 
were present in four of these rats. Although the cholangiofibrotic lesions were non-infiltrative 
and did not metastasize, some reached a very large diameter (up to 3 cm) and were considered 
to have progressed to cholangiocarcinoma (Gelderblom et al., 1991). In a preliminary study, 
Voss et al. (1993) reported that FBI was hepatotoxic in rats fed a diet containing 150 mg/kg 
for 4 weeks and also nephrotoxic at 15-50 mg/kg. Microscopic analysis of the livers revealed 
"scattered single cell necrosis", bile duct proliferation, and an increase in mitotic cells. The 
focal hepatocellular necrosis was subsequently confirmed as apoptosis, or programmed cell 
death (Tolleson et al., 1996a; Tolleson et al., 1996b). This is consistent with in vitro 
observations that FBI inhtl>its cell proliferation or induces apoptosis in cultured turkey 
lymphocytes (Dombrink-Kurtzman et al., 1994), cultured African green monkey kidney cells 
(Jones et al., 1995), and a renal epithelial cell line (Yoo et al., 1994; Yoo et al., 1995). The 
increase in mitotic cells noted in the hepatotoxicity studies with high dose FBI (Voss et al., 
1993; Tolleson et al., 1996b) was thought to reflect hepatocellular proliferation to replace the 
apoptotic cells. 
Cancer induction by FB I has been investigated by studying the mechanisms involved 
during cancer initiation and promotion in rat liver (Farber, 1984; Gelderblom et al., 1996b). 
FBI was shown to be a cancer promoter in a short-term initiation/promotion assay ~th 
diethylnitrosamine (DEN)-initiated rats and the induction ofy-glutamyl transpeptidase positive 
(GGT:+-) foci as endpoint (Gelderblom et al., 1988a). Although the role of cell proliferation in 
tumour promotion is controversial, many hepatocarcinogens are known to be inht"bitors of cell 
proliferation (Farber et al., 1989). FBI caused inhibition of regenerative hepatocyte 
proliferation eH-labelled thymidine incorporation) induced by partial hepatectomy (PH), when 
fed in the diet at a level of 50 mg/kg and higher for 21 days (Gelderblom et al. 1996b). FB I is 
also a cancer initiator, as evidenced by the induction of resistant hepatocytes in rat liver 
(Gelderblom et al., 1992b; Gelderblom et al., 1994). Although FBI is a complete carcinogen 
in rat liver, it is a poor cancer initiator, requiring prolonged exposure (21 days) to a relatively 
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high dietary level (250 mglkg) (Gelderblom et al., 1994). Thus a time and dosage dependent 
threshold level exists for cancer initiation by FBI (Gelderblom et al., 1994). At a dietary level 
of 1000 mg/kg for 21 days, only the FB fumonisins (FB 1, FB2 and FB3) initiated cancer in rat 
liver whereas the N-acetylated analogues FAI and FA2 and the hydrolysis products API, AP2 
and tricarballylic acid (TCA) did not (Gelderblom et al., 1993). Thus the free amino group 
and the intact molecule are required for cancer initiation. 
FBI is not mutagenic in the Salmonella mutagenicity test (Gelderblom and Snyman, 
1991; Park et al., 1992). Furthermore, FBI does not induce unscheduled DNA synthesis in 
isolated rat hepatocytes (Norred et al., 1991), and is not genotoxic in the in vivo and in vitro 
DNA repair assays in rat primary hepatocytes (Gelderblom et al., 1992a; Norred et al., 1992a; 
Norred et al., 1992b). This contrasts sharply with the carcinogenic effects of aflatoxin BI, the 
most intensively studied mycotoxin, which is a potent mutagen (see Appendix E). 
2.6. Effect on sphingolipid metabolism 
The fumonisins are structurally similar to the long chain base sphingosine, a component of the 
long chain backbone of sphingolipids (Bell et al., 1993). FBI and FB2 are naturally occurring 
specific inhibitors of de novo sphingolipid biosynthesis and sphingolipid turnover (Merrill et 
al., 1993b). The site of inhibition is at the formation of cerami des catalysed by sphingosine-
and sphinganine N-acetyl-transferase (ceramide synthase) (Wang et al., 1991). In primary rat 
hepatocytes this inhibition occurs at concentrations that are not toxic to the cells (ICso = 0.1 
J,tM) (Wang et al., 1991; Norred et al., 1992b). Similarly, FB I and FB2 inhibit de novo 
sphingosine biosynthesis (ICso = 10 - 15 J,tM) in a proliferating cell line of pig kidney cells 
(LLC-PKI) and cause a remarkable (128 fold) increase in ce11u1ar levels of sphinganine (Y 00 et 
al., 1992; Norred et al., 1992b). In these cells inhibition of sphingolipid biosynthesis is an 
early event in the toxicity of fumonisins, and precedes inhibition of cell proliferation and 
cytotoxicity. Inhibition of sphingolipid biosynthesis has also been observed in yeast cells 
(Kaneshiro et al., 1992). 
Inhibition of sphingolipid biosynthesis may be the primary effect of fumonisin toxicity 
in equine leukoencephalomalacia and porcine pulmonary oedema. It may also be responsible 
for the tumour-promoting ability of the fumonisins. In the latter, fumonisin-induced inhibition 
- ----------------------------------------------
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of sphingosine biosynthesis may lead to a deregulation of protein kinase C, which could lead 
to the proliferation of initiated cells (Norred et ai., 1992b). In addition, stimulation of DNA 
synthesis by FBI at concentrations of 10 J..lM to 100 J..LM in Swiss 3T3 fibroblasts was 
attnlmted to the mitogenic effect of the sphingoid bases that accumulated as a result of a 
disruption of sphingolipid metabolism (Schroeder et al., 1994). Conflicting results were 
however obtained from an in vitro DNA labelling study in primary hepatocyte cultures 
(Gelderblom et ai., 1995). FBI was found to inhibit the epidermal growth factor-induced 
DNA synthesis by up to 90% when incorporated at concentrations of 150 J..LM to 300 J..LM for a 
period of 44 h (Gelderblom et ai., 1995). In this study, no relationship was found between the 
disruption of sphingolipid biosynthesis by FBI and its mitoinhibitory effect or toxicity in 
primary hepatocytes. 
The ratio offree sphinganine to free"sphingosine (Sa/So ratio) in serum and tissues 
were found to increase when rats, ponies and pigs were exposed to fumonisins in their feed 
(Riley et ai., 1994b). In rats, ponies and pigs fed diets that contained 1 ppm offumonisins the 
ratio was < 0.35. Levels as low as 5 ppm in the feed of pigs cause statistically significant 
increases, so that this ratio has been suggested as a specific biomarker for fumonisin exposure 
(Rileyet ai, 1994b). Elevations in this ratio were seen before there was evidence of tissue 
damage as indicated by serum biochemical parameters or histopathology. 
Ceramide is a lipid second messenger that is believed to be one of the immediate 
signals for cell death generated in tumour cells treated with the chemotherapeutic agent, 
daunorubicin (Bose et ai., 1995; Jaffi:ezou et ai., 1996). Recent investigations have shown 
that the production of ceramide and the resultant apoptosis in P388 cells cultured in the " 
presence of daunorubicin, is prevented by pre-treatment with fumonisin BI (Bo~ et al. 1995). 
This inhibition of chemotherapy-induced apoptosis may relate to the result of specific 
inhibition of ceramide synthase by FB I (Wang et al., 1991). In contrast however, the lethality 
of doxorubicin in haploid mouse oocytes is blocked by pre-treatment with sphingosine 1-
phosphate, an endogenous downstream inhibitor of ceramide-promoted intracellular signalling, 
but not by FBI (Perez et ai., 1997). 
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2.7. Risk assessment 
The International Agency for Research on Cancer (IARC) recently evaluated the toxins 
derived from F. moniliforme as possibly carcinogenic to humans (Group 2B carcinogens) 
(IARC, 1993; Vainio et al. 1993). Risk assessment for humans exposed to carcinogenic 
mycotoxins consists of exposure assessment and hazard assessment (Kuiper-Goodman, 1990). 
Human exposure is calculated from estimates of the level of a mycotoxin in foodstuffs and 
food intake or from direct measurements on humans (Kuiper-Goodman, 1990), and expressed 
as probable daily intake (PDI). Based on the naturally occurring levels of total fumonisins in 
home-grown maize in Transkei and the assumption that a 70 kg person consumes 460 g maize 
per day, Thiel et al. (1992) calculated a PDI of 14 J.1g/kg/day for a person eating ''healthy'' 
maize and 440 J.1g/kg/day for a person eating ''mouldy'' maize. Hazard is an intrinsic property 
of a mycotoxin with reference to toxicological effects in a specific species at a specific level of 
exposure (Kuiper-Goodman, 1990). Hazard is calculated from toxicological studies in 
experimental animals and expressed as the no observed effect level (NOEL) and TD50 (dose 
rate at which 50% of animals develop cancer). Extrapolation is done by means of safety 
factors (NOEL: 100 - 1000 for toxins and 1000 - 5000 for carcinogens; TD50: 50000) to 
estimate the tolerable daily intake (TDI). TDI values have to be calculated with respect to 
carcinogenic risk to humans offumonisins in maize and maize-based foods in order to establish 
tolerance levels. The mechanism of carcinogenicity ofthe fumonisins is important in 
determining the safety factor calculate the TDI (Gelderblom et al., 1996a). Tolerance levels 
for fumonisins in maize and maize-based foods and feeds should have a firm scientific basis 
and must be practicable (Marasas et al., 1993a). These levels can only be established 
following compehensive exposure and hazard assessment and on the basis of reliable PDI and 
TDlvalues. 
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2.8. Conclusions 
The fungusF. moniliforme is one of the most prevalent seedbome fungi associated with maize 
intended for human and animal conswDption throughout the world. The fumonisin mycotoxins 
exhibit a remarkable species-specific variation in the target organ(s) affected in different 
animals, such as the brain in horses, the lungs in pigs, and the liver in rats. Although 
oesophageal carcinoma has not been reproduced experimentally in animals with either culture 
material ofF. moniliforme or pure fumonisins, both the culture material and FB 1 have been 
proven to cause hepatocellular carcinoma and cholangiocarcinoma in rats. The fumonisin 
mycotoxins have been found to disrupt sphingolipid metabolism, a finding that has potentially 
far-reaching implications for understanding the mechanisms offumonisin toxicity as well as the 
role of sphingolipids in cell function and regulation. 
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Stem cells may be defined as immature cells of nondescript morphology with unlimited cycling 
capacity, clonogenicity, and pluripotency (Pierce et al., 1978). Se)f:.maintenance is a 
fundamental and common trait ofall stem cells (Lajtha, 1970). They are undifferentiated or 
partially differentiated, and have the potential to proliferate and to devel p along several cell 
lineages. In rapidly renewing adult tissue, such as marrow, skin and gut, stem cells have long 
since been known to be part of the proliferative compartment, which is ultimately responsible 
for cell replacement. 
There is now a large body of evidence to suggest that the livers of adult animals and 
humans contain stem cells (Aterman, 1992; Faust , 1994; Marceau, 1994; Sell 1994; Sell and 
Pierce, 1994; Sigal et al., 1992; Thorgeirsson, 1993; Thorgeirsson 1996; Golding et al., 
1995). In the adult liver, cell turnover is extremely slow and hepatocytes maintain the capacity 
for replication, and can respond quickly to liver damage associated with mild to moderate cell 
loss (Reid, 1990; Fausto, 1994). However, when hepatocyte proliferation is impaired or 
overwhelmed, sma11 periportal cells with scant cytoplasm and ovoid nuclei proliferate and 
migrate into the surrounding liver parenchyma. In experimental animals, these cells have been 
. 
termed oval cells (Farber, 1956), and their association with defective regeneration has led to 
the belief that these cells represent a progenitor cell population (Fausto, 1994; Marceau, 1994; 
Sell and Pierce, 1994; Sigal et al., 1992; Thorgeirsson, 1993; Golding et al., 1996). In 
humans, these biliary cells have variously been referred to as ductular structures, neoductules, 
or neocholangioles, and have been observed in many forms of chronic liver disease, including 
cancer. Oval cells are thought to take over the burden of regenerative growth after substantial 
liver cell loss, suggesting that they are the progeny of stem cells. The liver is not, however, 
generally considered as a continually renewing stem cell-fed hierarchy. Rather it appears that 
the adult liver contains facultative ('potential') stem cells located in biliary ductules that can 
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The evidence for the presence of liver stem cells is derived mainly from studies on (i) 
embryogenesis of the liver; (ii) experimental hepatocarcinogenesis; and (iii) the properties of 
non-hepatocytic (stem-like) epithelial cells isolated from the liver and examined in culture, and 
after transplantation into the liver and other sites in vivo (Grisham and Thorgeirsson, 1997). 
Hepatic stem cells have aroused intense interest, because these cells may represent a target 
population for hepatic carcinogens, and may be useful clinically for the treatment of massive 
hepatic necrosis and as vehicles for gene therapy. The pwpose and fate of stem cells in normal 
adult liver remain obscure. 
3.2. Historical background 
The proliferation of bile duct-related cells from the portal tracts was first noted by Opie (1944) 
in rat carcinogenesis studies using butter yellow. Farber (1956) studied the histological 
changes induced in the liver by ethionine, 2-acetylaminofluorene (AAF), and 3'-methyl-4-
dimethylaminobenzene (Me-DAB), and found that all three agents caused the proliferation of 
nonparenchymal cells, which he termed 'oval cells' because of their shape. These cells were 
much smaller than hepatocytes and appeared to be bile ductular cells that proliferated from the 
po~al spaces, starting a few weeks after the administration of the carcinogens. The existence 
ofhepatic stem cells was first postulated by Wilson and Leduc (1958), based on experiments 
involving liver regeneration in the mouse after chronic injury induced with a methionine-rich 
basal diet mixed with an equal amount of bentonite. The authors concluded that ']>rolonged 
and severe injury may make direct restoration by division of pre-existing parenchymal cells 
impossible, and that, when this occurs, the new parenchyma is derived from the indifferent 
cholangiole cells". The ''indifferent cholangiole cells" were in fact oval cells. The major 
support for the existence of hepatic stem cells has since then come from extensive studies of 
chemical hepatic carcinogenesis in rats. Another landmark observation in the field was made 
by Desmet (1963), who proposed that hepatocellular carcinomas could derive from either 
hepatocytes (more differentiated tumours) or oval cells (less differentiated hepatoce11u1ar 
carcinomas and adenocarcinomas with cholangioce11u1ar differentiation). Evidence that oval 
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cells are precursors ofhepatocytes, based on the transformation of3H-thymidine-tagged oval 
cells into hepatocytes, has subsequently been provided by Onoe et al. (1973), Evarts et al. 
(1987), Lemire et al. (1991), and Dabeva and Shafritz (1993). 
The most recent approaches to research on liver stem cells have included (i) 
development of markers to identify stem cells and to distinguish among different types of 
biliary cells; (ii) study of the growth factors and receptors required for the proliferation and 
differentiation of progenitor cells; (iv) analysis in vivo of the fate of progenitor cells 
identifiable by expression of genetic markers; (v) identification of stem cells in human livers; 
and (vi) application of transgenic and knockout mouse models to the study of regulation of 
stem cell proliferation and differentiation. 
3.3. Stem cells and the embryological development of the liver 
Embryological studies provide possible explanations for some of the phenomena described in 
studies of liver regeneration and carcinogenesis. How endodermal cells become determined to 
form the liver and how these committed cells differentiate into the liver cell lineages are two of 
the fundamental issues that directly relate to the formulation of stem cell concepts applicable 
to the adult liver (Fausto, 1994). 
The liver is derived from an outgrowth of the primitive foregut, and consists of 
endodermal and mesodermal components (DuBois, 1963; MacSween and Scothome, 1985). 
The hepatic diverticulum is first visible in the mouse embryo on E9.5 and in the rat embryo on 
EIO - 10.5, as a thickening of the epithelium of the ventral foregut adjacent to the developing 
heart and projecting into the loose mesenchyme of the septum transversum (Le Douarin, 1975; 
Houssaint, 1980; Cascio and Zaret, 1991). In the developing human embryo, the hepatic 
diverticulum develops around the 3rd and 4th week of gestation (Gerber and Thung, 1993). 
The first functional evidence of the impending development of the liver epithelium is seen at 
E9 in mice and EIO in rats with the weak expression in the hepatic diverticulum of a-
fetoprotein (AFP) (Cascio and Zaret, 1991; DiPersio et al., 1991; Shiojiri et al., 1991), as well 
as of several liver-enriched transcription factors (Ang et al., 1993; Monaghan et al., 1993). 
In both rat and man the differentiation ofhepatocytes and biliary epithelial cells from 
multi potential endodermal stem cells of the hepatic diverticulum occurs via the development 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
ofhepatobtasts, which have bipotential differentiation capabilities (Van Eyken et at., 1988a; 
Van Eyken et at., 1988b; Haruna et at., 1996) (Figure 3.1). 
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Figure 3.1. Schematic diagram showing the general temporal sequence of the differentiation 
ofhepatocytes and biliary epithelial cells from multipotential endodermal cells of the hepatic 
diverticulum, through the development ofhepatoblasts with bipotential differentiation options 
(modified from Grisham and Thorgeirsson, 1997). 
Hepatoblasts initially bear little structural or functional resemblance to mature hepatocytes or 
bile duct epithelial cells, both of which morphologically differentiate during the last half of fetal 
development and the.first few postanatal days (Herzfeld et at., 1973; Luzzato, 1981; Feracci et 
at. 1987; Vassy et at., 1988). Morphological and functional changes in cells mirror the 
development of the extracellular matrix and adhesion molecules (Odin and Obrink, 1988; 
Stamatoglou et at., 1992; Martinez-Hernandez et at., 1993). 
Most of the hepatoblasts in the liver cell mass located in the septum transversum 
gradually develop into hepatocytes (Shiojiri et at., 1991). Expression ofhepatocyte-enriched 
transcription factors represents the earliest evidence ofhepatoblastic and hepatocellular 
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differentiation (Lai and Darnell, 1991; Lai, 1992; Xanthopoulos and Mirkovitch, 1993; Zaret, 
1996). These transcription factors, including HNF3, HNF4, HNF1a, CIEBP and DBP, are 
expressed sequentially during the period of gestation, and appear to be essential for embryonic 
liver development (Ang et al., 1993; Monaghan et al., 1993; Sladek et al., 1990; Tian and 
Schibler, 1991, Kuo et al., 1992; Nagy et al., 1994). Hepatocyte growth factor (HGF), a 
growth factor produced by mesenchymal cells which acts in a paracrine fashion on epithelial 
cells via the c-met receptor (Zarnegar et al., 1994; Michalopoulos and DeFrances, 1997), is 
also essential for embryonic liver development, and mice lacking the HGF gene die in utero 
with a liver that is reduced in size and shows extensive loss ofparenchymal cells (Schmidt et 
al., 1995; Uehara et al., 1995). The developing hepatocytes express the hepatocyte-specific 
proteins AFP and albumin, as well as the intermediate filaments CK8 and CK18 (TABLE 3.1) 
(Van Eyken et al., 1988a; Shiojiri et al., 1991) 
Hepatoblasts that surround the portal mesenchyme condense to form a double-layered 
cylinder of cells, the ductal plate, which remodels and migrates into the mesenchyme to form 
the intrahepatic bile ducts (Van Eyken et al., 1988a; Shiojiri et al., 1991). Differentiation of 
bile duct epithelial cells and formation of bile ducts is also a gradual and continuous process 
that begins in rats on about E15 - 15.5, and continues postnatally (Van Eyken et al., 1988a; 
Shiojiri et al., 1991). Little is known about specific changes in expression of transcription 
factors or synthesis of specific proteins during the differentiation of bile duct epithelium 
Biliary differentiation in hepatoblasts that touch portal mesenchyme in rats is heralded by the 
expression of reactivity for BD.1 antibody, following which the ductal plate then develops into 
a series of tubules that bind BD.1, OC.2, HBD.1 and CK19; biliary duct epithelium gradually 
expresses CK7 as ducts develop further (TABLE 3.1) (Van Eyken et al., 1988a; Sbiojiri et aI., 
1991; Hixson et al., 1992). The ductal plate cells initially express hepatocyte-specific proteins 
AFP and albumin as they migrate into the portal stroma, and additionally begin to express the 
bile duct specific marker, y-glutamyl transpeptidase (GGT) (TABLE 3.1) (Shiojiri et al., 
1991). 
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TABLE 3.1 
Antibody markers commonly used to assess differentiation and to trace lineage of liver 
epithelial cells (Modified from Grisham and Thorgeirsson, 1997). 
Markers Hepatoblasts Oval cells Hepatocytes Bile duct cells 
CK7 + 
CK8 + + + + 
CK18 + + + + 
CK19 + + + 
CK14 [+r [+] 
Albumin + +/_c + 
AFP + + 
GGT + + + 
OV-6 (+)b + + 
OV-l (+) + + 
BDI + 
OC.2 + + + 
OC.3 + + + 
H.l + 
H.2 +/_b 
HBD.l + + + 
a [ ] = mRNA transcripts detected by Northern blotting and in situ hybridisation, but 
imnumostaining negative 
b ( ) immunostaining weakly positive 
c +/_ = doubtful positivity of imnuJD 0 staining 
39 
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Haematopoiesis and hepatic development share common stages. During fetal development, 
haematopoietic stem cells move out of the yolk sac and into the developing liver (Kelemen et 
al., 1987; Sharp et al., 1987). In humans, haematopoiesis can be detected as early as 6 weeks 
of gestation, expanding exponentially for a few days, then stabilising with a doubling time of2 
days (Paul et al., 1969). The liver remains haematopoietic during the entire fetal period and 
for approximately the first week after birth in the neonate (Borghese, 1959). Simultaneous 
with the appearance ofhaematopoiesis, haematopoietic stem cells can be detected in the fetal 
liver. This pool ofhaematopoietic stem cells remains fairly constant throughout fetal life, but 
the concentration appears to drop as the liver grows to increase its mass. In the latter part of 
gestation and after birth, the haematopoietic function of the liver is considerably reduced, if 
not totally absent. As the liver loses its haemopoietic ability, the concentration of stem cells 
declines. Although the liver loses its haematopoietic functions, hepatic extramedullary 
haematopoiesis may return in some adult disease states, e.g. myeloproliferative disorders. 
There may be a closer relationship between the liver parenchyma and the 
haematopoietic system than previously thought. Our group has recently shown that in 
developing human liver haematopoietic stem cell markers CD34 and c-kit are co-expressed in 
ductal plate cells in a pattern similar to the early cytokeratin markers CAM 5.2 and CK 18 
(Blakolmer et al., 1995). Both stem cell factor (SCF) and its c-kit receptor are expressed by 
early liver progenitor cells in the rat liver during embryonic development and following liver 
injury (Fujio et al., 1994; Fujio et al., 1996). Similarly, proliferating oval cells in treated livers 
express the haematopoietic stem cell marker Thy-l in addition to traditional oval cell markers 
(AFP, GGT, OV-6, CK-19, and OC.2) (Petersen etai., 1998a). Most recently, cross-sex or 
cross-strain bone marrow and whole liver transplantation experiments were used to test the 
hypothesis that oval cells and other liver cells may arise from bone marrow cells during liver 
regeneration (Petersen et ai., 1999). Using markers for Y chromosome, dipeptidyl peptidase 
IV enzyme, and L21-6 > antigen, the investigators were able to show that a proportion of the 
regenerated hepatic cells were donor derived, thus proving that a stem cell associated with the 
bone marrow has epithelial lineage capability. 
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3.4. Normal biliary tree and the stem cell compartment in the 
adult liver 
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Periportal hepatoblasts give rise to bile ducts during liver development and, in the adult, the 
bile ducts remain connected to the hepatocyte parenchyma by the complex anastomoses of the 
bile canaliculi (Golding et ai., 1996). The canalicular network drains the bile produced by the 
hepatocytes to the portal tract interface. The bile passes through cholangioles composed of 
hepatocytes and specialised duct cells (Steiner and Carruthers, 1961) and, more distally, 
cholangioles lined exclusively by squamous ductular cells. From here bile passes into the 
peripheral or marginal interlobular ducts, and then into larger septal bile ducts (Millward-
Sadler and JezequeL 1992), and ultimately into the duodenum via the extrahepatic bile ducts. 
The precise location of the hepatic stem cell compartment in the adult liver is still 
unclear, but there are several possibilities. Cells located within or in contact with the portal 
stroma (Yavorkovsky et ai., 1995); small nondescript cells around the cholangioles, the 
'periductular cells' (Sell, 1993a; Sell and Salman, 1984); the cholangioles (canals of Hering or 
terminal bile ductules) (Sell, 1990; Sell, 1993a; Grisham and Porta, 1964; Lemire et ai., 1991; 
Factor et ai., 1994); and small interlobular ducts (Golding et ai., 1995; Alison et at, 1996; 
Nomoto et ai., 1992; Anilkumar et aI., 1995) have all been proposed as candidates for the site 
of stem cells. It is however also possible that any component of the intrahepatic biliary tree 
can give rise to oval cells (Golding et ai., 1995, Lenzi et ai., 1992). 
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3.5. The role of oval cell proliferation during liver regeneration 
Rats have been used most extensively to generate experimental models with which to examine 
the development and outcome of oval cell proliferation. The most commonly used models in 
rats are produced by (i) treatment with azo dyes (Inaoka, 1967; Rogers, 1978); (ii) feeding of 
a choline-deficient diet, with or without supplements of ethionine (Shinozuka et al., 1978) or 
2-acetylaminofluorene (Sell et al., 1981); (iii) treatment with 2-acetylaminofluorene and partial 
hepatectomy (AAFIPH) (Tatematsu et al., 1985); (iv) and treatment with D-galactosamine 
(Lemire et aI., 1991). Central to all these experimental models is the extensive destruction 
and/or compromised function ofhepatocytes, coupled with the apparent inability of the 
residual hepatocytes to proliferate (Solt and Farber, 1976). The common cellular response to 
all of these regimens is the proliferation of oval cells, also known as ductular cells, ductular 
oval cells, or ductular epithelial cells. A schematic diagram of the emergence and evolution of 
oval cells is shown in Figure 3.2. 
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Epithelium '" G2 g g / !ransitional @c:v g Hepatocytes 
g'0g 
"ovali8l1S ! 
0~G0 
Hepatocytes 
Figure 3.2. Schematic diagram illustrating the hypothesis that oval cells develop from 
facultative stem cells (bipotential progenitor cells) located inlnear the canals of Hering 
(modified from Grisham and Thorgeirsson, 1997). 
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Oval cells originate in portal zones in the regions of terminal bile ductules and then rapidly 
invade the entire liver lobule. As they migrate through the parenchyma, oval cells proliferate 
rapidly, with labelling rates after pulse doses of3H-thymidine of 5 - 20% during peak 
proliferation (Sell et al., 1981; Lemire et al., 1991). As oval cells proliferate, individual and 
small groups of small, intensely basophilic hepatocytes typically appear among them, after 
which the oval cells disappear and the parenchyma is gradually reconstructed. 
Proliferating oval cells comprise a heterogeneous, expanding population of cells, which 
has been termed an oval cell compartment (Fausto et al., 1992). Uhrastructurally, individual 
oval cells closely resemble cells that form terminal bile ductules (Lenzi et al., 1992; Sarraf et 
al., 1994), and, with other oval cells, they form irregular duct-like structures that enclose 
lumens which connect to adjacent, pre-existing bile ducts (Dunsford et al., 1985; Sarraf et al., 
1994). Based on ultrastructural characteristics, the oval cell compartment can be further 
subdivided into subpopulations, based on degree of differentiation (Sell, 1998). Oval cells 
express some markers of normal intrahepatic biliary epithelium (Sirica et al., 1990; Lemire et 
af., 1991; Lenzi et al., 1992), as well as phenotypic properties that distinguish them from 
biliary epithelial cells (TABLE 3.1). A subset of oval cells expresses mRNA for AFP (Lemire 
et al., 1991; Fausto et al., 1992), and reacts with antibodies to AFP (Onoe et al., 1973; 
Germain et al., 1985; Marceau, 1990; Fausto et al., 1992). Similarly, variable numbers of oval 
cells express albumin mRNA and bind antibodies to albumin (Dabeva and Shafritz, 1993), and 
some individual oval cells express both AFP and albumin simultaneously (Alpini et al., 1992; 
Dabeva and Shafritz, 1993). Oval cells also express the bile duct type cytokeratins CK8, 
CK18 and CK19 (Germain et al., 1985; Alpini et al., 1992 Lemire et al., 1991; Lenzi et al., 
1992) and GGT (Sirica and Cihla, 1984; Yokoyama et al., 1986; Marceau et al., 1992; Fausto 
et al., 1993). Recently, subpopulations of oval cells have been identified in CDE-treated rat 
liver that express fetal.hepatocyte markers (1t class glutathione S-transferase, MrPyruvate 
kinase) with or without adult hepatocyte (a- glutathione S-transferase, L-pyruvate kinase) and 
bile ductu1ar markers (CKI9) (Tee et al., 1996). Oval cells express several of the other 
antigenic markers that have been shown to react with either hepatocytes or biliary epithelial 
cells of adult rat livers (TABLE 3.1). OV -6 monoclonal antibody shows strong cytoskeletal 
staining of bile duct and oval cells, some nodular hepatocytes, and some hepatocellular 
carcinomas (Dunsford and Sell, 1989; Faris et al., 1991). 
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Further evidence of in vivo differentiation of oval cells into hepatocytes comes from 
studies combining lineage markers with cell labelling, usually by tagging of replicating DNA 
with 3H-thymidine. Although fraught with problems that complicate interpretation, labelling 
studies may help trace the fates of differentiating cells, including oval cells, that change their 
phenotype. Using the AAFIPH model, Evarts et al. (1989) combined 3H-thymidine tagging 
with the use of phenotypic markers to follow the fate of oval cells. The phenotypic properties 
expressed by oval cells gradually merged into properties that were typical ofhepatocytes, and 
this change in differentiation was correlated with the transfer of label from oval cells to 
basophilic hepatocytes (Evarts et al., 1989). Specifically, oval cells expressing several 
markers of fetal liver epithelial cells, including CK7 and CKI9, reactivity to OV-6 antibody, 
AFP and albumin (weakly), were heavily tagged with a pulse of~-thymidine. Residual 
hepatocytes were not tagged by this pulse, but 3H-thymidine-tagged small hepatocytes later 
appeared in basophilic foci; these 3H-thymidine-tagged small hepatocytes expressed higher 
levels of albumin and much lower levels of AFP than did oval cells and, in addition, they 
expressed other markers of hepatocyte differentiation (Evarts et al., 1989). Employing the 
galactosamine model, Lemire et al. (1991) also combined phenotypic marking of oval cells and 
hepatocytes with the assessment of time-dependent 3H-thymidine labelling of both cell types. 
Shortly after administration of3H-thymidine, label was found in oval cells that expressed CK7 
and CKI9, GGT, 2.1 kb mRNA for AFP, and bound peanut agglutinin. 3H-thymidine-Iabelled 
small hepatocytes expressing albumin and other hepatocytic markers appeared subsequently, 
together with the loss of the biliary epithelial phenotype (Lemire et al., 1991). Dabeva and 
Shafritz (1993) analysed the simultaneous occurrence ofa programme of hepatocyte 
differentiation in oval cells and the transfer of3H-thymidine between oval cells and , 
hepatocytes in the galactosamine model in rats. Tagged oval cells initially expressed fetal AFP 
mRNA and GGT; during the next few days AFP declined while the expression of albumin and 
glucose-6-phosphatase increased, as the tagged cells concurrently acquired the morphology of 
small hepatocytes. During late stages of recovery from galactosamine toxicity, 
morphologically and phenotypically identifiable hepatocytes also proliferated to augment the 
production of new hepatocytes. The authors concluded that in the galactosamine model the 
hepatocyte population is replaced by both differentiation of oval cells and by proliferation of 
the residual and newly formed hepatocytes (Dab eva and Shafritz, 1993 
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3.6. Interactions between oval cells and hepatic stellate (Ito) cells 
The proliferation of mesenchymal cells in conjunction with oval cells has long been known 
(Popper et ai., 1957). Evarts et ai. (1993) showed that desmin-positive hepatic stellate (Ito) 
cells represent an important category of mesenchymal cell intimately involved in the early 
stages of oval cell proliferation. The earliest cells that proliferate in the AAFIPH model are 
OV-6 antibody-reactive epithelial cells, as shown by combined 3H-thymidine tagging and 
immunohistochemistry (Evarts et ai., 1993). Both OV-6 positive and desmin positive 
mesenchymal cells are labelled with ~-thymidine within four hours after starting the AAFIPH 
regimen. 3H-thymidine tagged cells are identified as individual desmin positive cells embedded 
in the portal connective tissue matrix, or as OV -6 positive cells in biliary ductules located in 
close proximity to branches of the portal vein. These observations showed that the earliest 
cycling epithelial cells that lead to oval cell proliferation are closely associated with 
mesenchymal cells, particularly stellate cells. 
Interactions between stem cells/oval cells and hepatic stellate cells are mediated by 
growth factors. Coincident with the initiation of DNA synthesis in OV -6 positive and desmin-
positive cells in portal tracts, expression of transforming growth factor alpha (TGF-a), 
hepatocyte growth factor (HGF) and acidic fibroblast growth factor (aFGF) is observed, and 
expression of transforming growth factor beta 1 (TGF-~I) begins within 24 hours (Evarts et 
aI., 1990; Nakatsukasa et ai., 1991; Marsden et ai., 1992; Hu et ai., 1993). This group of 
growth factors continues to be expressed at high levels throughout the period of expansion 
and differentiation of the oval cell population. Transcripts for TGF-a and aFGF are expressed 
by both oval cells and hepatic stellate cells (Evarts et ai., 1992; Marsden et ai., 1992), whereas 
transcripts for HGF are expressed only by stellate cells (Hu et ai., 1993). Transcripts for 
TGF-~1 are also highest in hepatic stellate cells, although the earliest population of oval cells 
also expresses lower levels ofTGF-~1 mRNA (Nakatsukasa et ai., 1991). Oval cells express 
receptors for all of these growth factors (Lenzi et ai., 1992; Marsden et ai., 1992; Hu et ai., 
1993), providing a molecular pathway by which hepatic stellate cells may influence the growth 
and development of oval cells. Production of matrix proteins by stellate cells may be another 
mechanism by which they interact with oval cells. 
The stem cell factor/c-kit (SCF/c-kit) ligand/receptor system is also involved in the 
earliest stages of liver stem cell activation and oval cell proliferation (Fujio et al., 1994). In 
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the AAFIPH model, expression of SCF/c-kit occurs as early as the expression of AFP 
transcripts, and the levels ofSCF/c-kit transcripts reach a peak and decline prior to that of the 
other growth factors. Individual oval cell precursors express both SCF and c-kit, providing 
the basis for autocrine stimulation. The SCF/c-kit signal transduction system is believed to 
playa fundamental role in the survival, proliferation and migration of stem cells during 
gametogenesis, melanogenesis and haematopoiesis (Morrison-Graham and Takahashi, 1993). 
Nevertheless, mice which have a mutation for either SCF or c-kit, still respond to bile duct 
ligation with bile duct proliferation and formation of new bile ducts (Omori et al., 1997). This 
may be due to the compensatory/additive function of other early acting stem factors, such as 
the flt-3 ligand (FL)/flt-3 system (Omori et al., 1997). 
3.7. Properties of nonhepatocytic (stem-like) epithelial cells 
isolated from the liver 
In addition to the in vivo data discussed above, significant support for the existence of a 
hepatic stem cell has come from results obtained in studies on hepatic cell cultures. Isolation 
and establishment oflong-term cultures of small, morphologically and functionally simple 
epithelial cells by enzymatic perfusion of normal rat liver (fetal and adult) have been 
accomplished by several investigators (Tsao et al., 1984; Tsao and Liu, 1988, McMahon et 
al., 1986; Hampton et al., 1990; Hugget et al., 1991). These rat liver-derived epithelial (RLE) 
cells are morphologically similar, being small cells (9 - 12 Jl1D. in diameter) that grow in closely 
packed, regular monolayers. The functional and phenotypic properties of these cells lines have 
been extensively characterised (Grisham and Thorgeirsson, 1997), and while RLE cells share 
some phenotypic properties with both bile duct epithelial cells and hepatocytes, they are 
phenotypically much closer to oval cells. 
Because of the phenotypic similarities of oval and RLE cells, it has been suggested that 
RLE cells are also derived from hepatic stem cells. This suggestion is supported by data 
obtained from extensive use of RLE cells for in vitro transformation studies with both 
chemical carcinogens and oncogenes (see Chapter 4). In addition, a recent insight into the 
nature of the RLE cells and the potential role of hepatic stem cells in liver biology has been 
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provided by tagging and transplantation experiments. Coleman et al. (1993) genetically 
tagged RLE cells with the E. coli ~-galactosidase reporter gene and demonstrated that, 
following transplantation into the livers of syngeneic rats, the RLE cells integrated into hepatic 
plates and acquired the size and nuclear structure of mature hepatocytes. Furthermore, 
hepatocytes and other epithelial cells derived from intrahepatic transplants of the tagged RLE 
cells could be recovered from the livers of recipient rats, and the liver epithelial cells that were 
re-established in culture were morphologically identical to the original RLE cells (Grisham et 
al., 1993). Such tagging and transplantation studies have however not yet provided evidence 
for the ability ofRLE cells to differentiate into bile duct epithelium. 
3.S. Conclusions 
There now exists a strong body of evidence for the presence of facultative stem cells in the 
adult liver. The question currently dividing many is no longer whether stem cells exist. but 
what their exact role is in the liver. Increased understanding of the cellular and molecular 
biology of the hepatic stem cells and their progeny is likely to have significant impact on 
diverse areas of clinical hepatology, including hepatocarcinogenesis, artificial liver support, 
and gene therapy. 
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Chapter 4 
The role of cell types in hepato- and 
cholangiocarcinogenesis 
4.1. Introduction 
48 
Cancer must arise from a cell that has the potential to divide (Cohen and Ellwein, 1990). The 
two major nonexclusive hypotheses of the cellular origin of cancer are that malignancy arises 
(i) from stem cells due to maturation arrest or (ii) from dedifferentiation of mature cells that 
retain the ability to proliferate (Sell, 1993). There is no doubt that the hepatocyte frequently is 
the progenitor cell for liver tumours (Farber, 1992). The involvement of oval cells in the 
genesis of liver tumours, particularly hepatocellular carcinomas, is still hotly debated. On the 
one hand, Sell and Pierce (1994) have proposed that ''the cell of origin of liver cancer is the 
putative liver stem cell or its progeny, the transitional duct cell" (Sell and Pierce, 1994). 
Alternatively, Farber (1992) has stated that 'l-are original mature hepatocytes in zone 1,2, or 3 
of the adult liver appearing after initiation with genotoxic carcinogens have been shown to be 
the cell of origin for foci or islands of altered hepatocytes and of nodules derived from these 
foci." 
4.2. The resistant hepatocyte model of experimental 
hepatocarcinogenesis 
The liver serves as an excellent model in studies of cell growth regulation and carcinogenesis, 
because the normal cell cycle activity is low, with a growth fraction of only 0.02%. Cell 
replication is increased dramatically by mitogenic stimuli, such as partial hepatectomy, leading 
to growth fractions of 90%, and regeneration of normal hepatocytes can be blocked by 
mitoinhibitors such as 2- acetylaminofluorene (AAF). Several liver models for the study of 
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carcinogenic processes have been developed. The 'resistant hepatocyte' (RH) model was 
designed by Solt and Farber (1976) to cause rapid (and synchronised) development offoci of 
ahered hepatocytes, nodules, and cancers. As explained by the 'initiation-promotion' 
hypothesis of carcinogenesis, cells are 'initiated' by a non-necrotic dose of the genotoxic agent 
diethylnitrosamine (DEN), followed 2 weeks later by a 2-week feeding of AAF, with a partial 
hepatectomy (PH) performed after 1 week of AAF feeding. The AAF is given to inhibit 
proliferation of the non-initiated hepatocytes that would other wise be stimulated by the PH, 
thus allowing the growth stimulus of the PH ('promotion') to act on the DEN-initiated, 
growth inhibition-resistant cells. In the modified Solt-Farber regimen, the 'initiation' step of 
DEN injection is omitted. Although the initiation-promotion model is probably an artefact of 
the laboratory (Cohen, 1998), the Solt-Farber and modified Soh-Farber regimens have 
nevertheless become the standard methods for the study of experimental hepatocarcinogenesis 
in the rat. 
4.3. Chemical carcinogenesis and premalignant lesions: the role 
of initiated hepatocytes 
One penultimate site of origin of hepatocellular carcinoma in chemical carcinogenesis in the rat 
is the persistent hepatocyte nodule (Farber and Sarma, 1987; Bannasch et al., 1989). This 
small population is derived from a much larger population of early nodules, the majority of 
which appear to remodel in a process of redifferentiation. This population of early nodules, in 
tum, arises from islands of "enzyme altered" hepatic/oci that have a characteristic spectrum 
of biochemical changes as part of their phenotype (Farber and Sarma, 1987; Bannasch et al., 
1989). These changes include the expression ofy-glutamyl transpeptidase (GGT) and pi class 
glutathione S-transferase (GST-pi) (Moore et al., 1987; Satoh et al., 1989). Early studies 
with the RH model indicated an origin offoci from hepatocytes (Soh and Farber, 1976; Solt et 
al., 1977). These could be seen as changes in the appearance of liver parenchymal cells 
scattered randomly throughout the liver in the three zones of the liver acinus without any 
apparent geographic relationship to the very early proliferation of oval cells. In several reports 
since then, it has been proposed that HCC induced by chemical agents may arise in the liver 
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from oval cells, speculated to be the progeny of liver stem cells. Gindi et al. (1994) thus re-
examined the cellular origin of the foci, placing reliance on material (linear) continuity between 
cells rather than the use of phenotypic markers. Two major parameters were examined: (i) the 
zonal localisation of the foci and oval cells; and (ii) the time of appearance offoci and oval 
cells after PH. They found no correlation between oval cell proliferation and the time and site 
of first appearance of foci. The authors concluded that the origin of foci from hepatocytes and 
the dissociation between their appearance, growth and the proliferation of oval cells was 
obvious and striking (Gindi et al., 1994). 
Anilkumar et al. (1995) exploited the antiproliferative effect of AAF in the RH model 
of carcinogenesis, which results in a co-proliferation of oval cells and initiated hepatocytes, in 
order to clarifY the relationship of oval cell proliferation to the development of early 
hepatocyte nodules. Using a panel of monoclonal antibodies directed against intermediate 
filaments, the authors showed that the so-called oval cell response in the first few days after 
PH in the RH model was in fact a prominent ductular reaction, apparently emanating from 
portally located bile ducts (Anilkumar et al., 1995). These cells strongly expressed 
cytokeratins 8 and 19 and vimentin, and from 1 week after PH, they frequently underwent 
differentiation either into hepatocytes, expressing cytochrome P450 enzymes, or into 
intestinal-type cells. Five days after PH, numerous basophilic foci were discernible, and these 
foci expanded rapidly. The ductu1ar cells swirled around the foci, but their antigenic profile 
clearly indicated that these cells were not involved in the development of the early nodules. 
The authors concluded that early foci and nodules in the RH model are derived from resistant 
(initiated) hepatocytes and not ductular (oval) cells, the latter being a facuhative muhipotential 
stem cell compartment (Anilkumar et al., 1995). 
4.4. Chemical carcinogenesis and oval cell proliferation: the role 
of liver stem cells 
An important role for liver non parenchymal epithelial cells was provided by Farber (1956), 
who documented a detailed description of the early histological changes during 
hepatocarcinogenesis caused by three chemical carcinogens. The carcinogens ethionine, 2-
acetylaminotluorene (AAF), and 3'-methy14-dimethylaminoazobenzene (Me-DAB), in spite of 
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being structurally very different, caused similar histological aherations. The common features 
included (i) oval cell proliferation which progressively involved most of the liver lobule, 
beginning in the portal areas, (ii) degenerative and hypertrophic changes in hepatocytes 
adjacent to proliferating oval cells, and (iii) nodular regenerative hyperplasia of liver cells. 
There were, however, important differences in the time course of appearance and fate of the 
oval cells induced by these three hepatocarcinogens. Whereas oval cells appeared early 
following ethionine and AAF administration (7 and 14 days respectively), their appearance 
occurred significantly later after Me-DAB treatment (first seen at day 21). More importantly, 
the fate of the oval cells in the Me-DAB treated animals were different from those induced by 
ethionine and AAF. In the early stages the oval cells induced by Me-DAB were 
morphologically indistinguishable from those generated by ethionine and AAF. However, at 
later stages areas of apparent transition between oval cells and hepatocytes were numerous in 
the Me-DAB treated animals but absent in those receiving ethionine and AAF (Farber, 1956). 
Since then it has been established that many different chemical compounds capable of 
producing liver tumours in rats and mice, induce a similar sequence of histological changes in 
which oval cell proliferation is prominent (Dunsford et al., 1985). If the transition from oval 
cells to hepatocytes can be morphologically observed after Me-DAB treatment, then it is in 
principle established that oval cells have the capacity to differentiate into hepatocytes. 
Furthermore, the fact that a large population of oval cells is cycling during the early stages of 
chemical hepatocarcinogenesis and that these cells can differentiate into hepatocytes strongly 
suggests that at least a percentage of the HCCs are derived from oval cell progenitors 
(Thorgeirsson, 1995). 
In recent years there has been accumulating experimental evidence in support of this 
notion. Hixson and his colleagues (Hixson et al., 1990; Faris et al., 1991) used a battery of 
monoclonal antibodies specific for antigens associated with bile duct cells, oval cells and fetal, 
adult, and neoplastic hepatocytes to analyse the phenotypic relationship between oval cells, 
foci, nodules, and carcinomas during chemical hepatocarcinogenesis. These investigators 
found, using the RH model, that oval cells, GGT-positive hepatocellular foci, persistent 
hepatocyte nodules, and primary HCCs express both oval cell and hepatocyte antigens. This 
finding indicates a precursor-product relationship between oval cells and carcinomas. Similar 
results were obtained by Dunsford et af. (1989) using different monoclonal antibodies raised 
against oval cells. These lineage relationships between oval cells and HCCs also exist in other 
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models of liver carcinogenesis. For example, animals maintained on a choline deficient and 
ethionine (CDE) diet display markers for oval cells and hepatocytes in a significant percentage 
of nodules and HCCs (Hixson et ai., 1990; Faris et ai., 1991). Also, metastatic tumours in the 
lung from the animals harbouring these liver tumours show essentially the same phenotype 
(Hixson et ai., 1990). 
The most direct evidence that oval cells can progress to HCCs comes from in vitro 
transformation of rat liver-derived epithelial (RLE) cells (Yoshimura et ai., 1983; Tsao et ai., 
1984; Braun et ai., 1987; Garfield et ai., 1988; Germain et ai. 1988b; Fausto 1990b). These 
simple epithelial cells share some phenotypic properties with both bile duct epithelial cells and 
hepatocytes, but are phenotypically much closer to some of the oval cell lines (Grisham and 
Thorgeirsson, 1997). Spontaneous transformation ofRLE cells, as well as transformation 
with chemical carcinogens and dominant oncogenes, results in the tumours displaying a wide 
range ofphenotypes (Tsao and Grisham, 1987; Garfield et ai., 1988; Fausto, 1990; Marceau, 
1990). When the transformed RLE cells are transplanted into either syngeneic rats or nude 
mice, a spectrum of tumours is observed that includes highly differentiated HCCs, 
hepatoblastomas, cholangiocarcinomas, as well as mixed epithelial-mesenchymal tumours 
(Tsao and Grisham, 1987), demonstrating both the blastic nature of the RLE cells and the 
potential of the cells to differentiate via both the hepatocytic and biliary lineages (TABLE 4.1). 
TABLE 4.1 
Classification of tumours produced by chemically transformed rat liver epithelial cells (From 
Tsao and Grisham, 1987). 
Classification of tumours 
Carcinomas (epithelial) 
Epidermoid 
Adenocarcinoma 
Hepatocellular 
Poorly differentiated! anaplastic 
'Sarcomas' (mesenchymal) 
'Mixed epithelial-mesenchymal' tumours 
Unclassified 
Number 
54 
15 
13 
4 
22 
19 
30 
22 
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4.5. Cellular origin of human hepatocellular carcinoma 
Delineation of the sequence of preneoplastic cellular changes and characterisation of the 
multicellular lesions that precede the emergence ofhepatocellular carcinoma (HCC) is less 
complete in humans than in rodents, because it is more difficult to determine when the process 
ofhepatocarcinogenesis is 'initiated' by natural disease in humans than by experimental 
manipulation in laboratory rodents (Grisham, 1996). Identification ofhepatitis B virus (HBV) 
and hepatitis C virus (HCV) as aetiologic agents for HCC, together with the availability of 
sensitive and specific methods to detect the effect of these viruses on hepatocytes, has made it 
possible to begin to define the cellular pathogenesis ofHCC in humans. Preneoplastic cellular 
changes have been sought most intensively in cirrhotic livers, since most primary liver cancers 
in humans occur in this setting (Kew and Popper, 1984; Vandersteenhoven et ai., 1990). 
Analysis of preneoplastic changes in humans has emphasised classic morphologic changes of 
cellular dysplasia (Watanabe et ai., 1982; Thomas et ai., 1992), and the presence of dysplastic 
hepatocytes in cirrhotic nodules is correlated with increased risk ofHCC in prospective studies 
(Borzio et ai., 1995). The larger cirrhotic nodules (macroregenerative nodules) are an 
important site ofHCC development in human cirrhotic livers (Ferrell et ai. 1993; International 
Working Party, 1995). HCCs appear to emerge in populations of aberrant, but non-
neoplastic, hepatocytes contained in cirrhotic nodules or multiacinar nodules through the 
clonal proliferation of new populations that express additional aberrations, eventuating 
ultimately in frank neoplasia (Grisham, 1996). Hyperplastic nodules containing aggregates of 
dysplastic hepatocytes, similar to cirrhotic nodules, but not embedded in collagen, are also 
thought to be the site of cell proliferation and HCC development in noncirrhotic livers affected 
by chronic hepatitis (Esumi et ai., 1986; Unoura et ai., 1993). 
The cellular elements of an alternative pathway to the development ofHCC involving 
the proliferation and differentiation of stem-like ('oval') cells have been descnoed. In a study 
on 14 HCC resection specimens from China, Hsia et ai. (1992) observed the proliferation of a 
new population of epithelial cells in actively regenerating nodules and in liver tissue 
surrounding the cancers. These 'oval-like' cells stained strongly positive for cytokeratin 19 
and with OV -6 monoclonal antibody against rat oval cells. Oval cells and transitional types of 
cells appeared to be the principal producers of AFP in the regenerating liver (Hsia et ai., 
1992). In a subsequent study on 26 hepatocellular carcinoma resection specimens, oval cells 
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and transitional cells were shown to contain HBsAg and/or HBcAg by immunohistochemistry 
(Hsia et al., 1994). In contrast with these findings, immunohistochemical staining of 14 
surgical resections for hepatocellular carcinoma in noncirrhotic HBV-negative livers from 
South Allica (Lemmer et al., 1998b) did not demonstrate any proliferation ofOV-6 positive 
"oval-like" cells in non-neoplastic liver tissue surrounding the tumours. The interpretation of 
these results is that proliferation of oval-like cells in human liver tissue surrounding HCCs is 
related to the presence of underlying chronic hepatitis and cirrhosis. Furthermore, as in 
rodents, it is possible that potential cellular pathways to development ofHCC in humans may 
involve either differentiated hepatocytes or stem-like cells. 
Further support for the role of stem cells in human hepatocarcinogenesis comes from 
isolated reports of progenitor cell tumours in human liver. Robrechts et al. (1998) recently 
described a primary liver tumour composed of an immature cell type, displaying features of 
both hepatocytes and bile duct epithelial cells, and associated with a very rapid clinical course. 
The intermediate nature of the tumour, as well as the clinical course, was interpreted by the 
authors as an indication of an immature progenitor cell being the possible cell of origin for the 
tumour. Ruck et al. (1996; 1997), using electron microscopy and immunohistochemistry, 
described a population of small epithelial cells in human hepatoblastoma that ex1noit 
ultrastructural features of oval cells seen in rats. Small epithelial cells were found to co-
express markers for oval cells (OV-l and OV-6), hepatocytes (albumin) and bile duct cells 
(cytokeratin 7), suggesting that these cells are closely related to a putative bipotent stem 
4.6. Cholangiofibrotic lesions and cellular origin of 
cholangiocarcinoma 
Bile duct proliferative lesions ( cholangiofibromas) have been reported experimentally 
following treatment with a variety of carcinogens, including coumarin (Evans et al., 1989), 
polycholorinated biphenyls (Kimbrough et al., 1972), butter yellow (Opie, 1944), congeners of 
butter yellow, thioacetamide, N,N' -nitrosomorpholine (Bannasch and Massner, 1976), 2-
acetylaminofiuorene (Teebor and Becker, 1971), methapyrilene (Ohshima et al., 1984), and 
aflatoxin (Butler, 1965). These puzzling lesions, which do not have an exact counterpart in 
humans, are characterised histologically by focal proliferation of ducts containing luminal 
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debris and eosinophilic material, surrounded by dense fibrosis, and accompanied by a heavy 
inflammatory cell infiltrate (Evans et al., 1989). Although cholangiofibrotic lesions commonly 
persist throughout the lifetime of the host without further evolution (Edwards and White, 
1941), this lesion is considered to be a precursor for cholangiocarcinoma with some 
carcinogens, such as furan (Elmore and Sirica, 1993) and fumonisin Bl (Gelderblom et al., 
1991), and spontaneously in Long-Evans Cinnamon (LEC) rats with hereditary hepatitis 
(Masuda et al., 1988). Syrian golden hamsters fed dimethylnitrosamine (DMN) and infected 
with Clonorchis sinensis rapidly develop florid ductular proliferation, cholangiofibrosis, and 
cholangiocarcinoma (Lee et al., 1993; Lee et al., 1995), whereas ductular proliferation and 
periductal fibrosis without cholangiocarcinoma are seen after infection with the liver fluke 
alone. Although there is a paucity of published studies on the role of cell types in 
cholangiocarcinogenesis, there is some evidence that 'stem' cells may be involved. A review 
of the morphologic, autoradiographic, and phenotypic analysis of the cellular changes during 
different AAF-containing regimens supported a stem cell origin for both hepatocellular and 
cholangiocarcinomas induced by chemical carcinogens (Sell and Dunsford, 1989). And in 
Syrian golden hamsters fed dimethylnitrosamine and infected with Clonorchis sinensis, oval 
cells were thought to be the precursors of dysplastic duct cells that gave rise to 
cholangiocarcinomas (Lee et al., 1997). 
The aetiological factors for bile duct carcinoma in humans are far less well established 
than for HCC. Strong clinical associations have been found between cholangiocarcinoma and 
cystic abnormalities of the bile duct (Todani et al., 1979), infestation with the liver flukes 
Clonorchis sinensis and Opisthorchis viverrini (Hou, 1956), gallstones (Jones, 1950), primary 
sclerosing cholangitis (Rosen and Nagomey, 1991), the radio contrast agent thorium dioxide 
(Thorotrast) (Ito et al., 1988), and intrahepatic calculi (hepatolithiasis) (Sato et al., 1991). A 
common feature of these seemingly disparate predisposing conditions appears to be prolonged 
bile stasis and! or cmonic inflammation, which result in prominent bile duct proliferation (Hou, 
1956; Haswell-Elkins et al., 1994) .. 
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Materials and methods 
5.1. Isolation of fumonisin Bl 
57 
Fumonisin BI (FBI) was purified from maize cultures of Fusarium moniliforme strain MRC 
826 according to a method described previously (Cawood et al., 1991). Extraction of FBI 
was achieved with CH30HlH20 (3:1) followed by a solvent-partitioning step using CHCh. 
The subsequent purification of the aqueous phase was effected on Amberlite XAD-2, silica 
gel, and reverse-phase (CIS) chromatographic columns. The purity as compared to an 
analytical standard by high performance liquid chromatography (HPLC) (Alberts et al., 1993) 
was in the order of92-95%. The monomethylester derivatives ofFB}, which are artifacts of 
the purification procedure (Cawood et al., 1991), constituted the remainder of the FBI 
preparation. 
5.2. Animals and diets 
All the studies were approved by the Ethics and Research committee of the University of Cape 
Town, and the experiments were conducted in accordance with the laws and regulations 
controlling experiments on live animals in South Africa. Male Fischer 344 rats weighing 
between 150 and 200 g were used in all the experiments. The animals were caged individually 
in a controlled environment at 23 - 24°C and 50% humidity with a 12 h artificial light cycle. 
Food and water were available ad libitum, and rats were weighed weekly. All the rats 
received the AIN-76 diet (American Institute of Nutrition, 1980) with the following 
modifications: the maize starch was replaced with glucose/sucrose/maize starch (1:1:1) while 
sunflower oil was used instead of maize oil as a fat source. Maize products were excluded 
from the control diet in order to prevent any possibility of contamination by F. moniliforme. 
The cellulose was donated by Sappi Saicor, Umkomaas, Natal, South Africa. 
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5.2.1. Fumonisin BJ -containing diet 
Gloves and masks were worn for protection while preparing and administering fumonisin-
containing diets. The FBt-containing diet (250 mg FBt/kg diet) was prepared as follows: FBt 
stock sample dissolved in methanol (50 ml) was evaporated onto a subsample (200 g) of the 
diet, whereafter it was dried in a fume hood at room temperature for 12 h (Gelderblom et al., 
1994). Subsequently the subsample was thoroughly mixed into the diet (6 kg) to obtain the 
desired concentration ofFBt. The control diet was treated in a similar way using only an 
equal volume of methanol Each diet was prepared in 6 kg quantities at a time and stored at 
4°C until used. 
5.2.2. Acetylaminojluorene-containing diet 
The 0.02% 2-acetylaminofluorene (AAF)-containing diet was prepared by mixing 0.2 g AAF 
(Sigma Chemical Co., St. Louis, MO) per kg AIN diet. Gloves and masks were worn for 
protection during the preparation of AAF-supplemented diets. 
5.2.3. Iron-supplemented diet 
The 1 % (wtlwt) iron-supplemented diet was prepared by mixing 10 g of carbonyl iron (Sigma 
Chemical Co., St. Louis, MO) per kg AIN-76 diet. The iron content of the control AIN-76 
diet was only 35.7 mg iron per kg diet. Carbonyl iron is an extremely pure form of elemental 
iron (>98% iron with <0.8% carbon, <0.3% oxygen, and <0.9% nitrogen), prepared by 
reacting iron at high temperatures with carbon monoxide to form gaseous iron pentacarbonyl, 
Fe(CO)5. 
5.3. Liver histopathology 
5.3.1. Light microscopy 
For routine light microscopy, thin (4-5 mm) liver slices were immersion fixed in formalin for 
24 h before processing and embedding in paraffin wax. Routine processing protocols were 
adapted to a 4 h cycle to prevent the tissue from becoming brittle. All sections were mounted 
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5.3.2.4. Alpha-fetoprotein (AFP) 
For the detection ofAFP, tissues were fixed for 4 h in Bonin's fixative and embedded in 
paraffin wax (Omori et al., 1997a). Polyclonal rabbit anti-rat AFP (Accurate Chemicals, New 
York, NY) was used as primary antibody, and fetal rat livers were used as positive controls. 
5.3.2.5. Immunolocalization of mature TGF-fil protein 
Antibody to mature TGF-JH protein was a generous gift from Dr. K Flanders, National 
Cancer Institute, Bethesda, MD. Immunohistochemical staining for TGF-JH was done on 5-
J,tm deparaffinized sections with an indirect irnrnuDoperoxidase antiserum detection protocol 
(Elite kit; Vector Laboratories). Mature TGF131 protein was detected by the rabbit polyclonal 
LC (1-30) anoDody, as previously described (Sanderson et al., 1995). 
5.3.3. Apoptosis 
Cleavage of genomic DNA during apoptosis or programmed cell death yields double stranded 
low molecular weight DNA fragments (mono- and oligonucleosomes) as well as single strand 
breaks in high molecular weight DNA Cells undergoing apoptosis were detected in situ by 
TUNEL-specific labelling of nuclear DNA strand breaks, as described by Gavrieli et al. 
(1992). In this reaction the enzyme deoxynucleotidyl transferase (TdT) is used to label the 
free 3'-OH terminal with biotinylated-dUTP. 
Formalin fixed sections (5 ~) were deparaffinized and digested with 10 J,tg 
proteinase K (Boehringer Mannheim)/ml TrislHCl, pH 7.4, for 15 min at room temperature. 
Endogenous peroxidase activity was blocked by treating the sections for 10 min with periodic 
acid in phosphate buffered saline (PBS) followed by a 10 min treatment with sodium 
borohydride in PBS. The sections were equihorated for 5 min in reaction buffer (30 mM 
TrislHCL pH 7.4, 140 mM sodium cacodylate, 1 mM cobalt chloride, 0.3 % Triton X-lOO) 
then incubated (60 min at 370 C in a humidified chamber) with 25 U TdT and 0.3 nM 
biotinylated dUTP. The reaction was stopped by washing the slides with PBS containing 500 
J.1M EDTA Biotin labelled DNA was detected using peroxidase conjugated Streptavidin as 
described above and fast red as substrate for the peroxidase. Haematoxylin was used as a 
counterstain. 
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5.4. Liver biopsy technique 
Rat liver biopsies were performed under ether anaesthesia according to a modification of a 
method previously described (Cmielewski et al., 1997). Once fully anaesthetised, the rat was 
placed on a diathermy plate, the paws were carefully strapped down, and the abdomen was 
shaved and swabbed with iodine. A small midline incision (2 - 3 em) was made and the liver 
exposed (Figure S.lA). Part of one lobe of the liver was removed using a scalpel, and 
bleeding from the resected hepatic bed was controlled by diathermy (Figure S.lB). The 
abdominal incision was then sutured and the rat allowed ~o recover. A standard biopsy 
protocol was followed in all animals, commencing with the posteriorly situated left lobe, and 
rotating to the more accessible median lobe for repeat biopsy. On average, each rat underwent 
two liver biopsies during its lifetime before sacrifice. 
5.5. Iron studies 
5.5.1. Stainable hepatic iron 
Perls' Prussian blue stain for trivalent iron was used to assess storage iron content (Williams et 
al., 1962). Stainable iron in hepatocytes was graded 0 to 4, using a modification of the scale 
devised by Scheuer et al. (1962) (Table S.l). 
Table 5.1 
Grading of stainable iron in hepatocytes (modified from Scheuer et al., 1962). 
Stainable iron in hepatocytes (%) Grade 
absent 0 
less than 2S% 1 
2S%to SO% 2 
50% to 75% 3 
7S%to 100% 4 
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5.5.2. Hepatic iron concentration 
Liver tissue for determination of iron content was dried for 24 h at 105°C, weighed, digested 
in 50% nitric acid at 70°C for 1 h, and diluted in 0.2 M sodium acetate buffer pH 4.5. All 
glassware was rendered iron free and rinsed with iron free water (Torrance and Bothwell, 
1980). Iron concentration was determined using a Roche Unimate 5 Iron Kit (Roche 
Diagnostic Systems, Basel, Switzerland), on a Roche Cobas Fara II Centrifugal Analyser. 
5.5.3. Hepatic peroxidative damage 
Malondialdehyde (MDA) is formed when polyunsaturated fatty acids of membrane 
phospholipids undergo peroxidative decomposition. Lipid peroxidation was measured by the 
thiobarbituric acid (TBA) assay for malondialdehyde (MDA) concentration on samples of liver 
homogenate, as described by Esterbauer and Cheeseman (1990). Related substances such as 
sucrose, metal ions, and whole tissue homogenates may also react with TBA or influence the 
assay procedure, and the term thiobarbituric acid reacting substances (TBARS) more 
accurately describes the product of this assay (Esterbauer and Cheeseman, 1990). Liver 
samples were homogenised in 1.15% KCl containing 3 mM EDTA (PH 7.4) to obtain a 10 per 
cent solution. A mixture of2 m1 of the hepatocyte suspension (in saline) and 2 m1 ofTBA 
reagent, consisting of20% trichloracetic acid (TCA), 0.67% TBA and 0.01 % butylated 
hydroxytoluene (BHT) was incubated at 90°C for 20 min in a waterbath (Kinchington et at., 
1993). The samples were centrifuged at 3000 rpm for 10 min, 2 m1 of the supernatant was 
combined with 2 m1 ofa 0.67% TBA solution and heated for 10 min in boiling water. The 
mixture was allowed to cool and the absorbance measured at 532 nm (Esterbauer and 
Cheeseman, 1990). Lipid peroxidation was expressed as nmol MDA equivalents per mg 
protein, using a molar extinction coefficient of 1.56 x 10' M·I em·1 at 532 nm for MDA (Buege 
and Aust, 1978). 
5.5.4. Morphometric analysis oJ hepatic Joci and nodules 
Liver sections (5 J.lm thickness) were stained with GST pi for determination of the number and 
size of 'enzyme altered' foci and 'premalignant' nodules. Counterstaining was omitted in 
order to maximize differences in contrast for computerised morphometric analysis. One 
section from each of the left, right, and median lobes were examined for each rat. The number 
ofhepatic foci and nodules per section were counted, and were considered an estimate of the 
a 
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cancer initiating effects ofFB, and/or iron (Solt and Faber, 1976; Farber and Sarma, 1987). 
For the purposes of this study, a group ofGST pi positive cells was classified as a 'focus' ifit 
had an area ofless than 100 J..Lm2, and a 'nodule' ifit had an area of 100 J..LID2 or greater. The 
area (%) of liver occupied by GST pi positive foci and nodules was determined using a 
computerised morphometric analyser (Optimas, Bothell, WA), and was considered a 
measurement of the cancer promoting effects ofFB, and/or iron (Soh and Faber, 1976; Farber 
and Sarma, 1987). 
5.6. Molecular studies 
Northern (mRNA) analysis was performed on timed rat liver specimens in order to determine 
the the changes in expression of specific genes during feeding ofFB,. Poly(A)+ RNA was 
isolated from liver homogenate and separated according to size by electrophoresis through 
denaturing (formaldehyde) agarose gels. The mRNA was then transferred to nylon 
membranes by posiblotting, and visualized by autoradiography after hybridization to 
radiolabelled cDNA (antisense) probes. 
5.6.1. Probes 
Antisense riboprobes labelled with e2p]CTP were utilized for each of the following. A 429 bp 
piece of the 5' end rat AFP complementary DNA (cDNA) sub cloned into pGEM-4Z (kindly 
provided by Dr. Thomas D. Sargent, National Institute of Child Health and Human 
Development, Bethesda, MD) was linearized by Pst 1 and transcribed by SP6 RNA 
polymerase. A 600 bp cDNA fragment encoding the 3' end of rat HGF sub cloned into the 
pBluescript SK vector (kindly provided by Dr. Brian Carr, University of Pittsburgh School of 
Medicine, Pittsburgh, PA) was linearized by Hind ill and transcribed by T3 RNA polymerase. 
A 335 bp fragment of rat TGF-a cDNA was obtained by the reverse transcription 
polymerase chain reaction (RT-PCR) method and cloned as described previously (Hu et al., 
1994). EcoRVand SP6 RNA polymerase were used for its linearization and in vitro 
transcription. A fragment of rat SCF cDNA was also obtained by RT-PCR from poly(A)+ 
RNA isolated from rat liver as descn'bed previously (Fujio et al., 1994). This was linearized 
and transcribed by Xho 1 and SP6 RNA polymerase respectively. A 985 bp fragment of rat 
TGF-J31 cDNA cloned in pBluescript IT KS+ vector (kindly provided by Dr. Su Wen Qian, 
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Mouse cDNA for c-myc subc10ned into pGEM4 was linearized by EcoRl and 
transcribed by T7 RNA polymerase. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
cDNA probe labeled with [32P]dCTP by the random primer extension method was used as an 
internal control (Fort et al., 1985). 
5.6.2. RNA isolation and Northern blot analysis 
RNA was extracted from rat liver with guanidium thiocyanate followed by centrifugation in 
cesium chloride solution. Poly(A)+ RNA was selected by oligo (dT)-cellulose 
chromatography. Ten micrograms ofpoly(A) RNAs per lane were electophoresed on 0.8% 
agarose gels containing 2.22 mollL formaldehyde and were later transferred to nylon filters. 
After ultraviolet cross-linking, the filters were hybridized with appropriate probes at 60°C. 
Blots were washed twice each with Ix standard sodium citrate/O.l % sodium dodecyl sulfate 
(SSC/SDS) at room temperature (low stringency), O.lx SSC/SDS at room temperature, and 
O.lx SSC/SDS at 60°C (high stringency). Autoradiography was performed on Kodak X-
OMAT AR film (Rochester, NY) at -70°C using an intensifying screen. 
5.7. Liver cytosolic enzymes 
5.7.1. Thymidine kinase activity 
The in vitro conversion of thymidine to thymidine phosphate by rat liver cytosol was used to 
determine the level of thymidine kinase activity (Kahn et al., 1980). The reaction mixture 
contained 100 ~ cytosol (30% homogenate), prepared according to the method ofCorrigall 
and Kirsch (1988),850 III of incubation buffer consisting of5 mM adenosine triphosphate and 
3.6 mM MgCh in 50 mM Tris HCl (pH 8.0), and 50 ~ IIlM PH] thymidine. The reaction 
was allowed to proceed for 10 min at 37°C and terminated by immersion in boiling water for 2 
min. Denatured protein was removed by centrifugation at 1500g for 5 min at 4°C. A 100-~ 
aliquot of the supernatant was spotted on a square ofDEAE-cellulose paper. The paper 
squares were washed in 1 mM ammonium formate for 5 min, followed by distilled water for 3 
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min and placed in glass scintillation vials. A 0.1 M HC1I0.2 M KCI mixture was added to elute 
the radioactivity into solution. Ten m1 ACS scintillation fluid was added to each vial after 15 
min, and the radioactivity present in the vial was counted in a Packard Tri-Carb 460 CD liquid 
scintillation system (Downers Grove, IL). 
5.7.2. Glutathione S-transferase activity 
The spectrophotometric measurement of the rate ofthioether formation from electrophilic 
substrates by rat liver cytosol was used to determine the level of glutathione S-transferase 
(GST) activity (Habig et al., 1974; Corrigall and Kirsch, 1988). Whole liver GST activity was 
measured using l-chloro-2,4-dinitrobenzene (CDNB) as aromatic substrate (Habig et al., 
1974) in a Hitachi U 3200 dual beam spectrophotometer (Protea Nuclear Instruments, South 
Africa). All assays were performed at 25°C at a pH of6.5. To a 3 m1 cuvette the following 
reagents were added: (1) 2.75 m1 0.1 M potassium phosphate buffer; (2) 0.1 m1 stock 
substrate CDNB (30 mM), freshly prepared in 95% ethanol and kept in the dark; (3) 0.15 m1 
reduced glutathione (GSH, 20 mM), freshly prepared in degassed H20; and (4) rat liver 
cytosol 0.05 m1, containing the enzyme and prepared as stated above. The reagents were 
mixed well and the change of absorbance (A. = 340) was monitored over 1 min. This change 
was read against an assay blank which included all the reactants except the enzyme in order to 
correct for the small amount of non-enzymatic activity. Specific activity was calculated from 
the equation: 
AA / min final assay volume 103 
--- X x-----------(&) sample volume protein concentration (mg / ml) 
where AA = change in absorbance and J1.& = 9600 =difference in molar extinction coefficient 
for CDNB (M1cm·1). Results are expressed as /lmollmin/mg protein. Protein was measured 
according to the method of Lowry et al. (1951). 
l 
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Chapter 6 
Acute fumonisin Bt-induced hepatotoxicity: 
Histopathology and biochemical indices of liver 
injury 
6.1. Introduction 
67 
FBI has been shown to be hepatotoxic (Gelderblom et. al., 1988a) and hepatocarcinogenic 
(Gelderblom et aI., 1991) in rats. The principal pathological change in rats treated with FBI in 
the diet (1000 mg/kg) in short-term toxicity tests (21-33 days) is progressive ''toxic hepatitis" 
characterised by hepatocellular necrosis, bile duct proliferation (''hyperplasia''), and fibrosis 
(Gelderblom et. al., 1988a). During a chronic feeding study over a period of26 months with 
FBI 50 mg/kg, animals developed a 'chronic toxic hepatitis' that progressed to cirrhosis and 
cholangiofibrosis, and which terminated in hepatocellular carcinoma and cholangiocarcinoma 
respectively (Gelderblom et al., 1991). In a preliminary study, Voss et al. (1993) reported 
that FBI was hepatotoxic in rats fed a diet containing 150 mg/kg for 4 weeks and also 
nephrotoxic at 15-50 mg/kg. "Scattered single cell necrosis", bile duct proliferation, and an 
increase in mitotic cells were described. The "scattered single cell necrosis" was subsequently 
confirmed as apoptosis (Tolleson et al., 1996a). 
The bile duct proliferation (''hyperplasia'') noted in rats fed FBI (Gelderblom et al., 
1988a; Voss et al., 1993) may in fact represent the proliferation of 'oval cells' (Farber, 1956), 
thought to be the progeny of a liver progenitor ('stem') cell (Grisham and Thorgeirsson, 
1997). However, to date there have been no irnnnmohistological studies examining the role of 
oval cell proliferation during feeding of FBI to rats. Another striking histological finding in 
the short-term FBI feeding studies was the rapid development of hepatic fibrosis (Gelderblom 
et al., 1988a; Voss et al., 1993), but the role of hepatic stellate (Ito) cells in the prominent 
fibrogenesis has not been examined. 
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The aim of the present study was to descnoe in more detail the histopathological and 
immunohistochemical changes in rat liver during short-term (five weeks) feeding of FBI 250 
mg/kg, with particular emphasis on the role of oval cell and stellate cell proliferation. In 
addition, time changes in biochemical indices of liver injury, cellular proliferation, and 
premalignancy were measured during the study. 
6.2. Experimental methods 
6.2.1. Animals and diet 
The purification of FBI and preparation of the diets were performed as described in Chapter 5. 
6.2.2. Experimental 
Thirty male Fischer 344 rats (150 to 200 g) were randomly assigned to two groups and fed for 
up to five weeks with FBI 250 mg/kg diet or control AIN-76A diet, as shown in TABLE 6.1. 
TABLE 6.1 
Treatment and control groups for short-termfumonisin BI (FBI) feeding study. 
Group FBI (mglkg) No. of rats 
Fumonisin 250 
Control 0 
Total 
20 
10 
30 
Four rats from the FBI group and two rats from the control AIN group were sacrificed weekly 
till the end of 5 weeks. At sacrifice, the animals were anaesthetised by the intraperitoneal 
injection of a sodium pentobarbitone solution (6% m/v). Blood was collected from the 
abdominal aorta for the measurement of plasma levels of aspartate transaminase (AST), and 
animals died by exsanguination via the aorta. The liver was removed and weighed. Freshly 
cut slices of liver were snap frozen in liquid nitrogen and stored at -70°C for analysis of 
cytosolic thymidine kinase (TK) and glutathione S-transferase (GST) activity. 
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6.2.3. Light microscopy 
For routine light microscopy, slices of liver 4-5 mm in thickness were immersion-fixed in 10% 
neutral buffered formalin for 24 h before processing and embedding in paraffin wax (see 
Chapter 5). Stains included routine haematoxylin and eosin (H&E), sirius red for collagen, 
and Gordon & Sweet's method for reticulin. Coded sections were examined for evidence of 
hepatocyte injury, apoptotic bodies, fatty change, mitoses, architectural distortion, fibrosis, 
regenerative nodules, and oval cell proliferation. Cells undergoing apoptosis were detected in 
situ by TUNEL-specific labelling of nuclear DNA strand breaks, as descnoed by Gavrieli et ai. 
(1992). 
6.2.4. Immunohistochemistry 
Staining with Desmin D33 (Dako, Copenhagen, Denmark) for hepatic stellate (Ito) cells and 
rabbit polyclonal GST pi (Novacastra, Newcastle-Up on-Tyne, UK) for 'enzyme-altered' 
hepatic foci and 'preneoplastic' nodules was performed on paraffin sections. After sequential 
layering with biotinylated rabbit anti-mouse or swine anti-rabbit (Dako, Copenhagen, 
Denmark) 1:250 dilution as link antibodies, peroxidase conjugated Streptavidin (Dako, 
Copenhagen, Denmark) 1:500 was applied for 30 min at room temperature. The OV-6 mouse 
monoclonal antibody, which stains both oval cells and bile duct cells, was a generous gift from 
Professor Stewart Sell, Albany, New York. Acetone fixed cryostat sections were brought to 
room temperature and stained by means of a standard two-stage indirect peroxidase 
conjugated technique (Dako P 161, Copenhagen, Denmark). 
6.2.5. Biochemical indices 
Serum AST levels, and liver cytosolic TK and GST activity were measured weekly for 5 
weeks as biochemical markers of liver injury, cellular proliferation, and premalignancy 
respectively. Hepatic TK activity was measured as described by Kahn et ai. (1980), and 
hepatic GST activity was determined by the method of Habig et ai. (1974) (see Chapter 5). 
6.2.6. Statistics 
Statistical analysis was performed using two way analysis of variance, and significance was set 
at an alpha level (p value) of 0.05. 
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week 3 to 5. Some foci were close to the terminal hepatic venules while others abutted on the 
portal tracts. By weeks 4 and 5 some rats had developed large 'atypical' nodules that were 
readily seen in the H&E sections and confirmed by GST pi staining. Of note was the close 
relationship of some hepatic foci and nodules to portal tracts that contained the proliferating 
oval cells, and the presence of oval cells inside several of these 'atypical' nodules (Figure 
6.2F). 
Figure 6.1. Liver pathology in the fumonisin Bl-fed rat. (A) Liver at week 1 showing a 
terminal hepatic vein (centre), with numerous surrounding deeply eosinophilic apoptotic 
bodies and necrotic hepatocytes in zone 3, as well as a sparse mononuclear cell infiltrate. 
H&E, objective x 20. (B) High power magnification of liver at week 2 showing two classical 
apoptotic bodies (AB). These hepatocytes appear as shrunken and deeply eosinophilic cells, 
with evidence of nuclear chromatin condensation and margination below the cell membrane. 
H&E, objective x 60. (C) Liver at week 3 showing a terminal hepatic venule (centre) and 
numerous apoptotic hepatocytes scattered throughout the parenchyma. TUNEL method, 
objective x 10. (D) High power magnification of liver at week 3 showing prominent mitotic 
(MF) in two hepatocytes. H&E, objective x 60. (E) Liver at week 5 showing loss of the 
normal acinar architecture due to the presence of regenerative nodules ofhepatocytes which 
are partially or completely surrounded by bands of fibrous tissue. Gordon and Sweets stain 
for reticulin, objective x 4. (F) Liver at week 5 showing the features ofan early/developing 
cirrhosis. Sirius red, objective x 10. 
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Figure 6.2. Immunohistochemical studies of livers from fumonisin Bt-fed rats. (A) Liver at 
week 1 showing numerous desmin positive hepatic stellate cells which are located in the zone 
3 region of the liver with a similar distribution to the liver injury shown in Figure 6.l. P-A-P, 
objective x 20. (B) Liver at week 3 showing numerous desmin positive hepatic stellate cells 
which are located in the portal tracts and zone 1 regions. Numerous proliferating oval cells 
are also seen in the portal tracts, and the hepatocytes show mild fatty change. Objective x 10. 
(C) Liver at week 2 showing small numbers of OV -6 positive single cells and small ductules in 
the portal tracts. Objective x 10. (D) Liver at week 5 showing numerous proliferating oval 
cells, which are seen as single cells and small ductules that are OV -6 positive, located in the 
portal tracts and adjacent liver parenchyma. Objective x 4. (E) Liver at week 5 showing an 
'atypical' nodule composed ofGST pi positive hepatocytes which is located next to a portal 
tract (left). Proliferating oval cells, which are GST pi negative, are seen in the portal tract and 
within the nodule. Objective x 20. (F) Higher magnification of the liver in Figure 6.2.E 
showing oval cells with a group of GST pi positive hepatocytes. Objective x 40. 
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Figure 6.4. Liver cytosolic thymidine kinase (TK) activity in rats fed either FBI 250 mg/kg or 
control diet for 5 weeks. 
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Figure 6.5. Liver cytosolic glutathione S-transferase (GST) activity in rats fed either FBI 250 
mg/kg or control diet for 5 weeks. 
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6.4. Discussion 
In this short-term feeding study, FBI 250 mg/kg caused toxic liver injury, initially with 
apoptosis in zone 3, followed by apoptosis and mitoses in all zones of the liver, progressive 
hepatic fibrosis and regenerative nodule formation, and development of 'enzyme-ahered' 
hepatic foci and 'atypical' nodules. The bile duct proliferation (''hyperplasia'') previously 
described by Gelderblom et al. (1988a) was confirmed in this study as proliferation ofOV-6 
positive oval cells, radiating from portal tracts into the adjacent liver parenchyma. Oval cell 
proliferation occurred despite clear evidence of continued hepatocyte regeneration at all time 
points. Proliferation of adult hepatocytes has been noted in other models for oval cell 
activation, including galactosamine (Dabeva and Shafritz, 1993) and dipin (Factor et al., 
1994). FBI has been reported to cause a dose-dependent inhibition of PH-induced 
incorporation of [3H]-thymidine in hepatocytes (Gelderblom et al., 1996b), and bile ductu1ar 
proliferation has been noted at FBI dosages of 50 mg/kg diet (Dr. W.C.A Gelderblom: 
personal communication). FBI-induced oval cell proliferation does not appear to be an 'all-or-
nothing' phenomenon, which occurs only when hepatocyte regeneration is absent. Complete 
mitoinhibition ofhepatocytes thus does not appear to be an absolute requirement for the 
activation of the progenitor cell compartment, and other factors ( e. g. functional impairment of 
hepatocytes) may conceivably also playa role. 
Immunohistochemical staining demonstrated marked proliferation of desmin positive 
hepatic stellate cells from week 2, which appeared to mirror the distribution of the hepatocyte 
injury as well as the development of hepatic fibrosis. Hepatic stellate cells are perisinusoidal 
non-parenchymal cells which in normal liver are non-proliferative and are the main storage site 
for vitamin A (Friedman, 1996). Following liver injury of any kind, stellate cells undergo 
'activation' and transformation with loss of intracellular retinoid, enhanced production of 
extracellular matrix proteins, increased contractility, and secretion of a variety of growth 
factors and cytokines which act in an autocrine and paracrine fashion OJi cells in the liver 
(Thorgeirsson et al., 1993). Hepatic stellate cells thus playa major role in hepatic fibrogenesis 
(Friedman, 1996). 
The prominent pro-apoptotic effects of FBI in rat liver are intriguing, and contrast with 
the in vitro effects of this mycotoxin on chemotherapy-mediated tumour cell destruction (Bose 
et al., 1995). FBI has been found to have specific, potent activity as an inhibitor of 
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sphingolipid biosynthesis by blocking the conversion of sphinganine to ceramide (Wang et al., 
1991; Yoo et al., 1992; Merrill et al., 1996). Ceramide is a recently identified lipid second 
messenger that is believed to be one of the immediate signals for cell death generated in 
tumour cells treated with the chemotherapeutic agent, daunorubicin (Spiegel et al., 1996). 
The production of ceramide and the ensuing onset of apoptosis in murine leukaemia cells 
cultured in the presence of daunorubicin is prevented by pre-treatment with FBI (Bose et al., 
1995). The molecular mechanisms of action of FBI are thus complex, and it appears that this 
fungal toxin may act as either an inhibitor or promoter of apoptosis, depending on the 
experimental situation (Lemmer et al., 1998a). 
At later time points in this study, we noted the close relationship of some 'atypical' 
hepatic foci and nodules to portal tracts that contained proliferating oval cells and ductules, 
and the presence of oval cells and ductules inside several of these nodules. It is possible that 
some of these oval cells were in fact adjacent to ('swirling around') the 'atypical' nodules, 
depending on the plane of section of the liver specimens. These cells showed typical 
morphological features of oval cells, but did not express GST pi, thus aiding their recognition 
within the GST pi positive nodules. 
The histological picture of toxic hepatitis, hepatic stellate and oval cell proliferation, 
and formation of' enzyme-altered' hepatic foci and nodules was reflected by biochemical 
indices of liver injury, cellular proliferation, and premalignancy. Both serum AST levels and 
liver cytosolic TK activity were markedly increased. Coincident with the appearance of GST 
pi positive foci and nodules, whole liver GST activity was increased in FBt-fed animals. The 
glutathione S-transferases are a family of multifunctional proteins that catalyse the conjugation 
of glutathione with electrophilic compounds biotransformed from xenobiotics, including 
carcinogens (Tsuchida and Sato, 1992; Hayes and Pulford, 1995). In preneoplastic cells as 
well as neoplastic cells, specific molecular forms of GST are expressed and may participate in 
the mechanisms of their resistance to drugs (Sato, 1988; Sato 1989). The rat pi class form is 
strongly expressed in hepatic foci, nodules and carcinomas, and is regarded as one of the most 
reliable markers for preneoplastic lesions in the rat liver (Satoh et al., 1985; Sato, 1988; Sato 
1989). The precise role(s) and function(s) ofGST pi in preneoplastic cells is unclear. In 
addition to participation in conjugation reactions (Tsuchida and Sato, 1992; Hayes and 
Pulford, 1995), GST pi exhibits selenium-independent glutathione peroxidase activity toward 
lipid hydroperoxides. Thus, GST pi expression may be related to the prevention of lipid 
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peroxidation (Meyer et al., 1985; Ketterer et al., 1989), which is considered to play an 
important role during tumour promotion by various carcinogens, including the fumonisins 
(Abel and Gelderblom, 1998). 
6.5. Conclusions 
79 
Short-term feeding with FBI causes a severe toxic liver injury characterized by apoptosis, 
hepatic stellate cell proliferation, fibrosis, oval cell proliferation, and the appearance of 
'atypical' hepatic foci and nodules. The histological picture of FBI-induced hepatotoxicity is 
reflected by biochemical indices of liver injury, cellular proliferation, and premalignancy. Oval 
cells closely related to foci and nodules appeared to be undergoing phenotypic changes, and 
long-term FBI feeding studies are required to determine the ultimate fate of these oval cells. 
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Chapter 7 
Hepatic gene expression changes during short-term 
feeding of fumonisin Bl 
7.1. Introduction 
80 
Short-term feeding offumonisin BI (FBI) to rats causes zone 3 toxic liver injury, prominent 
apoptosis ofhepatocytes, oval and stellate cell proliferation, progressive hepatic fibrosis, and 
development of 'atypical' nodules (see Chapter 6). There is currently no information on the 
molecular mechanisms underlying these hepatic histopathological changes caused by FBI. This 
study employed Northern (m,RNA) blot analysis oftim~ liver specimens from rats fed FBI 250 
mg/kg diet for 5 weeks, in order to examine the hepatic gene expression changes for a-
fetoprotein (AFP), hepatocyte growth factor (HGF), transforming growth factor (TGF)-a, TGF-
~ 1, and c-myc. Changes in hepatic gene expression were correlated with liver histopathology, and 
immunolocalization of mature TGF-~ 1 protein was performed. 
It was postulated that TGF-~1 in particular might play an important role in the genesis of 
some of the hepatic histopathologic changes during feeding of FBI. TGF-fH expression in the 
liver is known to cause both apoptosis and fibrosis, and the two actions may be interrelated 
(Tsukamoto et aI., 1990; Rosser and Gores, 1995; Patel and Gores, 1995). Apoptotic cells 
secreting TGF-f31 may be the driving force for hepatic fibrogenesis. Stellate cells exposed to 
TGF-f31, originating from apoptotic hepatocytes, become activated ('myofibroblasts') and 
contribute to liver fibrogenesis by proliferating and secreting collagen (Rosser and Gores, 1995; 
Patel and Gores, 1995). Activated stellate cells in tum secrete TGF-f31 inducing apoptosis of 
neighbouring hepatocytes, via signalling through serine/threonine kinase (Smad) cascades 
(Massague et al., 1997). 
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7.2. Experimental methods 
7.2.1. Chemicals and diet 
The purification of FBI and preparation of the diets were performed as described in Chapter 5. 
7.2.2. Experimental 
Twelve male Fischer 344 rats were randomly divided into two groups and fed for up to 5 weeks 
with either diet containing FBI 250 mg/kg or control AIN diet as shown in TABLE 7.1. 
TABLE 7.1 
Treatment and control groups for fumonisin B1-induced hepatic gene expression study. 
Group FBI (mglkg) No. of rats 
Fumonisin 250 
Control 0 
Total 
9 
3 
12 
Three rats from the treatment group and one rat from the control group were sacrificed weekly 
from weeks 3 - 5 by decapitation. The livers were harvested, and sections were fixed in 10% 
neutral buffered formalin for light microscopy and itmmmohistochemistry. The remaining liver 
was snap frozen in liquid nitrogen and stored at -70°C for mRNA analysis. 
Liver samples from week 3 to 5 were examined by Northern blotting for expression of 
transcripts for AFP, HGF, TGF-a., TGF-JH, and c-myc. Liver specimens from day 9 post partial 
hepatectomy combined with acetylaminofluorene (AAFIPH regitnen) from another study (Omori 
et al., 1996: with permission) were included to serve as positive controls for oval cell proliferation 
and hepatic gene expression. Maximal oval cell proliferation is known to occur at this time point 
post AAFIPH (Thorgeirsson et al., 1993). 
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7.2.3. Light microscopy and immunohistochemistry 
Liver sections (5 Jl1ll) were fixed in 10% neutral buffered formalin and embedded in paraffin for 
routine light microscopy and immunohistochemistry (see Chapter 5). Routine stains included 
haematoxylin and eosin (H&E) and sirius red for collagen. Sections were examined for evidence 
ofhepatocyte necrosis and apoptotic bodies, fatty change, mitoses, architectural distortion, 
fibrosis and regenerative nodules, and oval cell proliferation. Immunohistochemical stains 
performed on paraffin sections included desmin for hepatic stellate cells, polyclonal GST pi for 
'enzyme-altered' hepatic foci and 'preneoplastic' nodules, and OV-6 monoclonal anuoody for 
oval cells. 
7.2.4. Probes 
Plasmid vectors containing cDNA sequences to hepatic gene transcripts were linearized by 
restriction enzymes and transcnoed by RNA polymerases. Antisense riboprobes labeled with 
[32p]CTP were utilised for each of the following. A 429 bp piece of the 5' end rat AFP cDNA 
sub cloned into pGEM-4Z (kindly provided by Dr. Thomas D. Sargent, National Institute of Child 
Health and Human Development, Bethesda, MD) was linearized by Pst 1 and transcribed by SP6 
RNA polymerase (Jagodzinski et ai., 1981). A 600 bp cDNA fragment encoding the 3' end of rat 
HGF sub cloned into the pBluescript SK vector (kindly provided by Dr. Brian Carr, University of 
Pittsburgh School of Medicine, Pittsburgh, PA) was linearized by Hind ill and transcribed by T3 
RNA polymerase. A 335 bp fragment of rat TGF-a. cDNA was obtained by the reverse 
transcription polymerase chain reaction (RT-PCR) method and cloned as described previously 
(Hu et ai., 1994). EcoRV and SP6 RNA polymerase were used for its linearization. and in vitro 
transcription. A 985 bp fragment ofrat TGF-JH cDNA cloned in pBluescript IT KS+ vector 
(kindly provided by Dr. Su Wen Qian, National Cancer Institute, Bethesda, MD) was linearized 
by Xho 1 and transcribed by T3 RNA polymerase. Mouse cDNA for c-myc subcloned into 
pGEM4 was linearized by EcoRl and transcribed by T7 RNA polymerase. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) cDNA probe labeled with [32P]dCTP by the random primer 
extension method (Fort et ai., 1985) was used as a RNA loading control for for all experiments. 
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7.2.5. RNA isolation and Northern blot analysis 
RNA was extracted from rat liver with guanidium thiocyanate followed by centrifugation in 
caesium chloride solution. Poly(A)+ RNA was selected by oligo (dT)-cellulose chromatography. 
Ten micrograms ofpoly(A) RNAs per lane were electophoresed on 0.8% agarose gels containing 
2.22 mollL formaldehyde and were later transferred to nylon fihers. After ultraviolet cross-
linking, the filters were hybridised with n"boprobes at 60°C and at 42°C with cDNA probes. Blots 
were washed twice each with Ix standard sodium citrate/O.l % sodium dodecyl sulfate (SSC/SDS) 
at room temperature, O.lx SSC/SDS at room temperature, and O.lx SSC/SDS at 60°C. 
Autoradiography was performed on Kodak X-OMAT AR film (Rochester, NY) at -70°C using an 
intensifying screen. 
7.2.6. Immunostainingfor TGF-f31 protein 
Antibody to mature TGF-Jn protein was a generous gift from Dr. K Flanders, National Cancer 
Institute, Bethesda, MD. Immunohistochemical staining for TGF-JH protein was done on 5-~ 
deparaffinized sections with an indirect immunoperoxidase antiserum detection protocol (Elite kit; 
Vector Laboratories). Mature TGF-JH protein was detected by the rabbit polyclonal LC (1-30) 
antibody, as previously descn"bed (Sanderson et ai., 1995). 
7.2.7. Statistics 
Rat weight gain of rats fed FB 1 or control diet was compared by two way analysis of variance. 
Significance for the acceptance interval was set at an alpha level (p value) of 0.05. 
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7.3. Results 
7.3.1. Rat weight gain 
In the total group of60 rats that were commenced on the long-term feeding study (Chapter 8), 
animals fed on control AIN diet showed more rapid weight gain during the first 5 weeks than 
FBI-fed animals, and their weights crossed the acceptance interval soon after the initiation of the 
study (Figure 7.1). The effect of FBI feeding on weight gain in rats has been noted previously 
(Gelderblom et at., 1991), and appears to be due to both a feed refusal effect and FBI toxicity. 
300 
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52 150 ~ 
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-O--control 
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0 1 2 3 4 5 
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Figure 7.1. Weight gain during the 5 week study period of rats fed either FBI 250 mglkg or 
control AIN diet. Animals fed on control AIN diet showed more rapid weight gaiD. during the 5 
week study period than FBI-fed animals, and their weights crossed the acceptance interval soon 
after the initiation of the study. 
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7.3.2. Light microscopy and immunohistochemistry 
The histopathological changes noted in rat liver during feeding with FBI 250 mg/kg diet were 
similar to those described previously (see Chapter 7), although the severity of liver injury and 
degree of resultant oval cell proliferation appeared somewhat le~s in this study. FBI caused 
ongoing zone 3 toxic liver injury with numerous apoptotic bodies and collapse of the reticulin 
framework. Immunohistochemistry showed proliferation of desmin-p0 sitive hepatic stellate (Ito) 
cells in zone 3, and also proliferation ofOV-6 positive oval cells. Numerous GST pi positive 
hepatocyte foci and nodules were noted at week 5. Sirius red stains for collagen showed the rapid 
development ofhepatic fibrosis. 
7.3.3. Expression of AFP, HGF, and TGF-a 
Transcripts for AFP were not detected in normal liver. Feeding with FBI 250 mg/kg resulted in a 
progressive increase in the expression of the 2.1 kb AFP transcripts from week 3 to 5. The peak 
level of AFP expression was however much less than that seen at day 9 post AAFIPH (Figure 
7.2). 
Transcripts for HGF were also not detected in normal liver. Feeding with FBI 250 mg/kg 
resulted in a moderate but sustained increase in expression ofHGF from week 3 to 5. HGF 
expression in FBI-fed animals was less than that seen at day 9 post AAFIPH (Figure 7.2). 
No expression ofTGF-a was detected in normal liver. Short-term feeding with FBI 250 
mg/kg resulted in a moderate but fluctuating increase in expression of TGF-a to levels that were 
similar to that seen at day 9 post AAFIPH (Figure 7.2). 
7.3.4. Expression ofTGF-pl and c-myc 
Some expression ofTGF-JH mRNA was detected in normal liver. Feeding with FBI 250 mg/kg 
resulted in a marked and progressive increase in expression ofTGF-'H from week 3 to 5. The 
maximum level of expression ofTGF-IH in FBI-fed rats was similar to that seen at day 9 post 
AAFIPH (Figure 7.3). 
Transcripts for c-myc were detectable at a low level in normal liver. Feeding with FBI 250 
mg/kg resulted in a marked increase in expression of c-myc, with maximum levels being expressed 
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at week 4. This level of expression of c-myc was similar that seen at day 9 post AAF/PH (Figure 
7.3). 
7.3.5. Immunolocalization ofTGF-fiI protein 
Staining with LC(1-30) antibody demonstrated a progressive increase in expression of mature 
TGF-fH protein in the rat liver over the 5 week FBI feeding period (Figure 7.4). Expression of 
TGF-fH protein by hepatocytes was initially focal (Figure 7.4B), but with continued feeding the 
protein was abundantly expressed in most hepatocytes (Figures 74.C and 7.4D). TGF-IH protein 
was not detected in zone 3 hepatocytes, which showed evidence of frequent mitoses and 
apoptosis. Oval cells, stellate cells, and Kupffer cells were consistently negative for TGF-P 1 
protein. 
7.4. Discussion 
Feeding with FBI 250 mg/kg resulted in increased expression ofHGF, TGF-a., and AFP 
transcripts at weeks 3,4 and 5, which coincided with desmin positive stellate cell and OV-6 
positive oval cell proliferation. AFP expression was used as a marker for oval cell proliferation 
(Omori et al., 1997a). HGF and TGF-a. are important growth factors in the liver, and are 
involved in both normal liver regeneration (Michalopoulos, 1990; Michalopoulos and DeFrances, 
1997) and activation/proliferation of the oval cell compartment (Thorgeirsson et al., 1994; 
Grisham and Thorgeirsson, 1997). Expression of transcripts for HGF and TGF-a. during feeding 
of FBI was less than seen at day 9 post AAF/PH (time of maximal oval cell proliferation in 
AAF/PH model). The moderately increased but sustained expression of genes for liver growth 
factors during feeding with FBI presumably reflects ongoing hepatotoxicity. This contrasts with 
the AAF /PH model, in which massive but transient liver injury and growth factor expression 
occurs. 
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FBI feeding resuhed in marked overexpression ofTGF-Jn in rat liver. Surprisingly, TGF-
J31 protein was expressed almost exclusively by hepatocytes, while stellate cells and oval cells 
were persistently negative. ImmuDostaining demonstrated a progressive increase in the numbers 
ofhepatocytes expressing mature TGF-J31 protein during FBI feeding, and by 3 weeks most 
hepatocytes in the liver lobule were stained by LC (1-30) anuDody. However, zone 3 hepatocytes 
remained persistently negative for TGF-J31 protein, and many of these hepatocytes were 
undergoing mitosis or apoptosis. The markedly increased levels ofTGF-J31 expression by 
hepatocytes may be responsible for the prominent apoptosis and fibrosis seen in the rat liver 
during feeding with FB 1. 
Feeding of FBI also resuhed in overexpression of c-myc, a proto-oncogene that has been 
characterised as a positive regulator of cell proliferation involved in tumour progression (Garte, 
1993; Nagy et al., 1988), and has also been implicated in TGF-J31 signalling (Alexandrow and 
Moses, 1995). Increased expression of c-myc and TGF-J31 may cooperate in the promotion of 
liver tumours in the FBI-fed rat. It has been shown that overexpression of c-myc in TGB-J31-
sensitive cells can resuh in the loss of sensitivity to TGF-J31 (Alexandrow et al., 1995). 
Furthermore, co-expression of c-myc and mature TGF-J31 in the livers of transgenic mice 
accelerates hepatocarcinogenesis that is associated with reduced TGF-J3 type IT receptor (TJ3IIR) 
expression (Factor et al., 1997). Overexpression ofTGF-J31 in transgenic mice may thus produce 
a mitoinhibitory environment that selects for the growth ofTGF-J31-resistant transformed liver 
cells. Once present, loss ofTGF-J31-transduced growth inlnoitory signals and up-regulation ofc-
myc expression result in the unrestrained growth of those transformed liver cells and facilitate 
liver tumour development (Factor et al., 1997). Although it is likely that transformed cells in the 
livers of FBI-fed rats have similarly acquired resistance to the antiproliferative effects ofTGF-J31, 
the underlying mechanisms have not been studied. 
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7.5. Conclusions 
Feeding with FBI results in increased expression of genes for AFP, HGF, and TGF-a, but levels 
of these transcripts are lower than following AAFIPH In contrast, feeding with FBI results in 
marked overexpression ofTGF-J31 and c-myc. The overexpression ofTGF-J31 maybe causally 
related to the prominent apoptosis and fibrosis seen in FBI -induced liver injury. Increased 
expression of c-myc and TGF-J31 may cooperate in the promotion of liver tumours in the FBI-fed 
rat, possibly due to the provision of a selective milieu for the outgrowth of preneoplastic cells 
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Chapter 8 
The effects of dietary iron overload on fumonisin B1-
induced cancer promotion in the liver 
8.1. Introduction 
Fumonisin BI (FBI) is hepatotoxic and hepatocarcinogenic in rats (Gelderblom et aI., 1988; 
Gelderblom et al., 1991). FBI acts as a strong promoter (and possibly weak initiator) of 
'enzyme ahered' hepatic foci and nodules in short-term cancer studies (Gelderblom et ai, 
1992b; Gelderblom et ai., 1996b). The mechanisms of FBI-induced toxicity and cancer 
induction in the liver are unclear, but there is some evidence that peroxidation of lipid 
membranes (Abel and Gelderblom, 1998; Yin et al., 1998) and oxidative DNA damage (Sahu 
et ai., 1998) might playa role. 
Dietary iron overload is common in sub-Saharan Africa, and hepatic iron 
concentrations rival those occurring in genetic haemochromatosis. Recent studies suggest that 
dietary iron overload may be a risk factor for HCC in Black Africans (Gordeuk et ai., 1996; 
Mandishona et al., 1998). The development ofHCC in humans with iron overload (genetic or 
dietary) usually occurs in the setting of iron- or alcohol-induced cirrhosis (Niederau et ai., 
1985), and it is not clear whether iron plays a direct role in the induction of liver tumours or 
whether the increased cancer risk arises solely from the cirrhotic process. Although 
mechanisms of iron-induced hepatotoxicity are incompletely understood, free radical-mediated 
peroxidative damage to cellular lipids, proteins, and DNA is likely (Britton et ai., 1994; 
Abalea et al., 1998). Experimentally, the potentiation of cancer induction due to 
polyhalogenated hydrocarbons by iron overload in rodents (Smith et al., 1990), would suggest 
that iron may act as a promoter of initiated hepatocytes. Studies carried out to test this 
hypothesis have, however, shown conflicting results, with both promoting and inhibiting 
effects on cancer induction by excess hepatic iron (Stil et al., 1995; Carthew et aI., 1997). 
Both FB I and excess hepatic iron may thus cause peroxidation of membrane lipids and 
oxidative liver injury (Abel and Gelderblom, 1998; Britton et al., 1994). Furthermore, both 
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agents may, either directly or indirectly, affect the induction of liver tumours. The aims of this 
study were to determine whether dietary iron loading (i) enhances FBI-induced hepatic lipid 
peroxidation, and (ii) modulates the cancer initiating and promoting properties of FBI. 
8.2. Experimental methods 
8.2.1. Chemicals 
FBI was purified from com cultures of Fusarium moniliforme strain MRC 826 according to 
the method described by Cawood et al. (Cawood et al., 1991) to a purity of 92-95%. 
Carbonyl iron (CI), an extremely pure form of elemental iron (>98% iron with <0.8% carbon, 
<0.3% oxygen, and <0.9% nitrogen), was purchased from Sigma Chemical Company (St. 
Louis, MO). 
8.2.2. Animals and diet 
The study was approved by the Ethics and Research Committee of the University of Cape 
Town, and the experiments were conducted in accordance with the laws and regulations 
controlling experiments on live animals in South Africa. Thirty eight male Fischer 344 rats 
were fed AIN-76A diet (American Institute of Nutrition, 1980), which has an iron content of 
50.6 mglkg feed (see Appendix C). The diets containing FBI 250 mglkg were prepared as 
described previously (Gelderblom et al., 1994) and stored under nitrogen at -20°C for the 
duration of the study. Animals that were randomised to receive dietary iron loading, were 
initially fed 2% (wt/wt) CI when weaned, but this had to be temporarily discontinued after 2 
weeks (for 1 week) due to growth retardation, whereafter iron supplementation was resumed 
with 1 % (wt/wt) carbonyl iron (Figure 8.1A). 
8.2.3. Experimental 
The 5 week FBI-feeding experiment (250 mglkg diet) was commenced when the rats weighed 
approximately 155- 165 g (group 1, 160.9 ± 5.0 g; group 2, 165.2 ± 1.9 g; group 3, 153.2 ± 
4.6 g; group 4, 155.7 ± 4.8 g). The 38 animals were divided into four treatment groups 
according to a 2 x 2 factorial design, i.e. controls (group 1, n = 8); FBI 250 mg/kg diet 
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Figure S.lA. Mean body weights of rats during the period of iron loading from the time of 
weaning until the start of the FB I feeding experiment. Animals that were randomised to 
receive dietary iron loading (groups 3 and 4), were initially fed 2% (wt/wt) CI from the time of 
weaning, but dietary iron supplementation was temporarily discontinued after 2 weeks (for 1 
week) due to growth retardation. During this seven day period of no iron supplementation, 
rats in groups 1 and 2 were feed restricted in order to allow for 'catch up' growth of the 
growth retarded animals in groups 3 and 4. Thereafter, iron loading of group 3 and 4 animals 
was resumed with 1% (wt/wt) carbonyl iron, and averaged feeding was instituted in order to 
control feed intake of group 1 and 2 rats, and to allow for comparable rates of body weight 
gain in all treatment groups. The mean body weights in the different treatment groups had 
equalised by week 4 after weaning, and total weight gain in the different groups over the six 
week period preceding the commencement of the FBI feeding experiment was comparable 
(group 1, 111.3 ± 3.7 g; group 2, 108.4 ± 4.3 g; group 3, 107.5 ± 71 g; group 4 110.0 ± 9.0 
g). Once instituted, dietary iron supplementation remained constant at 1% until the end of the 
study. Error bars have been omitted for the sake of clarity of the graph. 
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Figure S.lA. Mean body weights of rats during the period of iron loading from the time of 
weaning until the start of the FBi feeding experiment. Animals that were randomised to 
receive dietary iron loading (groups 3 and 4), were initially fed 2% (wt/wt) CI from the time of 
weaning, but dietary iron supplementation was temporarily discontinued after 2 weeks (for 1 
week) due to growth retardation. During this seven day period of no iron supplementation, 
rats in groups 1 and 2 were feed restricted in order to allow for 'catch up' growth of the 
growth retarded animals in groups 3 and 4. Thereafter, iron loading of group 3 and 4 animals 
was resumed with 1 % (wt/wt) carbonyl iron, and averaged feeding was instituted in order to 
control feed intake of group 1 and 2 rats, and to allow for comparable rates of body weight 
gain in all treatment groups. The mean body weights in the different treatment groups had 
equalised by week 4 after weaning, and total weight gain in the different groups over the six 
week period preceding the commencement of the FBi feeding experiment was comparable 
(group 1, 111.3 ± 3.7 g; group 2, 108.4 ± 4.3 g; group 3, 107.5 ± 71 g; group 4 110.0 ± 9.0 
g). Once instituted, dietary iron supplementation remained constant at 1% until the end of the 
study. Error bars have been omitted for the sake of clarity of the graph. 
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(group 2, n = 10); dietary CI 1 - 2% (group 3, n = 10); and FBI plus CI (group 4, n = 10). 
The quantities offeeds in the different groups were adjusted to match the average intake of 
animals in group 4 (FBtlCI). Two animals from each treatment group and one animal from 
the control group were sacrificed at weeks 3 and 4 for analysis ofhepatic histopathology, and 
the remainder of the animals (n = 6, each group) were sacrificed at week 5. The rats were 
weighed daily and feed intake and wastage were carefully determined. At sacrifice, animals 
were anaesthetised by the intraperitoneal injection of a sodium pentobarbitone solution (6% 
mJv). Blood was drawn by cardiac puncture for measurement of alanine transaminase (AL T) 
levels for biochemical assessment of liver injury, and animals were terminated by 
exsanguination. The livers were harvested and weighed. A slice of liver was taken from the 
left, right, and median lobes of each animal, and these were fixed in 10% neutral buffered 
formalin, routinely processed, and embedded in paraffin for light microscopy. The remaining 
liver was snap frozen in liquid nitrogen and stored at -70°C. 
8.2.4. Light microscopy and immunohistochemistry 
Liver sections (5 Ilm) were stained with haematoxylin and eosin (H&E) for routine light 
microscopy, and with sirius red for collagen. Perls' Prussian blue stain for trivalent iron was 
used to assess hepatic iron content (Williams et ai., 1962). Stainable iron in hepatocytes was 
graded 0 to 4, using a modification of the scale devised by Scheuer et ai. (Scheuer et al. 
1962). Staining with rabbit polyc1onal GST pi (Novacastra, Newcastle-Up on-Tyne, UK) was 
performed for 'enzyme-altered' hepatic foci and nodules (see Chapter 5). 
8.2.5. Morphometric analysis of hepatic foci and nodules 
A total of eighteen liver sections (3 sections per rat in 6 rats sacrificed at week 5) each from 
rats in group 2 (FBI) and group 4 (FBtlCI) were stained with GST pi for determination of the 
number and size of 'enzyme altered' foci and 'premalignant' nodules. One section from each 
of the left, right, and median lobes was examined for each rat. The number ofGST pi positive 
lesions (foci and nodules) per cm2 were counted, and were considered an estimate of the 
cancer initiating effects of FBI with or without iron loading (Soh and Faber, 1976; Farber and 
Sarma, 1987). For the purposes of this study, a group ofGST pi positive cells was classified 
as a 'focus' ifit had an area ofless than 100 Ilm2, and a 'nodule' ifit had an area of 100 Il~ 
or greater. The percentage area of liver occupied by GST pi positive foci and nodules was 
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measurement of the cancer promoting effects of FBI with or without iron loading (Solt and 
Faber, 1976; Farber and Sarma, 1987). 
8.2.6. Hepatic iron concentration 
95 
Liver tissue for determination of iron content was dried for 24 h at 105°C, weighed, digested 
in 50% nitric acid at 70°C for 1 h, and diluted in 0.2 M sodium acetate buffer pH 4.5 
(Torrance and Bothwell, 1980). All glassware was rendered iron free and rinsed with iron free 
water (Torrance and Bothwell, 1980). Iron concentration was determined using a Roche 
Unimate 5 Iron Kit (Roche Diagnostic Systems, Basel, Switzerland), on a Roche Cobas Fara 
IT Centrifugal Analyser. 
8.2.7. Assessment of oxidative damage 
Malondialdehyde (MDA) is formed when polyunsaturated fatty acids of membrane 
phospholipids undergo peroxidation. Lipid peroxidation was measured by the thiobarbituric 
acid (TBA) assay for MDA concentration on samples of liver homogenate, as described by 
Esterbauer and Cheeseman (Ester bauer and Cheeseman, 1990). Related substances such as 
sucrose, non-ferrous metal ions and whole tissue homogenates may also react with TBA or 
influence the assay procedure, and the term thiobarbituric acid reacting substances (TBARS) 
more accurately descnoes the product of this assay (Esterbauer and Cheeseman, 1990). 
Addition of EDT A to the liver homogenate and butylated hydroxytoluene (BHT) to the TBA 
reagent prevent further oxidative changes during the assay procedure. Lipid peroxidation was 
expressed as nmol MDA equivalents per mg protein, using a molar extinction coefficient of 
1.56 x 105 M-I cm-l at 532 nm for MDA (Buege and Aust, 1978). 
8.2.8. Statistics 
The data are presented as the mean ± SEM. Outcome measurements between the treatment 
groups were compared by one way analysis of variance (ANOVA). Individual comparisons 
were made using Scheffe's test. FBI-induced GST pi positive hepatic lesions in groups 2 and 
4 were compared using the Mann-Whitney U test for nonparametric data. Significance was 
set at a p value of 0.05. 
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8.3. Results 
8.3.1. Body weight gain and liver weight/body weight ratio 
Total feed intake was 222.35 ± 14.26 g per 100 g body weight (mean ± SEM), and equivalent 
total FBI intake was calculated as 55.59 ± 3.56 mg per 100 g body weight. Daily feed intake 
was 6.57 ± 0.40 g per 100 body weight and daily FBI intake was 1.64 ± 0.10 mg per 100 g 
body weight. Despite control of feed intake there were significant differences in weight gain in 
the treatment groups, presumably reflecting differential toxic effects (Figure 8.1B). 
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Figure S.lB. Body weight gain (g) of rats over 35 days according to treatment group. 
The liver weightlbody weight ratio was reduced only in rats from group 2 (FBI; P < 0.0001) 
(Figure 8.2). 
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Figure 8.2. Liver weight to body weight (LWIBW) ratio of rats according to treatment group. 
8.3.2. Liver injury analysis 
Serum levels of AL T in animals that received control AIN diet was 42 ± 2 U/l at 5 weeks. 
There was a marked increase in week 5 ALT levels in rats fed FBI (group 2, 200 ± 28 U/l) and 
FBtlCI (group 4, 191 ± 10 U/l), reflecting significant hepatotoxicity of FBI-containing 
regimens. Serum ALT levels in animals given CI (group 3) were mildly raised (66 ± 7 U/l) at 
5 weeks, indicating minimal hepatocellular injwy caused by dietary iron loading alone. 
8.3.3. Liver histopathology 
Pathological changes in rat liver caused by feeding of FBI 250 mglkg diet for 5 weeks are. 
described in Chapter 6, and include severe zone 3 injwy with collapse of the reticulin 
framework, frequent hepatocyte mitoses, and apoptotic bodies, seen after 1 week. These 
initial changes are followed by the development of 'enzyme-altered' foci and nodules, marked 
oval cell proliferation, and hepatic fibrosis by week 3. Sequential liver sections from week 3 
to 5 in group 2 animals (FBI) from the present study showed milder liver injwy, with cell loss 
and collapse in zone 3, mitoses, minimal fibrosis, and multiple small GST pi positive foci and 
nodules. Even though the FBI content of the diet was the same compared to the earlier study 
(Chapter 6), total intake of FBI in the present study was reduced because of averaged feeding. 
Similarly, liver sections of group 4 rats (FBI/CI) showed evidence of mild liver injwy 
histologically, and there appeared to be fewer hepatic GST pi positive foci in these animals, 
Liver sections from control animals and group 3 rats (CI) showed no evidence of liver injwy. 
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Peds' Prussian blue staining of sequential liver sections showed progressive hepatic 
iron loading from week 3 to 5 in animals that received iron supplementation (groups 3 and 4). 
There was a striking difference in the pattern of iron distnoution between animals in group 3 
(CI) and group 4 (FB\/CI). At week 5, livers from group 3 rats (CI) showed grade 3 - 4 
parenchymal iron loading and a zonal gradient of iron deposition, with maximum deposition in 
zone 1 (Figure 8.3A). Livers from group 4 rats (FB\/CI) showed evidence of marked iron 
deposition mainly in the Kupffer cells in zone 3, occurring in association with hepatocyte death 
in this region. (Figure 8.3B). 
8.3.4. Morphometric analysis ojGST pi-positivefoei and nodules 
Rats given dietary iron loading alone (CI) did not develop any GST pi positive hepatic foci or 
nodules. At 5 weeks, 4/6 rats treated with FB\ (group 2) had developed hepatic foci and 6/6 
rats from this group had developed hepatic nodules. In contrast, 3/6 rats treated with FBdCI 
(group 4) had developed foci by 5 weeks, and 4/6 rats from this group had developed nodules. 
At week 5, corresponding liver sections (3 sections/rat from 6 rats in each group) from rats in 
group 2 contained an average of5.34 ± 1.42 GST pi positive lesions per cm2, as compared 
with 1.50 ± 0.52 GST pi positive lesions per cm2 in livers of rats from group 4 (p < 0.05; 
TABLE 8.1). Furthermore, the area (%) of liver sections occupied by GST pi positive lesions 
in rats from group 2 was 0.33 ± 0.12%, as compared to 0.05 ± 0.03% in sections of rats from 
group 4 (p < 0.05; TABLE 8.1). These data indicate that there were more, and larger, lesions 
in the livers of rats that received FBI only (group 2). 
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TABLES.1 
Glutathione S-transferase (GST) pi positive hepatic lesions found at week 5 in rats treated 
with FBI (group 2) and FBI/CI (group 4) (n = 6, each). 
FBI (group 2) FBIICI (group 4) 
No. of rats with focia 4/6 3/6 
No. of rats with nodules 6/6 4/6 
No. oflesions per cm2b 5.34 ± 1.42c 1.50 ± 0.52 
Area (%) oflesionsb 0.33 ± 0.12c 0.05 ± 0.03 
aA GST pi positive lesion'was classified as a 'focus' ifit had an area ofless than 
100 J..lm2, and as a 'nodule' ifit had an area of 100 J..lID2 or greater. 
"Data presented as mean ± SEM. cp < 0.05 
8.3.5. Hepatic iron concentration 
Hepatic iron concentration (J..lIDoll g dry weight of liver) in the livers of rats treated with CI 
(group 3) and FBI/CI (group 4) was 444 ± 56 and 479 ± 80 J..lmollg dry weight respectively. 
In contrast, liver iron concentration in control animals (group 1) and rats treated FB I was 48 ± 
4 and 48 ± 5 J..lmollg dry weight respectively. 
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Figure 8.4. Liver iron concentration (J..lIDollg dry wt) in rats according to treatment group. 
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8.3.6. Hepatic lipid peroxidation 
Generation ofTBARS in liver homogenates differed between the treatment groups (Figure 
8.5), and these differences persisted when using differences in weight gain as the covariant (F 
ratio = 5.24, P < 0.01). Treatment with FBI (group 2) slightly increased TBARS generation 
above control levels, although the increases were not significant (p < 0.3). Treatment with CI 
(group 3), however, caused a significant increase in TBARS generation (p < 0.001). Contrast 
coefficient analysis revealed that hepatic TBARS generation due to FB I/CI (group 4) was 
significantly more than the sum ofTBARS generation by CI (group 3) plus FBI (group 2) (p < 
0.0001), indicating a potentiating effect of FBI on iron-induced lipid peroxidation (Figure 8.5). 
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Figure 8.5. Generation ofthiobarbituric acid reacting substances (TBARS) from liver 
homogenates according to treatment group. 
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8.4. Discussion 
FBI-induced hepatotoxicity may be caused, at least in part, by lipid peroxidation and oxidative 
damage to hepatocytes (Abel and Gelderb1om, 1998; Yin et al., 1998; Sahu et al., 1998). 
Abel and Gelderblom (1998) recently showed that FBI caused a dose-dependent increase in 
the level ofTBARS in rat liver in vivo and in primary rat hepatocytes in vitro. The in vitro 
effect was further potentiated by the addition of cumene hydroperoxide (CMHP), a potent 
oxidising agent. The authors suggested that lipid peroxidation with generation of TBARS 
appeared to be a secondary effect, rather than a causative mechanism, of FBI-induced hepatic 
injury (Abel and Gelderblom, 1998). Sahu et al. (1998) found no effect of metals (iron or 
copper) on FBI-induced peroxidation of lipid membranes and oxidative DNA damage of 
isolated rat nuclei. The present in vivo study, however, shows that excess liver iron (mean 
content 479 f..lIDoIlg dry weight) has a significant potentiating effect on FBI-induced lipid 
peroxidation, measured as generation of TBARS, in liver homogenates. In contrast to the 
study by Abel and Gelderblom (1998), FBI 250 mg/kg diet alone did not cause a significant 
increase in hepatic TBARS generation, although the level appeared to be slightly higher than 
in controls. This might have been due to the lower total dose of FBI administered in the 
present study due to averaged feeding of the animals. FBI-induced hepatotoxicity was 
reflected by a reduction in the liverlbodyweight ratio and a four-fold rise in serumALT levels, 
and was confirmed histologically. 
Agents may increase the risk of cancer by causing DNA damage (genotoxicity) and/or 
by causing increased proliferation (increased DNA replications) in a pluripotential cell 
population of the tissue (Cohen and Ellwein, 1990). FBI acts as a strong promoter, and 
causes apoptosis together with regeneration ofhepatocytes and proliferation of oval cells 
(Lemmer et al., 1999b), putative precursor cells for liver tumours (Grisham and Thorgeirsson, 
1997). Although FB I was found to be nongenotoxic in the Ames mutagenicity test 
(Gelderblom and Snyman, 1991, Park et al., 1992), recent studies have reported the DNA 
damaging potential of FBI (Tolleson et al., 1996b; Knasmuller et al., 1997; Sahu et al., 1998). 
FBI-induced lipid peroxidation might result in oxidative damage to DNA and errors in 
replication. These effects might be expected to be enhanced by oxidative injury due to iron 
loading. However, in the present study, iron overload significantly enhanced lipid 
peroxidation in the absence ofhepatotoxic injury, whereas FBI-induced hepatocyte injury was 
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associated with no significant change in lipid peroxidation. These findings are in accordance 
with the hypothesis of Abel and Gelderblom (1998) that lipid peroxidation is secondary to 
FBI-induced liver injury. With respect to cancer induction, this study showed that moderately 
severe hepatic iron overload (nine-fold increase in liver iron content) decreased the number 
and size of GST-pi positive foci and nodules in FBI-fed rats. A similar protective effect of 
hepatic iron loading (6- to 13-fold increase) was reported by StM et al. (1995), who added or 
substituted dietary iron loading for the initiating and promoting events in the Soh Faber model 
of chemical hepatocarcinogenesis. They showed a mild mitostimulatory effect of iron on 
normal hepatocytes, which may have protected against the promotion of resistant hepatocytes. 
Although hepatocyte proliferation was not measured in this study (e. g. BrdU labelling, 
PCNA), the liver weightlbody weight ratio was maintained in animals treated with FBdCI, 
suggesting that iron may augment the hepatic regenerative response to FBI-induced loss of 
hepatocytes and hence may counteract the selection (mitoinhibition of normal hepatocytes) 
that effects the outgrowth of initiated cells into GST pi positive foci and nodules. Under the 
present conditions, where cancer promotion was apparently impaired, the effect of excess 
hepatic iron on FBI-induced cancer initiation could not be determined. 
There was a striking difference in the pattern of distribution of liver storage iron 
between group 3 (CI) and group 4 (FBdCI). Dietary supplementation with CI is known to 
cause predominantly parenchymal (zone 1) hepatic iron deposition, with a zonal gradient, 
similar to that seen in genetic haemochromatosis (Park et al., 1987; Roberts et al., 1993). 
Addition of FBI feeding to iron loading resulted in a shift of liver iron from parenchymal cells 
to Kupffer cells, presumably due to ingestion of dead hepatocytes by liver macrophages. A 
similar shift in the distribution of iron from hepatocytes to reticuloendothelial cells !s seen in 
a1cohol-iron-CC4-treated rats (Mackinnon et al., 1995), and also occurs in genetic 
haemochromatosis with episodes of alcoholic hepatitis (Powell et al., 1995). Although 
African dietary iron overload is also characterized by massive deposition of reticuloendothelial 
iron (Bothwell and Bradlow, 1960), the pathogenesis of the hepatic siderosis is different, and 
appears to relate to associated ascorbic acid deficiency with impaired release of iron from 
Kupffer cells (Lipschitz et al., 1971). 
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8.5. Conclusions 
FBI had a potentiating effect on iron-induced lipid peroxidation in the liver. However, the 
effects on cancer induction by the fumonisin mycotoxins still need to be elucidated, 
particularly as dietary iron overload appears to protect against the promotion of GST pi 
positive hepatic lesions by FB 1, pOSSlOly due to a stimulatory effect on hepatocyte 
regeneration. These findings need to be interpreted with caution, however, as only a single 
marker of cancer promotion was used in this study, and a direct inhibitory effect of iron on 
GS T pi expression cannot be excluded. 
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Chapter 9 
Liver injury due to prolonged feeding of 
fumonisin Dh and the effect of 
inhibition of hepatocyte regeneration on oval cell 
proliferation and carcinogenesis 
9.1. Introduction 
In humans, hepatoce1lular carcinoma (HCC) usually occurs in the setting of chronic 
necrointlammatory liver disease and cirrhosis, most commonly due to chronic hepatitis B virus 
(Kew, 1978; Beasley et al., 1981; Moradopour and Wands, 1996; Okuda, 1997) or hepatitis C 
virus (Di Bisceglie, 1997; EI-Serag and Mason, 1999; Ince and Wands, 1999) infection. In 
rodents, on the other hand, experimental HCC is usually produced by chemical carcinogens, 
and occurs in the absence of cirrhosis (Goldsworthy and Hanigan, 1986). Although animal 
models have greatly aided the understanding of the molecular and cellular events underlying 
hepatocarcinogenesis, their applicability to the study of human HCC remains uncertain 
(Grisham, 1996). Furthermore, numerous chemical agents cause HCC in rats (Goldsworthy 
and Hanigan, 1986), and some cause cholangiofibrosislcholangiocarcinoma, but only a very 
limited number of carcinogens cause both types of liver tumour (Teebor and Becker, 1981; 
Maronpot et al., 1991; Masuda et al., 1988). 
Prolonged administration offumonisin BI (FBI) to rats causes a chronic toxic hepatitis 
and fibrosis, which progresses to cirrhosis, and sometimes terminates in HCC (Gelderblom et 
al., 1991). This model ofhepatocarcinogenesis may thus more closely resemble the process in 
humans. In addition, treatment with FB I results in the development of cholangiofibrotic 
lesions (cholangiofibromas). These fibrotic bile duct lesions have no exact countetpart in 
humans, and are caused by a number of carcinogen regimens (Teebor and Becker, 1981; 
Kimbrough et aI., 1972; Bannasch and Massner, 1976; Oshima et aI., 1984; Evans et al., 
1989). Although cholangiofibrotic lesions commonly remain static throughout the lifetime of 
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the animal (Edwards and White, 1941), progression to cholangiocarcinoma has been 
demonstrated with some carcinogens, particularly furan (Maronpot et al., 1991) and FB I 
(Gelderblom et al., 1991), and also in Long-Evans Cinnamon (LEC) rats with hereditary 
hepatitis (Masuda et al., 1988). FBI thus causes both hepatocellular and cholangiocellular 
carcinomas in rats, indirect evidence for a common ('stem') cell of origin of these tumours. 
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Hepatic oval cells proliferate under certain conditions, mainly when hepatocytes are 
prevented from proliferating in response to liver damage. 2-acetylaminofluorene (AAF) given 
before a partial hepatectomy (PH) of two thirds results in suppression of hepatocyte 
proliferation and allows sustained proliferation of oval cells (Solt and Farber, 1976; Evarts et 
ai, 1987; Evarts et ai, 1989; Thorgeirsson et al., 1993). Similarly, chemical injury with carbon 
tetrachloride (CCt.) or allyl alcohol in the presence of AAF results in a marked oval cell 
response (Petersen et al. 1998b). 
The present study describes the sequential changes in hepatic histopathology during 
prolonged feeding of FBI. In order to test the hypothesis that inhtl>ition of hepatocyte 
regeneration in the face of liver injury enhances FBI-induced oval cell proliferation and liver 
tumorigenesis, animals were treated with different FB I feeding regimens alone and in the 
presence AAF. Scoring systems were devised for selected hepatic histological parameters, and 
the time course changes in these parameters were followed by serial liver biopsies. All 
treatments were discontinued after 25 weeks, and the animals were followed for a further 25 
weeks on control AIN-76A diet, in order to distinguish reverS1l>le from persistent lesions 
('stop study') (Bannasch et al., 1982; Tatematsu et af., 1988; Bannasch and Zerban, 1990, 
Maronpot et af., 1991). Post mortem livers were examined at the time of sacrifice at the end 
of the study, or where animals died unexpectedly during the course of the study 
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9.2. Experimental methods 
9.2.1. Animals and diet 
The study was approved by the Ethics and Research Committee of the University of Cape 
Town, and the experiments were conducted in accordance with the laws and regulations 
controlling experiments on live animals in South Africa. The purification of FBI and 
preparation on the diets were performed as described in Chapter 5. 
9.2.2. Experimental 
107 
Fifty four male Fischer 344 rats (150 g) were randomly divided into four treatment groups 
(Figure 9.1) and a control group. The treatment regimens were administered for 25 weeks, 
after which animals in all groups were returned to control AIN-76A diet and followed for an 
additional 25 weeks. 
Group Treatment 
1 I FB I 250 
5 Control AIN 
o 5 7 Weeks 25 
Figure 9.1. Treatment regimens (groups 1 - 5) for 25 week 'on/off' study (see text for 
details). FBI 250, fumonisin BI 250 mg/kg; FBI 100, fumonisin BI 100 mg/kg; AAF, 0.02% 
2-acetylaminofluorene; AIN, American Institute of Nutrition-7 6A (control) diet. 
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Details of the treatments groups were as follows: Group J (FBIIFBI; n=12). FBi 250 mglkg 
diet (initial dose) for 5 weeks, and thereafter FBi 100 mglkg diet (maintenance dose) until 25 
weeks; Group 2 (FBI; n=12). FBi 250 mg /kg diet for 5 weeks, and thereafter AIN-76A diet 
only; Group 3 (FBI/AAFIFBI; n=12). FBi 250 mglkg diet for 5 weeks, followed by AAF 
0.02% for 2 weeks, and then FBi 100 mglkg resumed unti125 weeks; Group 4 (FBtlAAF; 
n=12). FBi 250 mglkg diet for 5 weeks, followed by AAF 0.02% for 2 weeks, and then AIN-
76A diet only; Group 5 (control; n=6). Control group fed AIN-76A diet only. 
The sequential development of hepatic histopathological changes in individual rats 
were studied by repeated open liver biopsies as descnbed in Chapter 5, and animals were 
sacrificed at the end of the study. Liver biopsies were performed at five and seven weeks, and 
then monthly (Figure 9.1). At each session, two rats from each of the treatment groups and 
one control animal were biopsied. Rats receiving biopsies were rotated at each session until 
all the animals in the different groups had undergone liver biopsy, whereafter repeat biopsies 
were performed in the same order. All 54 rats had one open liver biopsy, and 32 rats 
underwent a second biopsy before sacrifice at 50 weeks. Because of the high procedure-
related mortality rate encountered, no liver biopsies were performed during the last two 
months of the study. At sacrifice, the animals were anaesthetised by the intraperitoneal 
injection of a sodium pentobarbitone solution (6% mIv). The livers were removed, and slices 
of tissue were taken from the left, right, and median lobes of the liver for histopathological 
analysis. 
9.2.3. Light microscopy 
For routine light microscopy, blocks of liver 4-5 mm in thickness were immersion-fixed in 
10% neutral buffered formalin overnight before processing and embedding in paraffin wax (see 
Chapter 5). Stains included routine haematoxylin and eosin (H&E) and sirius red for collagen. 
9.2.4. Immunohistochemistry 
Immunohistochemical stains performed on paraffin sections included desmin D33, OV-6 
monoclonal antibody, and polyclonal GST pi (see Chapter 5). Staining with Desmin D33 
(Dako, Copenhagen, Denmark) for hepatic stellate (Ito) cells and rabbit polyclonal GST pi 
(Novacastra, Newcastle-Upon-Tyne, UK) for 'enzyme-altered' hepatic foci and nodules were 
performed on paraffin sections. After sequential layering with biotinylated rabbit anti-mouse 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
109 
or swine anti-rabbit (Dako, Copenhagen, Denmark) 1:250 dilution as link antibodies, 
peroxidase conjugated Streptavidin (Dako, Copenhagen, Denmark) 1:500 was applied for 30 
min at room temperature. The OV-6 mouse monoclonal antibody, which stains both oval cells 
and bile duct cells, was a generous gift from Professor Stewart Sell, Albany, New York. 
Acetone fixed cryostat sections were brought to room temperature and stained by means of a 
standard two-score indirect peroxidase conjugated technique (Dako P161, Copenhagen, 
Denmark). For the detection of a-fe to protein (AFP), tissues were fixed for 4 h in Bouin's 
fixative and embedded in paraffin wax (Omori et al., 1997a). Polyclonal rabbit anti-rat AFP 
(Accurate Chemicals, New York, NY) was used as primary antibody, and fetal rat livers were 
used as positive controls. 
9.2.5. Scoring offibrosis, oval cell proliferation, GST pi positive lesions and 
dysplastic nodules 
In order to follow selected histological features with time in each group, numerical scoring 
systems were devised for hepatic fibrosis, oval cell proliferation, and the extent of the GST pi 
positive lesions/dysplastic nodules (TABLE 9.1). Liver sections from the different treatment 
groups were scored for each of these parameters by two independent assessors, who were 
unaware of the treatment administered. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
TABLE 9.1 
Scoring of hepatic fibrosis, oval cell proliferation, and the extent of GS T pi positive lesions 
and dysplastic nodules. 
Hepatic fibrosis (modified from Scheuer, 1991) 
None 
Enlarged, fibrotic portal tracts 
Periportal or portal-portal septa 
Fibrosis with disturbed architecture, but no obvious cirrhosis 
Probable or definite cirrhosis 
Oval cell proliferation 
None 
Confined to portal tracts 
Radiating out from portal tracts into fibrous septa 
Infiltrating liver parenchyma 
Diffuse proliferation 
GST pi positive lesionsa 
None 
< 25% of liver section 
25 - 50% of liver section 
> 50% but < 75% of liver section 
75% - 100% of liver section 
Dysplastic nodulesa 
None 
< 25% of liver section 
25 - 50% of liver section 
> 50% but < 75% of liver section 
75% - 100% of liver section 
Score 
o 
1 
2 
3 
4 
Score 
o 
1 
2 
3 
4 
Score 
0 
1 
2 
3 
4 
Score 
0 
I 
2 
3 
4 
a % area occupied by GST pi positive lesions and dysplastic lesions was a simple visual 
assessment by the histopathologist. 
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Dysplastic liver nodules were labelled as low-grade dysplastic, high-grade dysplastic or well-
differentiated HCC, based on a modification of the International Working Party (Wanless et 
al., 1995) criteria for the classification of human nodular hepatocellular lesions (TABLE 9.2). 
In practice, the features that were found to be most useful in distinguishing low-grade from 
high-grade dysplastic nodules were the presence of mitoses, occasional pseudogland 
formation, and the compression of surrounding liver parenchyma. The predominant 
cytoplasmic change encountered in high-grade dysplastic nodules in the rat appeared to be 
eosinophilic large cell change. 
TABLE 9.2 
Histological criteria to distinguish between dysplastic nodules (low-grade and high-grade) and 
well-differentiated hepatocellular carcinoma. Modified from Wanless et al., (1995). 
Dysplastic Dysplastic Well-
Histological feature nodule, low-
grade 
nodule, high-
grade 
differentiated 
Mitotic figuresa 
Cell densitl 
Nuclear hyperchromasia 
Irregular nuclear contour 
Clone-like populations 
Hepatic plates> 3 cells wide 
Pseudogland formation 
Eosinophilic large cells 
Reticulin less than normal 
Compression of surrounding 
liver 
Invasion of stroma or portal 
tracts 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
~otic figures: + = 1-5/10 HPFs, ++ = greater than 5/10 HPFs; 
bCell density: + = greater than 1.3 times normal; ++ = greater than 2 times normal 
Abbreviations: HCC = hepatocellular carcinoma; HPF = high power field. 
Bee 
++ 
++ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
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9.2.6. Data presentation 
Although formal statistical analysis of the data was not performed because of the small number 
of animals from different groups at each biopsy time-point, histological parameters were 
compared using cumulative scores at each time-point. Post mortem histological data for 
hepatic nodules and bile duct lesions in the different groups were presented in the form of 
scatter plots. 
9.3. Results 
9.3.1. Rat deaths 
The 54 rats underwent 77 open liver biopsies. There were 22 deaths during the 50 week study 
period. Thirteen deaths were related to the biopsy procedure and anaesthetic (TABLE 9.3). 
These included uncontrolled haemorrhage from the raw liver surface (2), bowel perforation 
due to adhesions related to previous surgery (1), and 'anaesthetic deaths' presumably due to 
the effects of general anaesthesia and surgery in animals with chronic FBI-induced 
hepatotoxicity (10). Identified causes of deaths not related to surgery included pneumonia (3), 
sepsis (1), or poor general condition necessitating early termination (3). There were two rats 
for which the cause of death was unknown: rat #9 (group 1) died at week 38 just before it was 
due for a second biopsy, and rat #44 (group 4) died at week 45 shortly before the end of the 
study. Unfortunately, in these two cases, the animals died out of normal working hours aD:d 
the carcasses were disposed of in error before the deaths were reported to the project team 
Seven deaths occurred in group 1, eight deaths in group 2, four deaths in group 3, 
three deaths in group 4, and one death in the control group. The timing and causes of death in 
the animals are depicted in TABLE 9.3 below. 
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TABLE 9.3 
Causes of rat deaths in the different treatment groups, sorted according to timing of mortality. a 
Rat#. Group Week Cause 
36 1 5 perioperative (1 t 
33 2 6 perioperative (1) 
27 2 12 biopsy bleed (1) 
52 3 15 perioperative (1) 
43 5 15 perioperative (1) 
45 4 15 biopsy bleed (1) 
47 1 23 perioperative (1) 
51 2 24 otitis (culled) 
32 4 31 perioperative (2) 
13 2 35 perioperative (2) 
23 1 35 perioperative (2) 
12 1 39 perioperative (2) 
17 2 39 perioperative (2) 
31 2 39 bowel perforation (2) 
40 3 42 pneumoma 
34 2 45 poor condition 
16 3 47 pneumonia 
6 2 48 poor condition 
22 1 48 poor condition 
42 3 49 pneumonia 
aCause of death was not recorded for two animals (see text) 
hpor 'perioperative' deaths, the numbers in parentheses indicate during which liver biopsy 
procedure (lor 2) the death occurred. 
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9.3.2. Hepatic histopathology 
The hepatic histopathology is reported for each treatment group (1 - 5) according to a general 
schema. The sequential histological changes in liver biopsy findings are described. 
Cumulative scores are shown for fibrosis, oval cell proliferation, GST pi positive lesions, 
dysplastic nodules, and cholangiofibrotic lesions seen in liver biopsy specimens (Figures 9.2 to 
9.6). The liver post mortem findings in the livers are descn"bed separately, and the extent of 
GST pi positive lesions/dysplastic lesions, as well as the number of cholangiofibrotic lesions 
are depicted as scatter plots (Figures 9.7 to 9.9). 
9.3.2.1. GROUP 1 (FBtlFBt) 
Biopsy fmdings: 
(i) Fibrosis and hepatic stellate cells. A progressive increase in the cumulative score for 
hepatic fibrosis was noted over the course of the study (Figure 9.2). A prominent proliferation 
of desmin-p0 sitive hepatic stellate cells, radiating out from portal tracts into the surrounding 
hepatic parenchyma, was identified at weeks 5 and 7. Thereafter, the proliferation of stellate 
cells appeared to decline over the remainder of the study period. Sirius red staining for 
collagen showed early development ofhepatic fibrosis, and portal-portal linkage with 
architectural distortion (score 3) was evident by week 7. Further progression however 
appeared to occur more gradually, and only one liver section showed established cirrhosis. 
(ii) Oval cell proliferation. A progressive increase in the cumulative score for oval cell 
proliferation was noted till week 23, whereafter the score appeared to level out somewhat 
(Figure 9.3). Staining with OV-6 monoclonal antibody showed score 2 - 3 oval cell 
proliferation during the course of the study. Proliferating oval cells were noted to radiate out 
from the portal tracts along the fibrous septa, and to extend into the hepatic parenchyma. 
Staining with GST pi demonstrated cells with the morphology of oval cells and not expressing 
GST pi, that were proliferating inside developing GST pi positive lesions (Figures 9.lOC and 
9.1 OD). Conversely, hepatocytes within some dysplastic nodules and bile duct cells within 
cholangiofibrotic lesions showed expression ofOV-6 (see below). 
(iii) GST pi positive lesions. A progressive increase in the cumulative score for GST pi 
positive lesions was noted over the course of the study (Figure 9.4). GST pi positive lesions 
were seen as early as week 5. The GST pi positive lesions were larger at later time points, and 
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by week 19 these lesions occupied 25 -50% (score 2) of the liver sections. As described 
above, a striking feature was the presence of oval cells (GST pi negative) within almost all 
GST pi positive lesions. 
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(iv) Dysplastic nodules. There was a marked increase in the cumulative score for dysplastic 
nodules, particularly from week 15 onwards (Figure 9.5). At routine H&E staining, the 
hepatocytes within the nodules showed predominantly large cell eosinophilic change of the 
cytoplasm The nodules invariably showed features of high-grade dysplasia, as evidenced by 
the presence of mitoses, occasional pseudogland formation, and compression of the 
surrounding parenchyma. These 'atypica1' nodules were infiltrated by nonparenchymal (oval) 
cells, which radiated out from the portal tracts (Figure 9.lOE). From week 19 onwards, some 
of the hepatocytes in the nodules showed strong cytoplasmic expression ofOV-6 at the 
periphery of the cells. However, no expression of AFP by cells in the dysplastic nodules could 
be demonstrated at any stage in paraffin sections, and no unequivocal HCCs were diagnosed in 
liver biopsy specimens. 
(v) Cholangiofibrotic lesions. Two cholangiofibrotic lesions were identified in liver biopsy 
sections stained with sirius red for collagen (Figure 9.6). At routine light microscopy, these 
focal lesions were seen as proliferating and dilated bile ducts, which showed no evidence of 
dysplasia. The bile duct lesions were surrounded by desmin-positive hepatic stellate cells and 
dense fibrosis. The bile ducts within the cholangiofibrotic lesions expressed OV-6. 
Post mortem findings: 
(i) Fibrosis. Most livers showed evidence of score 2 - 3 fibrosis at post mortem, but one liver 
showed established cirrhosis (score 4). 
(ii) Oval cell proliferation. Oval cell proliferation in post mortem livers varied between score 
1 - 3. 
(iii) GST pi positive lesions. There was a wide scatter in percentage liver involvement by 
GST pi positive lesions at post mortem (Figure 9.7 and Appendix A), which ranged from less 
than 25% (score 1) to more than 75% (score 4). 
(iv) Dysplastic nodules. There was a wide scatter in the scores for dysplastic nodules in post 
mortem livers, and most of the dysplastic nodules showed features of high-grade dysplasia 
(Figure 9.8 and Appendix A). An unequivocal HCC (mixed trabecular/pseudoglandular 
pattern) was found in Rat #28 (Figure 9. I IF), and the rest of the liver was virtually replaced 
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Figure 9.2. Cumulative scores for fibrosis in rat liver biopsies from the different treatment 
groups. 
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Figure 9.3. Cumulative scores for oval cell proliferation in rat liver biopsies from the different 
treatment groups. 
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Figure 9.4. Cumulative scores for GST pi positive lesions in rat liver biopsies from the 
different treatment groups. 
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Figure 9.5. Cumulative scores for dysplastic nodules in rat liver biopsies from the different 
treatment groups. 
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Figure 9.6. Cumulative number of cholangiofibrotic lesions in the different treatment groups 
at the end of liver biopsy procedures. 
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Figure 9.7. Scatter plot ofGST pi positive lesions (%) in rat livers at post mortem in different 
treatment groups. 
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Figure 9.8. Scatter plot of scores for dysplastic nodules in rat livers at post mortem for the 
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dysplastic nodules, and hepatoce11u1ar carcinomas (HCC) in livers of anjmals from group 1 and 
group 3 are indicated. 
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Figure 9.9. Number of cholangiofibrotic (CF) lesions per rat liver at post mortem in the 
different treatment groups. D = number oflesions with features of dysplasia. 
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by high-grade dysplastic nodules. 
(v) Cholangiofibrotic lesions. One post mortem liver (Rat #4) contained a single 
cholangiofibrotic lesion and another (Rat #22) contained 9 lesions, all of which showed 
features of dysplasia (Figure 9.9 and Appendix A). Dysplastic cholangiofibrotic lesions 
showed irregularity of ducts, and there was evidence of severe cytological atypia of bile duct 
cells (e.g. crowding of cells, nuclear hyperchromasia, and mitoses), suggestive of intraductal 
cholangiocarcinoma. One of the dysplastic cholangiofibrotic lesions in Rat #22 produced 
pools of mucin, additional evidence for a cholangiocarcinoma. 
9.3.2.2. GROUP 2 (FBl/AIN) 
Biopsy fmdings: 
(i) Fibrosis. There was an initial progressive increase in the cumulative score for hepatic 
fibrosis until week 11, but thereafter the score appeared to level off somewhat in this group 
(Figure 9.2). Sirius red staining for collagen showed the presence of score 2 hepatic fibrosis 
by week 5, but the fibrosis scores of individual liver sections did not progress beyond score 2 
during the remainder of the study. 
(ii) Oval cell proliferation. There was an initial progressive increase in the cumulative score 
for oval cell proliferation until week 11, but thereafter the cumulative score appeared to reach 
plateau levels (Figure 9.3). Staining with OV-6 showed score 2 - 3 oval cell proliferation at 
weeks 5 to 11, but this proliferation appears to have levelled out by week 23. 
(iii) GST pi positive lesions. There was a progressive increase in the cumulative score for 
GST pi positive lesions until week 23, whereafter the score appeared to reach plateau levels 
(Figure 9.4). Small (score 1) GST pi positive lesions were seen at week 5, but the extent (%) 
of liver involvement by these lesions did not increase at subsequent time points. 
(iv) Dysplastic nodules. There was almost no increase in the cumulative score for dysplastic 
nodules (Figure 9.5). Furthermore, features of high-grade dysplasia were found in only three 
liver biopsies during the course of the study period. 
(v) Cholangiofibrotic lesions. Only a single small cholangiofibrotic lesion was detected in 
liver biopsy sections stained with sirius red for collagen (Figure 9.6). 
Post mortem fmdings: 
(i) Fibrosis. Post mortem livers showed mild (score 1 to 2) fibrosis only, and in no liver did 
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by high-grade dysplastic nodules. 
(v) Cholangiofibrotic lesions. One post mortem liver (Rat #4) contained a single 
cholangiofibrotic lesion and another (Rat #22) contained 9 lesions, all of which showed 
features of dysplasia (Figure 9.9 and Appendix A). Dysplastic cholangiofibrotic lesions 
showed irregularity of ducts, and there was evidence of severe cytological atypia of bile duct 
cells (e. g. crowding of cells, nuclear hyperchromasia, and mitoses), suggestive of intraductal 
cholangiocarcinoma. One of the dysplastic cholangiofibrotic lesions in Rat #22 produced 
pools of mucin, additional evidence for a cholangiocarcinoma. 
9.3.2.2. GROUP 2 (FBl'AIN) 
Biopsy fmdings: 
(i) Fibrosis. There was an initial progressive increase in the cumulative score for hepatic 
fibrosis until week 11, but thereafter the score appeared to level off somewhat in this group 
(Figure 9.2). Sirius red staining for collagen showed the presence of score 2 hepatic fibrosis 
by week 5, but the fibrosis scores of individual liver sections did not progress beyond score 2 
during the remainder of the study. 
(ti) Oval cell proliferation. There was an initial progressive increase in the cumulative score 
for oval cell proliferation until week 11, but thereafter the cumulative score appeared to reach 
plateau levels (Figure 9.3). Staining with OV-6 showed score 2 - 3 oval cell proliferation at 
weeks 5 to 11, but this proliferation appears to have levelled out by week 23. 
(iii) GST pi positive lesions. There was a progressive increase in the cumulative score for 
GST pi positive lesions until week 23, whereafter the score appeared to reach plateau levels 
(Figure 9.4). Small (score 1) GST pi positive lesions were seen at week 5, but the extent (%) 
of liver involvement by these lesions did not increase at subsequent time points. 
(iv) Dysplastic nodules. There was almost no increase in the cumulative score for dysplastic 
nodules (Figure 9.5). Furthermore, features of high-grade dysplasia were found in only three 
liver biopsies during the course of the study period. 
(v) Cholangiofibrotic lesions. Only a single small cholangiofibrotic lesion was detected in 
liver biopsy sections stained with sirius red for collagen (Figure 9.6). 
Post mortem fmdings: 
(i) Fibrosis. Post mortem livers showed mild (score I to 2) fibrosis only, and in no liver did 
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the amount of fibrosis exceed score 2. 
(il) Oval cell proliferation. Oval cell proliferation was either absent (score 0) or minimal 
(score 1) in most post mortem livers, and only one liver showed score 2 oval cell proliferation. 
(iii) GST pi positive lesions. The involvement (%) of liver by GST pi lesions at post mortem 
was consistently low (0 - 20%) (Figure 9.7 and Appendix A). 
(iv) Dysplastic nodules. Most post mortem livers did not contain any dysplastic lesions 
(Figure 9.8 and Appendix A). Two post mortem livers contained one low-grade dysplastic 
nodule each, and only one liver (Rat #5) contained high-grade dysplastic nodules. 
(v) Cholangiofibrotic lesions. A single cholangiofibrotic lesion was found in one post 
mortem liver (Rat # 17), and this lesion showed no evidence of dysplasia (Figure 9.9 and 
Appendix A). 
Figure 9.10. Liver pathology during prolonged feeding offumonisin B.-containing treatment 
regimens to Fischer 344 rats (see text for details). (A) Liver biopsy from Rat #23 (group 3) at 
week 23 showing loss of the normal acinar architecture due to the presence of regenerative 
nodules ofhepatocytes which are partially or completely surrounded by bands of fibrous tissue 
(fibrosis score 4, established cirrhosis). Sirius red stain for collagen, objective x 4. (B) Liver 
biopsy from Rat #32 (group 4) at week 7 showing extensive (score 4) proliferation ofOV-6-
positive oval cells and ductules, which are radiating out from a portal tract (PT) as nobons and 
cords into the hepatic parenchyma. Objective x 20. (C) Liver biopsy liver from Rat #22 
(group 1) at week 19 showing cells with the morphology of oval cells (arrows) which are 
proliferating inside a lesion composed of GST pi positive hepatocytes. The oval c~lls are GST 
pi negative, which aids their identification within the GST pi positive lesion. Objective x 20. 
(D) Higher magnification of the liver in Figure 9.1 OC showing oval cells (arrows) within a 
group ofGST pi positive hepatocytes. (E) Liver biopsy from Rat #36 (group 1) at week 5 
showing the proliferation of oval cells, which are radiating out from two portal tracts (PT) and 
infiltrating into surrounding 'atypical' nodules of dysplastic (low-grade) hepatocytes. H&E, 
objective x 20. (F) Liver biopsy from Rat #25 (group 3) at week 23 showing loss of the 
normal acinar architecture due to the presence of regenerative nodules ofhepatocytes, 
suggestive of established cirrhosis. Hepatocytes within some of the 'atypical' nodules stain 
positive for GST pi. Objective x 4. 
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(i) Fibrosis. A progressive increase in the cumulative score for hepatic fibrosis was noted 
during the course of the study (Figure 9.2). Prominent proliferation of desmin-positive hepatic 
stellate cells, radiating out from the portal tracts, was noted at weeks 5 and 7. Most liver 
biopsies during the study period showed score 2 - 3 fibrosis, but in three animals the biopsies 
showed established cirrhosis (Figure 9. lOA). 
(ti) Oval cell proliferation. A progressive increase in the cumulative score for oval cell 
proliferation was noted during the course of the study (Figure 9.3). Staining with OV-6 
showed score 2 - 3 oval cell proliferation throughout the study period, and one liver biopsy 
showed score 4 (diffuse) proliferation. 
(iii) GST pi positive lesions. A progressive increase in the cumulative score for GST pi 
positive lesions was noted during the course of the study (Figure 9.4). In most biopsies, these 
lesions occupied 50% or less of the section (score 1 - 2), but in one rat the GST pi positive 
lesions had virtually replaced the biopsy section (score 4). GST pi positive lesions were 
sometimes seen within regenerative nodules (Figure 9. 10F). Proliferating oval cells were seen 
inside GST pi positive lesions in liver biopsy specimens taken throughout the study. 
(iv) Dysplastic nodules. There was a progressive increase in the cumulative score for 
dysplastic nodules during the study period (Figure 9.5). Most of the nodules showed 
cytological features of high-grade dysplasia, but in one biopsy section a low-grade dysplastic 
nodule was found. Some hepatocytes in nodules showed strong cytoplasmic expression of 
OV-6 at the periphery of the cells, and almost all dysplastic nodules contained proliferating 
OV-6 positive oval cells and ductules. No expression of AFP could be detecte9, and no cases 
of unequivocal HCC were found in liver biopsy specimens. 
(v) Cholangiofibrotic lesions. Ten cholangiofibrotic lesion were identified in liver biopsy 
sections from group 3 animals (Figure 9.6). These cholangiofibrotic lesions were particularly 
striking in the biopsy taken from Rat #52, and were seen as proliferating bile ducts surrounded 
by hepatic stellate cells and dense fibrosis. Staining with desmin D33 demonstrated the 
presence ofvascular proliferation, as well as proliferating hepatic stellate 
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cells within the fibrous tissue (Figure 9. 12B). Some of the cholangiofibrotic lesions showed 
features of dysplasia (as described for group 1), without unequivocal evidence of invasion, and 
this was feh to be consistent with a diagnosis of intraductal cholangiocarcinoma (Figure 
9. 12C). 
Post mortem fmdings: 
(i) Fibrosis. Most livers showed evidence of score 2 -3 fibrosis, and none of the livers 
showed established cirrhosis. 
(ii) Oval cell proliferation. The amount of oval cell proliferation in post mortem livers varied 
between score 1 to 3. 
Figure 9.11. Liver pathology during prolonged feeding offumonisin BI-containing treatment 
regimens to Fischer 344 rats (see text for details). (A) Post mortem liver from Rat #24 (group 
3) at week 50 sacrifice showing an 'atypical' nodule with features of high-grade dysplasia. 
The dysplastic nodule contains both eosinophilic and clear hepatocytes, and these cells show 
evidence of cytological atypia. A mitotic figure (MF) is seen in an eosinophilic hepatocyte. 
H&E, objective x 20. (B) Post mortem liver from Rat #40 (group 3) at week 50 sacrifice 
showing a higher magnification view of a dysplastic hepatocellular nodule. Within the 
dysplastic nodule, cells with the motphology ofhepatocytes appear to be forming ductu1es 
(arrows). H&E, objective x 40. (C) Post mortem liver from Rat #25 (group 3) at week 50 
sacrifice showing curious cystic lesions that are lined by cuboidal cells with the motphology of 
hepatocytes (arrows). H&E, objective x 20. (D) Ttmmmostaining of the liver shown in Figure 
9.11C with OV-6 monoclonal antibody demonstrates that the cuboidal cells surrounding the 
cystic lesions express OV-6. These cystic lesions are inside an 'atypical' nodule, and some of 
the hepatocytes stain with OV-6. Objective x 20. (E) Immunostaining of post mortem liver 
from Rat #14 (group 3) at week 50 sacrifice shows expression ofOV-6 by cystic liver lesions, 
which are adjacent to an 'atypical' nodule containing hepatocytes that are expressing OV-6 in 
a peripheral pattern. Some of the OV-6 positive hepatocytes within the nodule appear to be 
forming ductu1es (arrows). (F) Post mortem liver from Rat #28 (group I) at week 50 sacrifice 
showing an unequivocal hepatocellular carcinoma. The malignant tumour is moderately 
differentiated and has a predominantly trabecular pattern, but in areas the formation of 
pseudoglands can be seen (arrows). 
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(iii) GST pi positive lesions. Most post mortem livers showed prominent involvement by 
GST pi positive lesions, which comprised up to 70% of the liver (Figure 9.7 and Appendix A). 
Of note was the presence of proliferating oval cells (GST pi negative) and columnar-lined 
cystic lesions within GST pi positive nodules (see below). 
(iv) Dysplastic nodules. The scores for dysplastic nodules ranged between 1 and 2, and 
individual nodules showed a mix oflow-grade and high-grade dysplasia (Figure 9.8 and 
Appendix A). Features of high-grade dysplasia included the presence of mitoses, occasional 
pseudogland formation, and compression of the surrounding parenchyma. High-grade 
dysplastic nodules showed predominantly eosinophilic large cell change, but occasional clear 
cell or mixed eosinophilic/clear cell (Figure 9.IIA) change was seen (e.g. Rat #25). Within 
some high-grade dysplastic nodules, there were ductular structures formed by cells with a 
hepatocellular phenotype (Figure 9 .IIB). In some liver specimens there were curious cyst-like 
lesions that were lined by cuboidal cells resembling hepatocytes (Figure 9.11 C). Both the 
ductular structures within dysplastic nodules and the cuboidal cell-lined cystic lesions showed 
expression ofOV-6 (Figures 9.11D and 9. 11E), and some cystic lesions were also found 
within dysplastic nodules (Figures 9.12E and 9.12F). 
(v) Cholangiofibrotic lesions. A total of 19 cholangiofibrotic lesions were found in post 
mortem livers, and eight of these showed features of dysplasia (Figure 9.9 and Appendix A). 
Dysplastic cholangiofibrotic lesions showed irregularity of ducts, and there was evidence of 
severe cytological atypia of bile duct cells, suggestive of intraductal cholangiocarcinoma. Of 
note was the presence of some cholangiofibrotic lesions adjacent to GST pi positive 
lesions! dysplastic nodules. 
9.3.2.4. GROUP 4 (FBl/AAF/AIN) 
Biopsy fmdings: 
(i) Fibrosis. A progressive increase in the cumulative score for hepatic fibrosis was noted 
during the study period (Figure 9.2). There was however a wide range in the score for fibrosis 
(score 0 - 3) noted in individual liver biopsies, and one biopsy showed established cirrhosis 
(score 4). 
(ii) Oval cell proliferation. A progressive increase in the score for oval cell proliferation was 
noted during the study period (Figure 9.3). Proliferation ofOV-6 positive oval cells and 
ductules were prominent (Figure 9.1 OB) until week 31, whereafter the proliferation appeared 
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to settle down (score 0 - I). 
(iii) CST pi {HMitWe l«i(JlI~ llLere mrs 8 progressive mcre8St: m tILe CUllllL!ative score fOr 
GST pi positive lesion during the study period (Figure 9.4). Although there was a wide range 
in the involvement (%) of liver sections by these lesions (score 0 - 3), most GST pi positive 
JISiDDS were Sl.DII11lOd occupied Jess duo 25~ oftlJe secIitm (score J) 
(iv) Dysplastic nodules. The increase in cumulative score for dysplastic lesions appeared to 
occur in a stepwise fashion (Figure 9.5), and there was a mix between low-grade and high-
grade dysplastic lesions. However, no unequivocal HCCs were found in liver biopsy 
specimens. 
Figure 9.12. Liver pathology during prolonged feeding offumonisin B1-containing treatment 
regimens to Fischer 344 rats (see text for details). (A) Post mortem liver from Rat #25 (group 
3) at week 50 sacrifice showing a cholangiofibrotic lesion with dense fibrosis surrounding 
proliferative bile duct lesions. Strands offibrotic tissue extend into the surrounding liver, 
which shows disturbance of the normal acinar architecture. Sirius red, objective x 10. (B) 
Liver biopsy from Rat #52 (group 3) at week 15 showing the proliferation of desmin-p0 sitive 
hepatic stellate cells around bile duct lesions in a cholangiofibrotic lesion. Objective x 40. (C) 
Liver from the same animal as in figure 9.12B showing a cholangiofibrotic lesion containing 
irregular bile ducts with features of severe cytological atypia, suggestive of intraductal 
cholangiocarcinoma. A mitotic figure is seen in a dysplastic bile duct cell (arrow). (D) Post 
mortem liver from Rat #25 (group 3) at week 50 sacrifice (same liver as in Figures 9: 11 C and 
9 .IID) showing a lesion made up of GS T pi positive hepatocytes, which is directly adjacent to 
bile duct lesions (GS T pi negative) of a cholangiofibrotic lesion. Furthermore, cells with the 
motphology of oval cells (also GST pi negative) are proliferating within the GST pi positive 
lesion (arrows). A mitotic figure (MF) is seen within one of the GST pi positive hepatocytes. 
Objective x 20. (E) Low-power magnification of post mortem liver from Rat #49 (group 4) at 
week 50 sacrifice showing cystic lesions (arrow) within a subcapsular nodule ofpale staining 
'atypical' hepatocytes. H&E, objective x 4. (F) Higher magnification of the same liver as 
shown in Figure 9.12E showing deeply eosinophilic ('atypical') hepatocytes (arrows) located 
between the irregular cystic lesions. H&E, objective x 40. 
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(v) Cholangiofibrotic lesions. Two cholangiofibrotic lesions were identified in liver biopsy 
sections by sirius red staining (Figure 9.6), and neither lesion showed cytological features of 
dysplasia. 
Post mortem rmdings: 
(i) Fibrosis. There was a wide variation in the amount of amount of fibrosis of post mortem 
livers (score 0 - 3), but no liver showed established cirrhosis. 
(ii) Oval cell proliferation. Oval cell proliferation in post mortem livers ranged from score 1 
- 3. 
(iii) GST pi positive lesions. There was a wide scatter in the involvement (%) of liver by 
GST pi lesions at post mortem (Figure 9.7 and Appendix A), which ranged up to 50% (score 
2). Of note was the presence of cells with the morphology of oval cells within some GS T pi 
positive lesions (e.g. Rat #49). 
(iv) Dysplastic nodules. Six dysplastic nodules were found in post mortem livers, and four of 
these showed features of high-grade dysplasia (Figure 9.8 and Appendix A). 
(v) Cholangiofibrotic lesions. Thirteen cholangiofibrotic lesions were found in post mortem 
livers, and four of these showed features of dysplasia (Figure 9.9 and Appendix A). 
9.3.2.5. GROUP (AIN control) 
Biopsy rmdings: Liver biopsies from control animals all showed normal liver histology, apart 
from a blinded review of a biopsy on one rat (Rat #26) that reported score 1 fibrosis (Figure 
9.2) and score 1 oval cell proliferation (Figure 9.3). However, at subsequent post mortem 
examination the liver of this animal was found to be normal, with no evidence of fibrosis or 
oval cell proliferation. 
Post mortem rmdings: Post mortem livers showed normal histology, apart from two cases 
(Rat #3 and Rat #7) that contained a few cells that stained GST pi positive (technically score 1 
as liver involvement> 0% but considered to be insignificant). 
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9.4. Discussion 
The present study is the first to demonstrate that prolonged feeding of FBI in a normal diet 
causes dysplastic hepatocellular nodules and bile duct lesions in rats. Male Fisher 344 rats fed 
different FBI-containing regimens for 25 weeks and returned to normal AIN-76A diet for 
another 25 weeks developed a variety of preneoplastic and neoplastic hepatic lesions, 
including GST pi positive lesions, dysplastic liver nodules, cholangiofibrotic lesions, 
intraductal cholangiocarcinomas, and one unequivocal HCC. The single HCC showed a 
trabecular pattern histologically and was found in a post mortem liver specimen from a group 
1 (FBtlFB1) animal. Two other long-term FBI studies have been performed in rats and mice, 
but there are problems in the designs of both of these trials. In a 26 month feeding study 
performed by the South African Programme on Mycotoxins and Experimental Carcinogenesis 
(PROMEC) (Gelderblom et al., 1991), BD IX rats were fed FBI 50 mg/kg in a semi-purified 
maize-based diet and showed the development of chronic toxic hepatitis, cirrhosis, HCCs, 
cholangiofibromas, and cholangiocarcinomas (see Appendix B). The basal diet, which was 
deficient in multiple vitamins and lipotropes (see Appendix C), was used in an attempt to 
induce oesophageal lesions in the animals (Van Rensburg et al., 1985). Diets deficient in 
lipotropes such as choline and methionine have however been shown to induce liver cancer in 
rats (Ghoshal and Farber, 1984), and also render the liver more susceptible to the carcinogenic 
action of carcinogens (Newbeme, 1986). Thus, the diet used in the PROMEC study may have 
had an enhancing effect on the action of FBI in the liver. The results of recently completed 2-
year studies on the toxicology and carcinogenesis in rats and mice performed by the United 
States National Toxicology Program (NTP) have appeared in a preliminary report (Howard et 
al., 1999). Male F344IN rats fed diets containing 0, 5, 15, 50, or 150 ppm FBI for 2 years 
developed renal tubular neoplasms (adenoma and carcinoma) but no hepatocellular neoplasms 
only, and there was no evidence of carcinogenic activity of FBI in females (see Appendix B). 
In contrast, female B6C3F1 mice fed diets containing 0,5, 15,50, or 80 ppm FBI for 2 years 
developed hepatocellular neoplasms (adenoma or carcinoma), while there was no evidence of 
carcinogenic activity of FBI in males (see Appendix B). The reasons for the lack of 
hepatocarcinogenic effect of FBI in F344IN rats is not clear, but the NTP feeding studies 
employed the ammonium sahs of FBI. Ahhough this chemical compound was apparently not 
tested for efficacy before the start of the experiments, the absence of any differences in body 
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weight gain between treated and control animals would suggest lack of toxic effect. 
Open wedge liver biopsies were performed under ether anaesthesia, according to a 
modification of the technique described by Cmielewski et al. (1997). The technique offers a 
number of advantages for histological studies: (i) relatively large amounts of liver can be 
obtained under direct vision; (ii) repeated liver biopsies can be taken, permitting longitudinal 
studies and limitation of the number of animals used; and (iii) liver histology at sites distant 
from previous biopsy sites is essentially unaffected (Cmielewski et aI., 1997). The success of 
the technique is dependent on the experience and technical skills of the operator, and with 
repeated biopsies the procedure can become more difficult as adhesions gradually develop at 
the site ofbiopsy. In this study, the overall perioperative mortality rate was significant at 
16.8% (13 deaths from 77 biopsy procedures). The high mortality rate may in part be ascribed 
to anaesthesia and surgery in the face of ongoing hepatotoxicity and chronic liver disease, 
since there was only one postoperative death recorded in the control group. However, there 
were wide variations in the perioperative mortality rates among the different treatment groups, 
and mortality rates in individual groups did not appear to reflect the perceived intensities of 
the treatment regimens. The large number ofbiopsy-related deaths in this study unfortunately 
limited the potential advantages over conventional sacrifice at predetermined time-points, and 
open liver biopsies were discontinued during the last two months of the study. 
The dysplastic hepatic nodules and bile duct lesions occurred in a setting of chronic 
hepatic fibrosis and regenerative nodules. Prolonged feeding with FBI resulted in a 
progressive increase in the cumulative scores for hepatic fibrosis in sequential biopsy 
specimens in all the treatment groups, apart from group 2, where the score appeared to level 
off after week 11. Nevertheless, established cirrhosis was found in only 1 biopsy specimen 
from group 1, three from group 3, and one from group 4. At post mortem examination, only 
one liver from group 1 was cirrhotic. It is possible that the maintenance dose of FBI 100 
mglkg was too low, and that a higher dose of FBI and/or a longer duration of treatment is 
required to produce cirrhosis in all animals. Although not specifically quantitated in this study, 
hepatic stellate cell proliferation appeared to subside rapidly after discontinuation of treatment 
25 weeks in all the groups. In a previous long-term FBI feeding study (50 mglkg diet), 
cirrhosis was seen in all animals that were sacrificed from 18 months onwards, but in no 
animals sacrificed before that time period (Gelderblom et al., 1991). 
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In order to study whether inhibition ofhepatocyte proliferation in the face of FBI-
induced liver injury enhances oval cell proliferation, animals in the present study were treated 
with different FB I feeding regimens alone and in the presence of the potent mitoinhibitor AAF. 
Although a treatment group fed with AAF alone for 2 weeks was not included in the present 
study, this regimen is reported to produce little cellular change (Sell and Dunsford, 1989). 
Indeed, cumulative oval cell scores appeared to indicate that rats which received FB I in the 
presence of AAF (groups 3 and 4) had a more sustained hepatic oval cell response, as opposed 
to rats were given FBI alone (groups 1 and 2). 
In order to determine the effect of AAF-induced mitoinhibition and oval cell 
proliferation on cancer induction, GST pi positive lesions and dysplastic nodules in the 
different groups were analysed in sequential liver biopsy specimens and in post mortem liver 
tissue. There were striking discrepancies between the cumulative scores for GST pi positive 
lesions and dysplastic nodules in biopsy specimens, indicating that these two histological 
features are not identical. The cumulative scores for GST pi ositive lesions were greater (in 
most instances by factor 2 or more) than those for dysplastic lesions in all treatment groups, 
indicating that only a proportion of 'enzyme-altered' lesions form dysplastic nodules. The 
slopes of the curves for GST pi positive lesions differed among the treatment groups, and 
presumably the curves with the steeper slopes (groups 1, 3 and 4) were the more 'toxic' ones. 
Cumulative scores for dysplastic lesions appeared to increase in a stepwise fashion in most 
treatment groups, and after week 15 the cumulative scores increased most rapidly in group 1, 
while there was a plateau effect in group 2. The slope of the curves for cumulative scores in 
liver biopsies for focal lesions relates to the chance of including lesions in the biopsy specimen, 
and depends on the number and size of the lesions, as well as sample variation. A linear 
increase in the cumulative score for a particular focal lesion may thus reflect either a change 
between biopsies or even a steady state, depending on sample variation. Likewise, a flattening 
out of the curve for a cumulative score could represent either a decrease in the number of 
focal lesions or else lesions being 'missed' in the biopsy. AAF-induced mitoinhibition 
appeared to increase the development ofGST pi positive lesions in both group 3 and 4, while 
the effect on the development of dysplastic nodules was noted only in group 4. Some caution 
is needed in interpreting these results, as the number of animals biopsied at each time point 
was small, and marked inter-animal variation for the different scores was found at the different 
time points. 
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Post mortem livers from animals that either died from non-operative causes or were 
culled at the end of the study were examined for GST pi positive lesions and dysplastic 
nodules. The extent of liver involvement by both of these 'preileoplastic' lesions was scored 
according to specially designed scoring systems. In addition, dysplastic lesions were classified 
into low-grade dysplasia, high-grade dysplasia, or well-differentiated HCC, based on a 
modification of the International Working Party (Wanless et al., 1995) criteria for the 
classification of human nodular liver lesions. The distinction between high-grade dysplasia and 
well-differentiated HCC may be difficult (Ferrell et al., 1993; International Working Party, 
1995), and additional criteria such as loss of reticulin staining or expression of AFP may be 
helpful in such cases. Reticulin staining was unsuccessful, possibly due to problems with 
fixation/storage of the liver specimens, and AFP protein could not be detected in the nodules, 
despite positive fetal rat liver controls (reason unclear). At post mortem, group 3 and 4 livers 
were most extensive1y involved by GST pi positive lesions, which suggested a potentiating 
effect on the development of these lesions by AAF-induced mitoin1n1>ition. These findings 
were reflected in the sequential liver biopsies, and it thus appears as if there was a good 
correlation between biopsy and post mortem findings for GST pi positive lesions. The highest 
scores for dysplastic nodules in post mortem livers were recorded in groups 1, 3, and 4, which 
also contained the most high-grade dysplastic lesions. These three groups also contained the 
highest cumulative scores for dysplastic nodules in sequential liver biopsies. Thus, there was a 
good correlation between the biopsy and post mortem findings for dysplastic nodules, and 
sampling error did not appear to be a problem. 
In order to study the effect of AAF-induced mitoin1n1>ition on the development of FBI-
induced bile duct lesions, the cumulative number of cholangiofibrotic lesions in th~ different 
treatment groups at the end of the liver biopsy procedures were analysed and compared. This 
method of analysis was employed because biopsy specimens at week 15 from two animals in 
group 3 that contained three cholangiofibrotic lesions each otherwise skewed the data 
presented as cumulative scores. Cholangiofibrotic lesions developed in all the treatment 
groups, but were particularly prominent in biopsies from group 3 livers. These lesions 
appeared as focal areas of bile duct proliferation, surrounded by desmin-positive hepatic 
stellate cell proliferation within dense fibrous tissue. It is likely that the proliferating stellate 
cells were responS11>le for the prominent fibrosis surrounding the bile ducts. AAF had a clear 
potentiating effect on the development FBI-induced cholangiofibrotic lesions, suggesting that 
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inhibition of hepatocyte proliferation and activation of the oval cell compartment may be 
important in the generation of these lesions. Post mortem livers were also examined for the 
presence of cholangiofibrotic lesions. Most post mortem cholangiofibrotic lesions were found 
in group 3 and 4 livers. There was thus a discrepancy between the post mortem and biopsy 
findings for cholangiofibrotic lesions, and the likely explanation is that potential sampling error 
becomes an important factor for isolated focal hepatic lesions. Some cholangiofibrotic lesions 
from group 1 (n = 1), group 3 (n = 4), and group 4 (n = 3) livers showed features of severe 
cytological atypia, and were considered to have progressed to intraductal cholangiocarcinoma. 
Dysplastic bile duct lesions within dense surrounding fibrous tissue were reminiscent of 
sclerosing cholangiocarcinoma in humans (Mac Sween and Scothome, 1985). 
This immunohistochemical study attempted to gain some insights into the role (if any) 
of proliferating oval cells in the genesis of'preneoplastic' hepatocellular lesions and bile duct 
lesions in the FBl-fed rat. A striking finding in all treatment groups was the intimate spatial 
relationship between proliferating oval cells, bile ductules, GST pi positive lesions/dysplastic 
nodules, and cholangiofibrotic lesions. Cells with the mOlphology of oval cells were noted 
inside GST pi positive foci/dysplastic nodules, and also within/adjacent to cholangiofibrotic 
lesions. Furthermore, particularly in group 3, columnar cell-lined cystic lesions were found 
inside some high-grade dysplastic nodules, and in other dyplastic lesions cells with the 
morphology ofhepatocytes appeared to be forming ductular structures. Many of these 
different liver cells expressed the OV -6 antigen, suggesting that all of these cell types may 
have a common cell of origin. In addition to proliferating oval cells, OV-6 was expressed by 
ductules within high-grade dysplastic nodules, bile ducts in cholangiofibrotic lesions, and 
columnar cells lining cystic lesions. Furthermore, some hepatocytes within nodules showed 
peripheral cytoplasmic staining for OV -6, and the antibody presumably detected cytokeratin 
filaments just below the hepatocyte plasma membranes. Observations from this and other 
immunophenotypic studies (Sell and Dunsford, 1989; Tee et al., 1996; Tian et al., 1997) 
suggest that these closely related cells that are all expressing OV-6 might be the progeny of a 
common 'liver stem cell'. There is now strong evidence that the 'oval cell compartment' in 
the liver contains a heterogeneous population of cells, based on both immunophenotypic (Tee 
et al., 1996) and ultrastructural characteristics (Sell, 1998). It is also postulated that increased 
proliferation of some/all of these putative pluripotential progenitor cells due to chronic FBl-
induced hepatotoxicity (Cohen and Ellwein, 1990) may underlie the risk of both the 
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hepatocellular and bile duct tumours that arise during prolonged feeding ofFB •. 
9.5. Conclusions 
Long-term feeding ofFB. in a normal diet resulted in oval cell proliferation with the formation 
of dysplastic hepatic nodules, dysplastic bile duct lesions, and a trabecu1ar/pseudoglandular 
HCC. AAF enhanced the effects ofFB. feeding, probably by blocking hepatocyte 
regeneration. Proliferating oval ('progenitor') cells may be the source of both the dysplastic 
nodules and bile duct lesions induced by FB.. This study supports the involvement of dietary 
FB. in hepatocarcinogenesis in male Fischer 344 rats. 
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Overview and future directions 
10.1. Fumonisin feeding studies in rats 
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For the present series of studies, male Fischer 344 rats were fed fumonisin BI (FBI) 250 mglkg in 
normal AIN-76A diet for 5 weeks, a dose known to cause severe hepatotoxicity and cancer 
induction (Gelderblom et ai., 1994), and this basic feeding regimen was modified in individual 
experiments. Although this basic regimen proved to be a very efficacious one, some difficuhies 
were experienced during the course of the individual feeding studies. Problems not anticipated at 
the time of design of the studies included the marked sensitivity of our rat strain to the 
gastrointestinal side-effects of oral iron loading and the high operative mortality rate in the 
animals undergoing open liver biopsies during chronic FBI feeding. Another problem was the 
high cost and short supply of FBI, mainly due to the slow and labour intensive methods required 
for its purification. Nevertheless, observations from the present studies have provided new 
insights into the cellular and molecular mechanisms of FBI-induced hepatocellular and bile duct 
tumours in the rat. Furthermore, th se studies come at a time of rapidly increasing interest in 
these carcinogenic mycotoxins in other countries, including the USA FBI was recently 
nominated by the Food and Drug Administration (FDA) Center for Food Safety and Applied 
Nutrition for study, because of its occurrence in maize and maize-based products in the United 
States, the toxicity of FBI in field exposure of horses and pigs, and the reports of carcinogenicity 
in rats (Howard et ai., 1999). 
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10.2. Cellular origin of liver tumours caused by fumonisin B. 
Agents may increase the risk of cancer by causing DNA damage (genotoxicity) and! or by causing 
increased proliferation (increased DNA replications) in a pluripotential cell population of the 
tissue (Cohen and Ellwein, 1990). To increase the number of DNA replications, an agent can 
either increase cell births (direct mitogenesis or toxicity and regenerative proliferation) and! or 
decrease cell deaths (inhibition ofapoptosis) (Cohen, 1998). There is currently little evidence for 
any genotoxic effects by FBI, and it is more likely that this strong cancer promoter increases the 
risk. of liver tumours by causing chronic hepatotoxicity and cellular proliferation. FBI appears to 
be a unique carcinogen which causes marked apoptosis together with regeneration ofhepatocytes 
and proliferation of oval cells (Lemmer et al., 1999b), putative precursor cells for liver tumours 
(Grisham and Thorgeirsson, 1997). 
To date, in vivo studies of liver carcinogenesis in rats during feeding of FBI have focused 
exclusively on the role of 'initiated' hepatocytes in the formation ofhepatocellular carcinomas via 
the hepatic foci/nodule sequence, according to the 'resistant hepatocyte' model (Solt and Farber, 
1976). In contrast, the role (if any) of oval cell proliferation during FBI-induced carcinogenesis 
has been ignored, and there have been no studies on the cellular origin of the bile duct tumours 
that are seen in this model of carcinogenesis. In this dissertation, the "bile duct hyperplasia" 
during FBI-induced hepatotoxicity is identified as proliferation ofOV-6 positive oval cells. 
Proliferating cells with the morphology of oval cells were found inside/adjacent to GST pi positive 
lesions, dysplastic nodules, and cholangiofibrotic lesions, suggesting that oval cells may be 
involved in FBI-induced hepato- and cholangiocarcinogenesis in the liver. Furthermore, the OV-6 
antigen was expressed by proliferating oval cells and bile ductules, hepatic nodules, 
cholangiofibrotic lesions, and cystic lesions, indicating that all of these cells may have a common 
('stem') cell of origin. While the present series of observations do not provide direct proof that 
oval cells are the source of the dysplastic nodules and hepatocellular carcinomas seen in FBI-fed 
rats, they add to the growing weight of evidence from other carcinogenesis models of such a 
concept. Furthermore, it is proposed that both the hepatocellular and bile duct tumours induced 
by FBI are derived from a common ('stem') cell of origin. 
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10.3. Isolation of liver progenitor cells 
Adequate data have been gathered that show that oval ('progenitor') cells exist in the rat and 
human liver, but their place of origin and their role in liver development, regeneration, and 
carcinogenesis remain enigmatic. Specific problems that still need to be addressed include (i) 
understanding the mechanisms involved in oval cell activation; (ii) developing a system to track 
these cells in vivo to determine their final fate in the liver; (iii) development of an in vitro system 
to understand differentiation mechanisms; and (iv) the possibility of being able to use these cells as 
a target for gene therapy. These questions and many other could be addressed if a reasonably 
pure population of progenitor cells could be routinely obtained, something that has been difficult 
to achieve in the past. It now appears that there may be a close relationship between the liver 
parenchyma and the haematopoietic system (Fujio et al., 1994; Blakolmer et al., 1995; Petersen et 
al., 1999; Baumann et al., 1999). This intriguing observation has led to the development of an 
immunoaffinity method for the enrichment from human fetal liver of 'progenitor' cells that co-
express CD34 haematopoietic stem cell and CAM 5.2 epithelial cell markers (Lemmer et ai., 
1998c; see Appendix D). Similarly, using Thy-l anttl>ody (another cell surface marker expressed 
by primitive haematopoietic stem cells) as a new marker for the identification of oval cells in 
combination with flow cytometry, Petersen et al. (1998a) were able to obtain a highly enriched 
population of 'progenitor' cells from rat livers treated with chemical carcinogens. Efforts are 
currently underway at our institution to isolate oval cells from FBI-treated rats with 
immunomagnetic beads for ex-vivo labelling and transplantation experiments (Dr. C. Vessey, 
personal communication). 
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carcinogenesis 
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The fumonisin mycotoxins are strong cancer promoters, and as such are predicted at a molecular 
level to cause deregulation of cell cycle control, resulting in aherations in the balance between 
cellular proliferation and apoptosis. Liver cells in vivo are impinged on both by growth inhibitors, 
such as transforming growth factor (TGF)-JH, and growth stimulators, such as hepatocyte growth 
factor (HGF) and TGF-a (Mills et al., 1995). When the effects of these two opposing types of 
growth factors balance, the cells remain in the resting phase (Go). In contrast, an imbalance in 
growth factor signals can either stimulate liver cells to enter the cell cycle, thereby causing cell 
proliferation, or induce cells to undergo apoptosis. Once in the cell cycle, further regulation of 
progression through the cycle occurs by cell cycle control factors (e.g. tumour suppressor genes, 
oncogenes, cyclins, cyclin dependent kinases), which exert their control independently from 
external influences and act on cell cycle restriction (R) checkpoints, such as GtiS. 
The molecular mechanisms underlying FBI-induced hepatotoxicity and carcinogenesis 
have not previously been studied. Northern blot (mRNA) analysis showed increased hepatic 
expression ofHGF, TGF-a, and especially TGF-JH and c-myc during short-term feeding of FBI. 
Overexpression of mature TGF-J31 by zone 1 and 2 hepatocytes may be responsible for the 
prominent pro-apoptotic effects of FBI in the liver. The proto-oncogene c-myc is a positive 
regulator of cell proliferation that is involved in tumour progression (Garte, 1993; Nagy et al., 
1988), and has also been implicated in TGF-J31 signalling (Alexandrow and Moses, 1995). 
Increased expression of c-myc and TGF-J31 may cooperate in the promotion ofliyer tumours 
during feeding of FBI, possibly by providing an environment that selects for the growth ofTGF-
J31 resistant transformed liver cells. Future immunohistochemical studies should include staining 
of liver specimens from FBI-fed rats for expression ofTGF-J3 type IT receptor (TJ3IIR) protein by 
preneoplastic/neoplastic lesions and surrounding liver tissue. 
Oncogenesis due to overexpression of both c-myc and TGF-a appear to involve 
disruption of the Rb/E2F pathway and deregulation of cell cycle control (Santoni-Rugiu et al., 
1998). Both c-myc and TGF-a contnoute to induction of cyclin Dl expression and resultant 
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inactivation of retinoblastoma (Rb) tumour suppressor protein, and c-myc may directly induce 
E2F (Santoni-Rugiu et al., 1998). Short-term feeding of FBI has recently been shown to cause 
overexpression of cyclin Dl in the nucleus (Ramljak et al., 1997). Increases have also been 
observed in FBI-treated liver samples ofcyclin dependent kinase 4 (cdk4) complexes with cyclin 
Dl, and consequently elevated cdk4 activity, as shown by increased phosphorylation ofRb (Dr. 
D. Ramljak, personal communication). Future studies in this field should be directed at 
unravelling the molecular events involved in the disruption of the Rb/E2F cell cycle control 
pathway by FBI. Specifically, the changes in cell signalling that transduce the epigenetic toxic 
effects of FBI on the cell membrane, such as disruption of sphingolipid (Merrill et al., 1996) or 
fatty acid (Gelderblom et al., 1999) metabolism, to the molecular events in the nucleus need to be 
elucidated. 
10.5. Fumonisins and human health 
Chronic liver disease, cirrhosis, hepatocellular carcinoma, exposure to mycotoxins, and dietary 
iron overload are important health problems in Africa. Although epidemiological studies have 
focused on the possible association between human exposure to fumonisins and oesophageal 
carcinoma, these carcinogenic mycotoxins might also be a risk factor for hepatocellular carcinoma 
in certain regions of the world where maize is the staple diet (Ueno et al., 1997). Well-conducted 
epidemiological studies are required to assess any association between dietary ingestion of FBI 
with human hepatocarcinogenesis in southern Africa, as well as possible interactions with known 
major risk factors (e.g. chronic hepatitis B virus infection, aflatoxin exposure) or minor risk 
factors (e.g. African siderosis) for human HCC. The ingestion of traditional maize-based 
alcoholic beverages that are brewed in iron pots or drums in certain regions of Africa (Bothwell 
and Bradlow, 1960) could potentially result in exposure to increased levels of FBI in the presence 
of dietary iron overload. Swprisingly, data from our study in rats indicates that dietary iron 
overload may in fact protect against the cancer promoting effects ofFB I, possibly due to a 
mitostimulatory effect on normal hepatocytes (Lemmer et al., 1999a). Thus, the interactions 
between FBI and iron appear to be complex and deserve further study. 
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10.6. Conclusions 
Feeding with FBl causes marked proliferation of oval cells in rat liver. Observations presented in 
this dissertation support the hypothesis that oval cells are the precursors of both the hepatocellular 
and bile duct tumours that are seen in this model of carcinogenesis. The FBl-fed rat is a 
promising model for the study of liver injury, oval ('progenitor') cell proliferation, and 
carcinogenesis. 
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Appendix A 
Summary of hepatic nodules and bile duct lesions 
found at post mortem in male F344 rats during 
prolonged feeding of fumonisin Bl 
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TABLE At Summary ofhepatic nodules and bile duct lesions seen at post A-2 
mortem in male F344 rats in the 25 week onl25 week off 
fumonisin B 1 feeding study 
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TABLE Al 
Summary ofhepatic nodules and bile duct lesions seen at post mortem in male F344 rats in the 25 
week onl25 week offfumonisin Bl feeding study (data presented in Chapter 9). Post mortem 
liver tissue was available from rats that either died from non-operative causes or were culled at 
the end of the study. 
Rat##- Group"· Week Dysplastic No. of GSTpi+ No.ofCF 
score nodules % {score} lesions 
47 1 23 2 H7 50 (2) 0 
51 2 24 0 1 (1) 0 
16 3 30 1 H2,L 30 (2) 1 
4 1 33 1 HI,L2 30 (2) 1 
13 2 35 0 1 (1) 0 
17 2 39 0 1 
31 2 39 0 1 (1) 0 
34 2 40 0 0 0 0 
40 3 42 2 H6 25 (2) 0 
22 1 48 0 5 (1) 9 (D9) 
42 3 49 1 ID 70 (3) 4 
4 1 50 (cull) 1 HI,L2 1 
18 1 50 (cull) 0 1 (1) 0 
20 1 50 (cull) 1 LI 30 (2) 0 
28 1 50 (cull) 4 H5 (HCC) 80 (4) 0 
29 1 50 (cull) 1 H2 5 (1) 0 
2 2 50 (cull) 1 LI 5 (1) 0 
5 2 50 (cull) 1 H2 10 (1) 0 
10 2 50 (cull) 1 LI 5 (1) 0 
11 2 50 (cull) 0 5 (1) 0 
8 3 50 (cull) 2 H2,LI 70 (3) 0 
14 3 50 (cull) 2 H4, LI 50 (2) 1 
24 3 50 (cull) 1 HI 40 (2) 0 
25 3 50 (cull) 1 H4 45 (2) 7 (D7) 
30 3 50 (cull) 2 H5,L5 70 (3) 2 
35 3 50 (cull) 2 ID.L2 45 (2) 2 (DI) 
46 3 50 (cull) 2 H4 70 (3) 2 
54 3 50 ~culll 0 2 ~Il 0 
H = high-grade dysplasia; L = low-grade dysplasia; CF lesion = cholangiofibrotic lesion; 
D = dysplastic ductal lesion 
aThe data has been sorted according to timing of death and group. 
hGrOUp 1 (FB11FB1); Group 2 (FBl/AIN); Group 3 (FBl/AAFIFB 1); Group 4 (FBl/AAF/AIN); 
Group 5 (AIN control). 
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TABLE At !Continued} 
Rat # Group'" Week Dysplastic No. of GSTpi+ No.ofCF 
score nodules % (score) lesions 
1 4 50 (cull) 1 HI 40 (2) 5 (D2) 
15 4 50 (cull) 0 30 (2) 2 
37 4 50 (cull) 0 10 (1) 0 
38 4 50 (cull) 0 0 
39 4 50 (cull) 1 HI 30 (2) 1 (DI) 
48 4 50 (cull) 1 LI 2 (1) 0 
49 4 50 (cull) 1 H2 40 (2) 4 
50 4 50 (cull) 1 LI 20 (1) 0 
53 4 50 (cull) 0 5 (1) 1 (DI) 
3 control 50 (cull) 0 1 (1) 0 
7 control 50 (cull) 0 1 (10 0 
19 control 50 (cull) 0 0(0) 0 
26 control 50 !culll 0 o !O} 0 
H = high-grade dysplasia; L = low-grade dysplasia; CF lesion = cholangiofibrotic lesion; 
D = dysplastic ductal lesion 
aThe data has been sorted according to timing of death and group. 
hGrOUp 1 (FBtlFB1); Group 2 (FBI/AIN); Group 3 (FBtlAAFIFB1); Group 4 (FBI/AAF/AIN); 
Group 5 (AIN control). 
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AppendixB 
Summary of long-term fumonisin Bl feeding studies in 
rats and mice 
Page 
TABLE Bl Summary of the pathologic changes in the livers of male BD-IX B-2 
rats given a diet containing 50 ppm fumonisin Bl in the South 
African Programme of My co toxins and Experimental 
Carcinogenesis (PROMEC) 26 month feeding study 
TABLE B2 Summary of the United States National Toxicology Program B-3 
(NTP) 2 year carcinogenesis fumonisin Bl feeding studies in 
F3441N rats and B6C3F 1 mice 
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TABLEDl 
Summary of the pathologic changes in the livers of male BD-IX rats given a diet containing 50 ppm3 
fumonisin Bl in the South African Programme of My co toxins and Experimental Carcinogenesis 
(PROMEC) 26 month feeding study (data presented in Gelderblom et al., 1991) 
Duration Bodyweigbt Liver weigbt Regenerative Cbolangio- Cirrbosis 
(months) gain (g) (% body weigbt) nodules fibrosis 
6 montbs 
Controlb 381.6 ± 25 4 NO 0/5 0/5 
50 ppm FBI 330.2 ± 14.5 NO 5/5 4/5 
12montbs 
Control 434.0± 60.6 NO 0/5 0/5 
50 ppm FBI 353.0 ± 18.4 NO 5/5 5/5 
20 months 
Control 482.2± 53.7 2.6 ± 0.3 0/5 0/5 
50 ppm FBI 404.2± 24.5 4.2 ± 0.3 5/5 5/5 
26 montbs 
Control 618.4 ± 56.8 2.3 ± 0.2 0/5 0/5 
50 ppm FBI 454.8 ± 88.8 8.6 ± 3.4 5/5 5/5 
18 - 25 months 
Control NO NO 0/5 0/5 
50ppmFBIc NO NO 5/5 5/5 
FBI = fumonisin B1; HCC = hepatocellular carcinoma; ppm = parts per million; NO = not determined 
81 ppm is equivalent to 1 mg/kg diet 
"The control feed was found to contain 0.5 ppm FBI and 0 ppm aflatoxin B!, and was marginally deficient in some 
nutritional components (see Appendix C). 
'These animals died during the 18 to 25 month period. 
0/5 
0/5 
0/5 
0/5 
0/5 
5/5 
0/5 
5/5 
0/5 
5/5 
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TABLEB2 
Summary of the United States National Toxicology Program (NTP) 2 year carcinogenesis fumonisin 
Bl feeding studies in F344IN rats and B6C3F1 mice (data presented in Howard et al., 1999) 
Male Female Male Female 
F3441N rats F3441N rats B6C3F1 mice B6C3F1 mice 
Concentration 0, 5, 15, 50, or 150 0, 5, 15, 50, or 150 0,5, 15, 50, or 150 0, 5, 15, 50, or 150 
in feed ppm ppm ppm ppm 
Body weights Exposed groups Exposed groups Exposed groups Exposed groups 
similar to controls similar to controls similar to controls similar to controls 
Survival rates 16/48,17/40,25/48, 25/48, 22/40, 24/48, 41148,39/48,45/48, 35/48, 44148, 46/48, 
18/48,25/48 30/48, 29/48 37/48,42/48 39/48, 28/48 
Nonneoplastic Kidney: renal tubule None Liver: hepatocellular Liver: hepatocellular 
effects epithelial hyperplasia, hypertrophy (10/47, hypertrophy (0/47, 
focal (2/48, 1140, 4/48, 9/47,24/48,25/48, 0/48,27/47,31/45); 
14/48,8/48) 30/48) hepatocellular 
apoptosis 
(0/47,0/48,0/48, 7/47, 
14/45) 
Neoplastic effects Kidney: renal tubule None None Liver: hepatocellular 
adenoma (0/48, 0140, adenoma (5/47, 3148, 
0/48, 2148, 5/48); renal 1148, 16/47,31145); 
tubule carcinoma hepatocellular 
(0/48,0/40,0/48, 7/48, carcinoma (0/47,0/48, 
10/48); renal tubule 0/48, 10/47,9/45); 
adenoma or carcinoma he~ocellular 
(0/48, 0140, 0/48, 9/48, adenoma or carcinoma 
15/48) (5/47,3/48, 1148, 
19/47,39/45) 
Level of evidence Clear evidence No evidence No evidence Clear evidence 
of carcinogenic 
activity 
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Dietary compositions of feeds used in fumonisin Bl 
feeding studies 
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TABLE Cl Comparison of dietary composition of AIN-76A diet with semi- C-2 
purified diet used in short-term and long-term fumonisin Bl 
feeding studies 
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TABLECI 
Comparison of dietary composition of AIN-76A diet with semi-purified diet used in short-term 
and long-term fumonisin Bl feeding studies 
AIN-76A 
PROTEIN (g/kg) 214.3 
Soy protein 
Casein 200 
Egg albumin 
Methionine 3 
CHO (g/kg) 605.1 
Com starch 150 
Sucrose 500 
Glucose 
Dextrin 
FAT (g/kg) 46.4 
Saturated 5.9 
MUFA 9.0 
PUFA 29.3 
Sunflower seed oil 44 
ENERGY 
kcal 3639 
kJ 15235 
FIBRE (g/kg) 54.8 
SEMI-
PURIFIED 
94 
30 
10 
10 
0.5 
659.1 
750 
111.25 
54.3 
47.6 
6.33 
11.7 
27.0 
30 
3448 
14426 
37.2 
AIN-76A 
VITAMINS· 
Thiamine (mg) 6 
Riboflavin (mg) 6 
Nicotinic acid (mg) 30 
Vitamin B6 (mg) 7 
Folate (mg) 2 
Vitamin B12 (J.1g) 10 
Pantothene (mg) 16 
Biotin (mg) 0.2 
Vitamin A (IV) 66000 
Vitamin D (IV) 1000 
Vitamin E (mg) 80 
Vitamin K (mg) 5 
MINERALSb 
Calcium 5122.5 
Iron 50.6 
Magnesium 514.5 
Phosphate 4059 
Potassium 3707 
Sodium 1083 
Zinc 44.9 
Copper 5.7 
SEMI-
PURIFIED 
3.9 
3.55 
32 
0.6 
0.5 
8· 
3 
0.1 
55567 
250 
41.33 
0.25 
515 
17.3 
488 
1133 
2307 
1028 
20.8 
Abbreviations: CHO = carbohydrate. MUF A = monounsaturated fatty acids. PUF A = polyunsaturated fatty acids. 
amglkg or units/kg 
bmglkg 
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AppendixD 
Isolation from human fetal liver of cells 
co-expressing CD34 haematopoietic stem cell and 
CAM 5.2 pancytokeratin markers 
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Isolation from human fetal liver of cells co-expressing CD34 
haematopoietic stem cell and CAM 5.2 pancytokeratin markers 
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Background! Aims: Ductal plate and bile duct cells in 
developing human liver express haematopoietic stem 
cell markers, such as c-kit and CD34, in association 
with cytokeratin markers CAM 5.2 and CK 18. The 
identification of such ductal plate cells as likely pro-
genitors for both bile duct epithelial cells and hepato-
cytes and their possible reappearance as oval cells in 
the regenerating liver have generated much interest in 
their pluripotential capacities. This study aimed to 
isolate cells from human fetal liver that co-express 
haematopoietic stem cell and epithelial cell markers. 
Methods: Human fetal liver was harvested following 
legal termination of pregnancy at week 14-22. 
CD34+ mononuclear cells were isolated from liver 
cell suspensions with immunomagnetic beads. Im-
munofluorescent staining, using anticytokeratin CAM 
5.2 against CK 8 and 18, was performed on permea-
bilised CD34+ cells for flow cytometry and fluor-
escent microscopy. CD34+ cells were also stained for 
other stem cell markers (HLA-DR, c-kit) and com-
mitted haematopoietic cell markers (CD33, CD38). 
T HE HUMAN liver is derived from an endodermal outgrowth of the primitive foregut into the mes-
enchyme of the septum transversum at around the 
third and fourth weeks of gestation (l). In both rat and 
man, the two major types of hepatic epithelial cells, 
hepatocytes and bile duct cells, arise from the primitive 
hepatoblast, a progenitor cell that has pluripotential 
differentiation capabilities (2,3). The hepatoblasts that 
surround the portal mesenchyme condense to form a 
double-layered cylinder of cells, the ductal plate, which 
remodels and migrates into the mesenchyme to form 
Received 8 January; accepted 8 March 1998 
Correspondence: Enid G. Shephard, MRC/uCT Liver Re-
search Centre, K47 OMB, Groote Schuur Hospital, Ob-
servatory, Cape, 7925. South Mrica. Fax: +27 (21) 448-
6815. e-mail: enid@liver.uct.ac.za. 
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Results: Approximately 0.9% (range 0.07-4.0%) of 
the mononuclear cells isolated were CD34+ cells. The 
number of mononuclear cells isolated correlated with 
fetal liver weight (r=0.508). About 3-8% of these 
CD34+ cells stained positively for CAM 5.2. In ad-
dition, CD34+ cells were positive for HLA-DR, but 
only a small percentage was positive for c-kit. Stain-
ing for the committed haematological markers, CD33 
and CD38, was consistently negative. 
Conclusions: This study describes an immunoaffinity 
method for the enrichment from human fetal liver of 
cells that co-express haematopoietic stem cell and 
epithelial cell markers. Such cellular subsets may 
correspond to pluripotential ductal plate and bile 
duct cells. 
Key words: Anticytokeratin CAM 5.2; Bile duct cells; 
CD34+ haematopoietic stem cells; Ductal plate cells; 
Human fetal liver. 
intrahepatic ducts (4,5). These cells initially express the 
hepatocyte-specific proteins a-fetoprotein (AFP) and 
albumin as they migrate into the portal stroma, and 
additionally begin to express the bile duct-specific 
marker y-glutamyl transpeptidase (GGT). Initially iIi-
termediate filament expression is restricted to cytoker-
atin 8, but during the later stages of ductular morpho-
genesis, the ductal cells begin to express the character-
istic biliary cytokeratins 7, 8, 18, and 19 (6). These dif-
ferentiated ductal cells continue to express hepatocyte 
traits during the early neonatal period (7). In contrast, 
hepatoblasts not in contact with the portal mesen-
chyme differentiate into hepatocytes that form the liver 
cell plates. The hepatocyte intermediate filament ex-
pression is restricted to cytokeratin 8 and 18, but these 
cells continue to express GGT until birth (4). 
The fetal liver becomes the main site of haema-
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topoiesis by the 12th to 16th week of gestation (8). 
Haematopoietic cells of the fetalliver are derived from 
stem cells that migrate from the yolk sac prior to the 
15th week (9,10). Erythropoiesis is established first, 
followed by myelopoiesis, and further migration of 
cells ensues to populate the spleen and bone marrow 
(11). Ultimately, as bone marrow haematopoiesis is es-
tablished, the role of the fetal liver is diminished (8). 
Our group has recently shown that in developing hu-
man liver haematopoietic stem cell markers CD34 and 
c-kit are co-expressed in ductal plate cells in a pattern 
similar to the early cytokeratin markers CAM 5.2 and 
CK18 (12). Similarities appear to exist between hepatic 
and bile duct precursors and bone marrow stem cells 
with respect to the expression of prototypic early 
marker, viz. the presence of stem cell factor (SCF) and 
the specific receptor c-kit have been demonstrated in 
both embryonic and adult rat liver (13). This signalling 
system appears to be uniquely associated with the early 
activation of hepatic stem (oval) cells (14,15). Con-
versely, hepatocyte growth factor (HGF) appears to 
have a synergistic effect on the proliferation of CD34+ 
haematopoietic progenitor cells isolated from human 
cord blood, that express the c-met receptor (16,17). 
Hepatoblasts in the developing human liver, that may 
be in paracrine communication with haematopoietic 
cells, could thus have a closer relationship with the 
haematopoietic system than hitherto suspected (5). 
This study reports on the isolation from human fetal 
liver of cells that we can show co-express stem cell and 
epithelial cell markers. Our techniques are based on 
methods for positive immunomagnetic selection of 
CD34+ haematopoietic stem cells from bone marrow 
(18,19) and fetal liver (20), and were highly reproduc-
ible. This procedure has the potential to generate suf-
ficient quantities of precursor cells and hence develop 
techniques of cellular transplantatio . 
Materials and Methods 
Tissues 
Human fetal livers were obtained from legal termin-
ation of pregnancy at week 14- 22. The fetal livers were 
obtained after termination had been performed by in-
duction of labour using intravaginal prostaglandin 
E2a. All patients gave written informed consent and 
had no known family history of an inherited condition. 
The research team were not involved in the clinical de-
cision to terminate the pregnancy. Authority to obtain 
fetal tissue was granted by the Department of National 
Health and Population Development, South Africa, 
according to the Human Tissue Act, 1983 (Act 65 of 
1983), as amended by the Human Tissue Amendment 
Act, 1989 (Act 51 of 1989). The study was approved 
Isolation of CD34 and CAM 5.2 
by the Ethics Committee of the Faculty of Medicine of 
the University of Cape Town. 
Preparation of cell suspensions 
Liver cell suspensions were obtained in Hepes isolation 
buffer pH 7.4 (Hepes 20 mM, CaCl2 . 2H20 1.2 mM, 
NaCl 140 mM, KCl 4 mM, D-glucose 5 mM, 
MgCh . 6H20), Na2HP04 0.5 mM) by thorough for-
ceps disruption of the fresh fetal liver specimen. The 
liver suspension was then dissociated by adding col-
lagenase 0.1 % final concentration (Sigma Chemical 
Co., St. Louis, MO, USA) and incubating for 10 min 
at 37°C. The reaction was stopped by adding an equal 
volume of fetal calf serum (FCS, Gibco Laboratories, 
Grand Island, NY, USA), and the suspension was fil-
tered through a very fine Swiss silk filter. The cell fil-
trate was subjected to Ficoll (Histopaque®, Sigma 
Diagnostics, St. Louis, MO, USA) density gradient 
centrifugation for 20 min at 800 g. Mononuclear cells 
were collected from the interface, and these cells were 
washed with Hepes isolation buffer and then citrate 
buffer (phosphate-buffered saline, 0.6% citrate, 2% bo-
vine serum albumin). Aliquots of the cell suspension 
were counted and assessed for viability, using the try-
pan blue exclusion technique. 
Isolation of CD34 + stem cells 
CD34+ mononuclear cells in citrate buffer were separ-
ated with Dynabeads® M-4S0 CD34 immunomagnetic 
beads (Dynal, Oslo, Norway), according to the manu-
facturer's instructions, using a bead concentration of 
40x 106/ml and a cell concentration of 25-S0x 106/ml. 
Briefly, the cell bead suspension was mixed in a U-bot-
tomed tube, and incubated for 30 min at 4°C with 
gentle tilt rotation, using the Dynal sample mixer (Dy-
nal, Oslo, Norway), to allow rosettes to form. The tube 
was exposed to the magnet, and the non-rosetted cells 
were aspirated and discarded. Cells were detached from 
the beads by incubation with polyclonal anti-murine 
Fab Detachabead® CD34 (Dynal, Oslo, Norway) 100 
III per 40X 106 beads for 45 min at, room temperature 
and gentle tilt rotation. The detached cells were washed 
twice in citrate buffer and counted, and viability was 
checked using the trypan blue exclusion method. 
Flow cytometry and fluorescent microscopy 
Characterization of the CD34+ cell suspensions was 
performed using a Coulter Epics-Profile II flow cyto-
meter (Coulter Electronics, Hialeah, FL, USA). Mor-
phology of the cells was assessed by immunofluore-
scent microscopy on cytospin preparations. Intracyto-
plasmic cytokeratin 8 and 18 was detected by indirect 
immunofluorescent staining, after permeabilization of 
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TABLE 1 
Details of fetal weight, liver weight, gestational age, mononuclear cells 
and CD34+ cells isolated in 17 successful experiments. Approximate-
ly 0.9% of the mononuclear cells isolated were CD34+ cells. The 
number of mononuclear cells isolated correlated with fetal liver 
weight (r=0.508) 
Fetal wt Liver wt Gestation Mono cells CD34+ 
(g) (g) (weeks) (million) (million) 
I 120 8.2 15 920 8.6 
2 400 17.9 16 1760 11.2 
3 480 26 21 1640 1.2 
4 200 7.8 20 350 1.6 
5 250 13.9 19 552 1.2 
6 100 4.6 14 440 1.2 
7 280 13.6 19 270 11.2 
8 390 19.9 16 1108 1.3 
9 500 18.3 22 2880 4.5 
10 110 4.9 15 270 2 
II 200 11.6 20 710 6.4 
12 200 8.2 15 408 6.4 
13 120 4.4 14 363 1.8 
14 660 12.2 18 680 5.4 
15. 110 4.5 16 520 2.6 
16 400 12.4 18 780 5.8 
17 350 25.5 20 296 6 
the cells with methanol, using mouse monoclonal anti-
human cytokeratin CAM 5.2 (Becton Dickenson, San 
Jose, CA, USA) and fluorescein isothiocyanate 
(FITC}-conjugated goat anti-mouse antibody (DAKO, 
Copenhagen, Denmark). Using direct immunofluore-
scent staining with FITC, cells were also analysed for 
stem cell markers HLA-DR (clone C243, Becton Dick-
enson, San Jose, CA, USA) and c-kit (Immunotech, 
Marseille Cedex, France), with other indicators of 
haematologic lymphoid and myeloid lineage specificity, 
CD38 (Leu ITM_17, Becton Dickinson, San Jose, CA, 
USA) and CD33 (MY9, Coulter Immunology, Hiale-
ah, FL, USA). 
Statistics 
The correlation between fetal weight, liver weight, ges-
tational age, mononuclear cells and CD34+ cells was 
calculated by Pearson's correlation coefficient, using 
Statgraphics® software. 
Results 
Tissue collection and isolation of stem cells 
The data from 17 successful experiments are shown in 
Table 1. Gestational ages ranged from 14-22 weeks, 
fetal weight ranged from 110-660 g, and liver weight 
ranged from 4.4-25.5 g. The total number of mono-
nuclear cells isolated ranged from 270-2880 x 106, and 
the number of CD34+ cells isolated with immunomag-
netic beads ranged from 1.2-11.2x 106. Approximately 
0.9% (range 0.07-4.0%) of the mononuclear cells iso-
452 
lated were CD34+ cells. Pearson's correlation coef-
ficient was used to test any correlation between the 
variables fetal weight, liver weight, gestational age, 
number of mononuclear cells and CD34+ cells. The 
number of mononuclear cells isolated correlated with 
liver weight (r=0.508). There was, however, no corre-
lation between the number of CD34+ cells isolated 
and any of the other variables examined. 
Flow cytometry and immunofluorescent. microscopy 
Characterization of the CD34+ cells by flow cytome-
try revealed that about 3-8% of these cells showed in-
tense immunofluorescence for CAM 5.2 (Fig. 1). This 
was confirmed with immunofluorescent microscopy on 
the CD34+ cell suspensions, which demonstrated oc-
casional cells with bright intracytoplasmic fluorescence 
(Fig. 2). In addition, most CD34+ cells showed fluor-
escence for HLA-DR (Fig. 3), but only occasional cells 
stained positive for c-kit. Staining for the committed 
lymphoid and myeloid haematological markers, CD38 
and CD33, was consistently negative. 
Discussion 
Currently the most widely used technique for separat-
ing early haematopoietic progenitor cells has been 
based on immunoaffinity techniques (19). Once 
labelled with antibody, cells can be separated using a 
range of methods, including solid phase immunolog-
ical methods, immunomagnetic particles or flow cyto-
metry. The characterisation of the CD34 antigen, 
which is expressed on only 0.5-5% of human bone 
marrow cells, has been central to the development of 
this approach for use on clinical samples (21). CD34 is 
expressed on early progenitor cells but not on their 
I 
I 
" I~ 
, .... \ 
Fig. 1. Single parameter histogram following immuno-
fluorescent staining of CD34 + cells isolatedfromfetalliver 
with monoclonal antihuman cytokeratin CAM 5.2. A small 
percentage (about 6.7%) of the cells shows intense fluor-
escence following immunostaining with CAM 5.2 (arrow). 
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"-Ir! :: Imml/ll"'''II'f!',~n'lI/ m/(rlHn'pr vi CD}'I+ 1110110-
Iwdcr/1 ,r{fl /.w/n/c'd ./rOIll "",mill ./Ntli / in'r. IIIOU IIIg i'l -
I<'IIW illlfflf\'lup/Oolllif slIIiniflC uf 1/ sing/,> rt!1I jor e/I! 
5.2. COllllt"'St'lIl/lII.~ "'iil, ('I/udilllll "JVI/lld(' dt'J//(lJI,I/rotn 
Ih" lIudcl "f'he CfH.f+ (1'11.1 (OIIlmg"/, 
"-1{< J 11111111111011,1<"1 'Iml mi. ,'uwuP.I' 01 CDJ.f+ mono-
lIudcor ('(,/1, iwMI,>d jrom IlIImll/, {i.'lIIl In,,'r, "/(1l1"lIIg illl-
IlIIlImn'lIni!'i'.!" ror lit/-OR (ltllK( }:rr"'!'l'"ffm. '!{lUlc,1 
,cllI'!, C"'mll' .... '(llIllllg (,-iIJr cIIIIJiwlIl,rolllllf" ""!twlI'twlel 
11,(, (ell'lluI" 111/('/<'1 ,-- m'wu,:,' J. ,/ I:(XI', i:,I/<'-I "l rnidutll imrnulI-
url/aXIlt!lir /1('<'1I1, (-"'111/1, I',J/II1J, grl'<'II hudieSI (Ife imcr-
mll/gled Inlfl CDN t 0://1 
more mature <.:oUn\efpan., C!2), and there ,Ire nOI\ IllI-
merous commercl,'Uy ;\\;jil;\hle antlh,xlies and devices 
for sep;\f,tting CDJ4+ .;ells from hone Ilw.rro\\- and 
..:yt'')\..lnc·muhili,eJ pcnph.::ral h loW pwgenltol and 
~tem u:lb. I'or resc;lll:h pur roses rar;I!\l"gnctic hcad~ 
Ihal can t-le dtreclly conlugaled 10 .Inl ib<xh h,I\C been 
""jdcl) u..;:;d f IR2,l.~4). Cclls !;lbdkd "" Ith CDU--.- con-
IIIg;JteJ beaJ~ C;III b<' t!,l'>i l ~ "qXH.lh:d I'r(>m unl.lhdled 
..:elh 1I"lIg J m.lgn<!l Aflcr""dlh Ihc i-;;.)I;)lOO ..:dh an:: 
ddJ('hed fmOl Ihe bC"Jd~ ""ilb t J'I>hdoTl;l1 alllibod~ 
,lgaill~1 murine F:lb fr:lgmcnt-. R~-":"lItl~ 11m. tedillique 
has also hccn utilised t~) I'>OLl t\: I'U\;uilc progenitor en-
""/«""'1 .. I ('{) /,1, III/ ( .1 If \" ~ 
.:!othelial cells. tit:!! arc I.nO"1L \u e\pr,-'~> CD34 125.26). 
from the lcul..,~c.'te fr;lctiOlh of htll.lan J-'I-'riplwral 
blood (27), 
"''e h;l~e ;llbrt ... J thiS tedlJltquc for lhe I:>olation 
from hum;J11 klal hler of r.:dh II hi..:11 lIe ~ho\\ to co--
c,prc><l> h,le~M:opOI!:tl~ \1t!1ll \.'\:11 ,HIJ Cpdlelt,,1 cell 
m:,Hkns. hJ-.ed on rUrlJi..:it~iOlI \\uh (,(),4+ magnetic 
h...--ads and ::h,u:lCieri/alloll ,,,,It ( \ \1 ~ 2 illlll..:\to\..er-
<t1!1l ant;',)ooy. l-el,11 hum;Hl \ih~h tWill )<XonJ In-
rnc~ter ler:llinalil\n~ \If pregn.t:1c) I\ere utili...cd in order 
to Isolate ~utft<.:lent n\llllher_ of CD,ol + ,tem l:eJ1~ The 
P;I(I(lt)' 01 cc:J~ (~'·e\pr~~IIl->! 'kill cell and epltheti,tl 
(ell markel' pr(llidc, i! Ir,;ljllf Lhallenge 10 lhell iM'>-
)iltion ,md .:h;trJCh:nS:l.tion. 111 lhl~ stud) o1l1~ 0,07 
4.0' or the mononuclc.n cells Isolated "ere CDJ4 
n:lb. ;\l1d finly ,tbUUl 3 jo)"." of Ihese (0,4+ ee1b 
stamed fur (A'\'I 5:!, We attempled te> identify vari-
ables that \~uuld predict lh(' YldJ of CDJ4+ celb from 
felalliver, Allhvugh the JlUI1It>er ot nWI1f1llude.tr celb 
i~olated correlated Wltlt retalliver \Ieight, there wa~ no 
correhl\iu:l b.:lllccn the numb<'r of (1),4+ cells i~o­
laled and any of the other V,lfl;jhle~ C\oIll1ineJ 
Althougr. tiles.: CDJ4 eclb \Lailled for HLA-DR 
C) I. they d,J 1101 uprear (,) rep~~llt true stem eelh ill 
that Ihey "ere clear!) .\I rc:ld~ eo11lllli!leJ 11) an CPI-
thel ial cdl hneJ.~. ill> e\i(knecJ h~ their ullen,;: stain-
ing for CAM :-.2 In ';Ol\lr;ll>I, Ihe "h,.:nce of ,l<lining 
for CDn .mJ CDJ"l S\;ggcslcJ Ihal then; lias no com-
I'lilmenl of til.: CDJ4 ... progenitor ..:ell:. 10 either the 
myeloid or I>mphotd lineage C!tI) 1'11" 111;\) rellet.:1 lhe 
dedine in lh:: r"k (If the fl:!la\ hler as ,I tucmatojl<.\ietie 
organ 'l~ler .... eek 10 of ge,I'lll,lTI r\ ~urrn")1lg finJing 
.... ,b the dltTl<.:uhy m (.lcmon:.l(;lIing e-\..II. the receptor 
for SCF which i~ e\rfe,~eu h~ progenitor cells III hu-
miln fet;llli\'er (I~) ~lIld oval cell, m rat livcr (I 'I. albeit 
at 1o\\- k"d.~. Sunilar pluhk~m, havc been reponed dur-
ing the isolation of progcnilo! l-ell, trom rat li\er. and 
mdY rchlle to mterfcrencc I\ilh Ihe c·kil receptor b) 
the CD34 lahelled immunomagnelie heads (Dr R. 
Padlll<lll;lbhllll pers~'I1JI eommunicatlon). 
Conclusiun 
We repon a tcdllllr,lUC [or the i~ol,ttion from human 
f('tal liver or cdl~ Il1<1t c(l-e~pre" CD34 ,Iem <.:cll and 
CA/ll 5.2 pill1c)'tl)kcmtin Ill.trkcr\, h;ls.-::d on immu-
noaffillit) isolation mcthoJ~ lUI' haell,;! topolelle stem 
cdb It j, p.:r.;s:hlc lhat ~IllC of thco;e ,--ell~ correspond 
to the plur:potc:lIial dJclal plale <JIlJ bile duel cells 
Identified 1:1 ,'ur pre\ tOllS inllnUllllh"tochemieal slud;. 
Th::. :.ttld~ cC'nfirm, Ihe do..e rel'lIIflllShlr bell\ecn epl' 
lhd.al ;Ill,' luen1<l1~)poictic cdh in Ih~ deh-:lopmg hu-
tn.tn lI1.-er\i:huu,;:h h,er ,lIld h.lcmulologiL.11 prot,>e!1'-
IOf (dh ha"e ot dilT~'rcnl c:llhryoll)~lc:tJ JeTl\:ttwn {e..:-
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toderm vs. mesoderm), it IS conceivable that these 
primitive cells may share phenotypic markers and 
growth factor receptors during embryogenesis. 
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AppendixE 
Comparison of carcinogenic effects of fumonisin Bl 
and aflatoxin Bl 
Page 
TABLE El Comparison of chemical characteristics and toxic/carcinogenic £-2 
effects offumonisin BI and aflatoxin BI 
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